1hiv Aids Surveillance Report Europe 2013

SURVEILLANCE REPORT
HIV/AIDS surveillance in Europe
2013
www.ecdc.europa.eu
www.euro.who.int
HIV/AIDS surveillance in Europe
2013
HIV/AIDS surveillance in Europe 2013
Suggested citation for full report:

European Centre for Disease Prevention and Control/
WHO Regional Office for Europe. HIV/AIDS surveillance
in Europe 2013. Stockholm: European Centre for
Disease Prevention and Control; 2014.
Tables and figures should be referenced:
European Centre for Disease Prevention and Control/
WHO Regional Office for Europe. HIV/AIDS surveillance
in Europe 2013.
This publication follows the ECDC terminological practice which reflects the European Union Interinstitutional
Style Guide with regard to names and designations of
countries. The names and designations of countries
used in this publication should not be understood as an
endorsement by WHO of the terminology used in this
publication.
The maps are reproduced with the permission of the
WHO Regional Office for Europe. The designations
employed and the presentation of this material do not
imply the expression of any opinion whatsoever on the
part of the Secretariat of the World Health Organization
concerning the legal status of any country, territory,
city or area or of its authorities, or concerning the
delimitation of its frontiers and boundaries.
WHO keywords:
ACQUIRED IMMUNODEFICIENCY SYNDROME
EPIDEMIOLOGY
AIDS AND ITS CONTROL
DISEASE OUTBREAKS STATISTICS
HIV INFECTIONS EPIDEMIOLOGY
POPULATION SURVEILLANCE
The WHO Regional Office for Europe is responsible for the accuracy of the translation of the Russian summary.
World Health Organization, 2014.
Cover picture Stockxpert
ISBN 978-92-9193-608-3
ISSN 2363-3085
doi 10.2900/42271
Catalogue number TQ-AL-14-001-EN-N
European Centre for Disease Prevention and Control, 2014.
Reproduction is authorised, provided the source is
acknowledged.
ii
SURVEILLANCE REPORT
The European Centre for Disease Prevention and

Control (ECDC) and the WHO Regional Office for Europe
would like to thank the nominated national operational
contact points for HIV/AIDS surveillance from EU/EEA
Member States and the national HIV/AIDS surveillance
focal points from other countries of the WHO European
Region for providing data and valuable comments on
this report.
The report was coordinated by Anastasia Pharris (ECDC)
and Annemarie Stengaard (WHO Regional Office for
Europe). Report review and production support were
provided by Andrew J. Amato-Gauci, Martin Donoghoe,
Nedret Emiroglu, Guenael Rodier, Valentina Lazdina,
Mike Catchpole, Julien Beaut, Marc Rondy, Phillip
Zucs.
SURVEILLANCE REPORT
Contents
Overview of HIV and AIDS in Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .vii
European Union and European Economic Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .vii
WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . viii
Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . x
/ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .xiii
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .xiii
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xvi
Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xix
1 HIV and AIDS in the European Union and European Economic Area. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1.1 HIV diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1

1.2 Trends in HIV diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.3 AIDS cases, morbidity and mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.4 Conclusions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2 HIV and AIDS in the WHO European Region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9

2.1 HIV and AIDS diagnoses in the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.2 HIV and AIDS diagnoses in the East . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.3 HIV and AIDS diagnoses in the Centre. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.4 HIV and AIDS diagnoses in the West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2.5 Number of HIV tests performed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.6 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Tables
TableA: Characteristics of HIV diagnoses reported in the WHO European Region, the EU/EEA, and by geographical area, 2013 . . . . . . . . . . . . . . . . . . . .vii
Table1: HIV diagnoses and rates per 100 000 population, by country and year of diagnosis (20042013) and cumulative totals, in EU/
EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Table1a: HIV diagnoses and rates per 100 000 population, by country and year of statistics (20042013) and cumulative totals, in EU/
EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Table2: HIV diagnoses in males and rates per 100 000 population, by country and year of diagnosis (20042013) and cumulative
totals, in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Table3: HIV diagnoses in females and rates per 100 000 population, by country and year of diagnosis (20042013) and cumulative
Table4: HIV diagnoses in men infected through sex with men, by country and year of diagnosis (20042013) and cumulative totals, in
EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Table5: HIV diagnoses in persons infected through injecting drug use, by country and year of diagnosis (20042013) and cumulative
totals, in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Table6: HIV diagnoses in persons infected through heterosexual contact, by country and year of diagnosis (20042013) and cumulative
totals, in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Table7: HIV diagnoses in persons infected through mother-to-child transmission, by country and year of diagnosis (20042013) and
cumulative totals, in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Table8: HIV diagnoses, by geographical area, sex, transmission group and year of diagnosis (20042013) and cumulative totals . . . . . . . . . . . . . . . 34
Table8a: EU/EEA and non-EU/EEA countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Table8b: Geographical areas, WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
iii
SURVEILLANCE REPORT
Table9: HIV diagnoses, by geographical area, sex, age and year of diagnosis (20042013) and cumulative totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Table9a: EU/EEA and non-EU/EEA countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Table9b: Geographical areas, WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Table10: HIV diagnoses in persons infected through heterosexual contact, by country and transmission subcategory, cases diagnosed
in 2013, in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
43
Table11: HIV diagnoses, by country of report and country or subcontinent of origin, cases diagnosed in 2013, in EU/EEA and other
countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Table12: HIV diagnoses, by geographical area, transmission mode and country or subcontinent of origin, cases reported in 2013
..............
46
Table12a: EU/EEA and non-EU/EEA countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46

Table12b: Geographical areas, WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
Table13: HIV diagnoses, by probable region of infection, in 2013, in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . 48
Table14: Percentage of new HIV diagnoses (2013) reported with information about CD4 cell count, by CD4 cell count level (<200 and
<350 cells per mm3 blood) and by transmission mode in cases with CD4 <350, in EU/EEA and other countries of the WHO European Region . . . . . . 51
Table15: AIDS cases and rates per 100 000 population, by country and year of diagnosis (20042013) and cumulative totals, in EU/EEA
and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52
Table15a: AIDS cases and rates per 100 000 population, by country and year of statistics (20042013) and cumulative totals, in EU/
EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
54
Table16: AIDS cases in males and rates per 100 000 population, by country and year of diagnosis (20042013) and cumulative totals,
in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
56
Table17: AIDS cases in females and rates per 100 000 population, by country and year of diagnosis (20042013) and cumulative totals,
in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
58
Table18: AIDS cases in men infected through sex with men, by country and year of diagnosis (20042013) and cumulative totals, in
EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
Table19: AIDS cases in persons infected through injecting drug use, by country and year of diagnosis (20042013) and cumulative
totals, in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
Table20: AIDS cases in persons infected through heterosexual contact, by country and year of diagnosis (20042013) and cumulative
Table21: AIDS cases in persons infected through mother-to-child transmission, by country and year of diagnosis (20042013) and
cumulative totals, in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
63
Table22: AIDS cases, by geographical area, sex, transmission mode and year of diagnosis (20042013) and cumulative totals . . . . . . . . . . . . . . . . . . 64
64
Table22b: Geographical areas, WHO European Region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
Table23: AIDS cases, by geographical area, sex, age and year of diagnosis (20042013) and cumulative totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Table23b: Geographical areas, WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
Table24: The most common AIDS-indicative diseases diagnosed in 2013, by geographical area ordered by frequency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
Table24b: Geographical areas, WHO European Region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
Table22a: EU/EEA and non-EU/EEA countries
...................................................................................................................
Table25: Deaths among AIDS cases, by country and year of death (20042013) and cumulative totals in EU/EEA and other countries of
the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73
Table26: Deaths among AIDS cases, by geographic area, transmission mode and year of death (20042013) and cumulative totals
.............
74
Table26a: EU/EEA and non-EU/EEA countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .74

Table26b: Geographical areas, WHO European Region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .74
Table27: Number of HIV tests performed, excluding unlinked anonymous testing and testing of blood donations, by country and year
(20042013) and number of tests per 1 000 population in 2013, in EU/EEA and other countries of the WHO European Region . . . . . . . . . . . . . . . . . . . . .
76
Figures
FigureA: Rate of new HIV diagnoses per 100 000 population, by year of diagnosis, in the EU/EEA and the WHO European Region, 19842013 . viii
FigureB: Cumulative number of new HIV diagnoses in the EU/EEA and other countries of the WHO European Region, 19842013
.................
ix
FigureC: Male-to-female ratio in HIV diagnoses, by country, EU/EEA, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

FigureD: Percentage of new HIV diagnoses, per age group, by transmission mode, EU/EEA, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
FigureE: Percentage of new HIV diagnoses in people between 15 and 24 years old, by country, EU/EEA, 2013
.........................................
FigureF: Percentage of new HIV diagnoses acquired through sex between men out of all reported HIV diagnoses with known mode of
HIV transmission, by country, EU/EEA, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
FigureG: Percentage of new HIV diagnoses among persons originating from countries with generalised HIV epidemics out of all cases
reported as heterosexually acquired, EU/EEA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
FigureH: Percentage of new HIV diagnoses among migrants out of all reported diagnoses with known region of origin, by country of
report, EU/EEA, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
iv
SURVEILLANCE REPORT
5
5
FigureK: New HIV diagnoses, by transmission mode and year of diagnosis, adjusted for reporting delay, EU/EEA, 20042013 . . . . . . . . . . . . . . . . . . . . . 6
FigureL: Percentage and number of the most common AIDS-indicative diseases per transmission mode, EU/EEA, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
FigureM: Rates of new HIV diagnoses, by geographical area and year of diagnosis, WHO European Region, 20042013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
FigureN: New HIV diagnoses, by transmission mode and year of diagnosis, WHO European Region, 20042013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
FigureO: Rate of AIDS cases per 100 000 population, by geographical area and year of diagnosis, 20042013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
FigureP: Male-to-female ratio in new HIV diagnoses and heterosexually infected cases, by country, East, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
FigureQ: New HIV diagnoses, by transmission mode and year of diagnosis, East, 20042013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
FigureR: Distribution of the three most common AIDS-indicative diseases per transmission mode, East, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
FigureS: Male-to-female ratio in new HIV diagnoses, by country, Centre, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
FigureT: New HIV diagnoses, by transmission mode and year of diagnosis, Centre, 20042013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
FigureU: Distribution of the three most common AIDS-indicative diseases per transmission mode, Centre, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18
FigureV: New HIV diagnoses, by transmission mode and year of diagnosis, West, 20042013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18
FigureW: Distribution of the three most common AIDS-indicative diseases per transmission mode, West, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18
Map 1: HIV diagnoses per 100 000 population, 2013: All cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Map 2: HIV diagnoses per 100 000 male population, 2013: Males . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Map 3: HIV diagnoses per 100 000 female population, 2013: Females . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Map 4: HIV diagnoses per 100 000 population, 2013: Heterosexual transmission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Map 5: HIV diagnoses per 100 000 population, 2013: Injecting drug use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Map 6: HIV diagnoses per 100 000 population, 2013: Sex between men . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
Map 7: AIDS cases reported per 100 000 population, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
Figure1: AIDS cases diagnosed, by transmission mode and geographical area, 20042013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
FigureA1: Geographical/epidemiological division of the WHO European Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
FigureI: Percentage of reported cases with a CD4 cell count <350/mm3 and <200/mm3 at presentation, by transmission mode, EU/EEA, 2013 . . . .
FigureJ: Percentage of reported cases with a CD4 cell count <350/mm3 and <200/mm3 at presentation, by age category, EU/EEA, 2013 . . . . . . . . . . . .
Annexes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
85
89
Annex3: Completeness of variables for data reported in 2012 and 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
Annex4a: HIV surveillance system overview: data source information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
Annex4b: AIDS surveillance system overview: data source information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
Annex5: Country-specific comments regarding national HIV and AIDS reporting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
Annex1: Framework for data collection, validation and presentation
Annex2: List of variables for the 2013 HIV/AIDS data collection
....................................................................................... .
..............................................................................................
Annex6: HIV diagnoses and rate per 100 000 population, adjusted for reporting delay and adjustment coefficients, EU/EEA countries,
20102013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
Annex7: HIV/AIDS surveillance in Europe: participating countries and national institutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
95
SURVEILLANCE REPORT
Overview of HIV and AIDS in Europe

Three decades after the beginning of HIV surveillance
in Europe, HIV infection continues to be of major public health importance in the Region. In 2013, 136 235
new HIV infections were diagnosed in 51 of the 53 countries of the WHO European Region1. Of those infections,
56 507 were officially reported to ECDC/WHO Regional
Office for Europe by 50 countries including 29 157 infections from the European Union and European Economic
Area (EU/EEA)2, while information about 79 728 infections was published by the Russian Federal Scientific
and Methodological Centre for Prevention and Control of
AIDS [1].
Surveillance data suggest an overall rate of 7.8 diagnoses per 100 000 population for the WHO European
Region and 5.7 per 100 000 for the EU/EEA (Figure A).
When data for Russia are included, the regional rate is
15.7 per 100 000 population. As in recent years, rates
are highest in the East of the Region and lowest in the
Centre (TableA). The main transmission mode varies by
geographical area, illustrating the diversity in the epidemiology of HIV in Europe; heterosexual transmission
is the main mode of transmission in the WHO European
Region, while sexual transmission between men is the
most common mode in the EU/EEA and transmission
through injecting drug use remains substantial in the
East of the Region.
In 2013, 15 789 AIDS cases were diagnosed in 49 countries of the WHO European Region and the rate of new
diagnoses was 2.2 per 100 000 population for the WHO
European Region and 0.9 per 100 000 for the EU/EEA 3.
Although the number of AIDS cases continued its steady
1 No data available from Uzbekistan or Turkmenistan.

2 Liechtenstein is not presented separately in the tables (see Country
Comments in Annex5).
3 No data available from Russia, Sweden, Turkmenistan or Uzbekistan.
decline in the West and the EU/EEA, it has tripled in the

East since 2004.
European Union and European

Economic Area
In 2013, 29 157 HIV diagnoses were reported by 30 EU/
EEA countries, with a rate of 5.7 per 100 000 population
(Table1). Countries with the highest rates of HIV diagnoses in 2013 were Estonia (24.6), Latvia (16.8), Portugal
(10.4), Belgium (10.0), and Luxembourg (9.9). The lowest
rates were reported by Slovakia (1.5) and Croatia (2.0).
Since the start of reporting on the HIV epidemic, 504 455
HIV diagnoses have been reported in the EU/EEA;
361 524 were in men and 139 527 in women (Tables13),
3 404 not having gender information available.
In 2013, the male-to-female ratio was 3.3 (Table A).
Young people aged 15 to 24 years accounted for 11% of
all HIV diagnoses reported, but this varied widely from
6% in Norway to 25% in Romania (FigureE).
Similar to recent years, the highest proportion of HIV
diagnoses was reported in men who have sex with men
(MSM) (42%), with heterosexual transmission the second most common transmission mode (32%). One third
(33%) of cases with a heterosexually-acquired infection
originated from a country with a generalised HIV epidemic. Transmission due to injecting drug use accounted
for 5% of HIV diagnoses, and for nearly 20% of the cases,
the transmission mode was unknown (TableA).
Despite prevention efforts, there appears to have been
no decline in HIV diagnoses per 100 000 population over
the last decade, with the rate remaining fairly stable,
at 6.5 per 100 000 in 2004 (28 259 cases) compared to
6.2 per 100 000 (31 977 cases) in 2013 when adjusted
for reporting delay (Table 1, Annex 6). Trends by transmission mode show that the number of HIV diagnoses
TableA: Characteristics of HIV diagnoses reported in the WHO European Region, the EU/EEA, and by geographical
area, 2013
Geographical areas
Reporting countries/Number of countries
Number of HIV diagnoses
Rate per 100 000 population
Percentage age 1524 years
Male-to-female ratio
Transmission mode
Men who have sex with men
Heterosexual
Injecting drug use
Mother-to-child transmission
Unknown
WHO European Region*

50/53 (51/53)
56 507 (136 235)
7.8 (15.7)
10.2%
2.2 (1.7)
West
23/23
26 847
6.3
10.3%
3.3
Centre
15/15
4166
2.2
14.4%
4.9
East*
12/15 (13/15)
25 494 (105 222)
22.7 (41.2)
9.5%
1.3 (1.4)
EU/EEA
30/31
29 157
5.7
10.9%
3.3
23.6% (10.1%)
46.1% (30.6%)
16.2% (21.3%)
0.9% (0.6%)
13% (37.3%)
43.1%
33.6%
4.1%
0.7%
18.2%
30.1%
24.8%
5.9%
1.1%
37.9%
2% (0.8%)
62.7% (30.0%)
30.6% (26.3%)
1.1% (0.6%)
3.6% (42.2%)
41.9%
32.4%
5.0%
0.7%
19.7%
No data received from Lichtenstein, Turkmenistan or Uzbekistan. All data presented were reported to ECDC/WHO through the European Surveillance System (TESSy),
except for data for Russia which were published by the Russian Federal Scientific and Methodological Center for Prevention and Control of AIDS [1].
* Figures including Russia are presented for the WHO Region and East in (brackets)
vii
SURVEILLANCE REPORT
among MSM in countries with consistent reporting have

increased by 33% since 2004 (Table 8), with sustained
increases over the last decade in all but four EU/EEA
countries (Table 4). In contrast, the number of cases
among people who inject drugs (PWID) has decreased by
36% over the period (Table8), although an increase was
observed in 2011 and 2012 due to localised outbreaks
in Greece and Romania (Table 5). The numbers of HIV
diagnoses due to heterosexual transmission decreased
by 45% during the last decade, with sharper decreases
seen among heterosexuals from countries with generalised HIV epidemics (Table 8, Figure K). Mother-to-child
transmission and transmission through blood transfusion have decreased continuously between 2004 and
2013 and remain at less than 1% of cases diagnosed
(Table8).
In 2013, information on CD4 cell counts at the time of
diagnosis was available in 21 countries for 17 526 cases
(61% of all cases reported in 2013) (Table 14). Nearly
half of these cases (47%) were diagnosed late (CD4
cell count <350/mm3), including the 27% of cases with
advanced HIV infection (CD4 <200/mm3). The proportion
of those diagnosed late was highest among heterosexually acquired cases originating from countries with
generalised HIV epidemics (59%) and among PWID
(52%). The lowest proportions of those diagnosed late
were observed in MSM (37%) and in cases of mother-tochild transmission (26%) (Table14, FigureI). A clear age
gradient was seen with increasing proportions of late
diagnosis in older age categories (FigureJ).
In 2013, 4 369 AIDS cases were diagnosed and reported
by 29 EU/EEA countries4, which is a rate of 0.9 cases per
100 000 population (Table 15). The highest rates were
reported by Latvia (6.6) and Portugal (3.1). In the EU/
EEA, the number of AIDS cases has consistently declined

since the mid-1990s.
WHO European Region

With inclusion of 136 235 new HIV diagnoses reported
in 2013, the cumulative number of infections diagnosed
in the WHO European Region increased to 1 715 344,
including 914 8135 officially reported to ECDC and the
WHO Regional Office for Europe (Figure B) and 800 531
infections diagnosed in Russia [1]. The 136 235 new HIV
diagnoses were reported by 51 of the 53 countries of
the WHO European Region6, corresponding to a rate of
15.7 per 100 000 population for 2013 and includes 56 507
cases officially reported to ECDC/WHO Regional Office
for Europe by 50 countries, corresponding to a rate of 7.8
per 100 000 population; and 79 728 cases from Russia
[1]. Among officially reporting countries, forty-five percent of new diagnoses (25 494 cases) were reported in
the East, 48% (26 847 cases) in the West and 7% (4 166
cases) in the Centre of the Region, while the rate (cases
per 100 000 population) was highest in the East at 22.7,
over three times higher than in the West (6.3 per 100 000)
and ten times higher than in the Centre (2.2 per 100 000)
(Table 1). When data for Russia are included, 77% percent of diagnoses were reported in the East, 20% in the
West and 3% in the Centre, and the rate in the East was
41.2. Among reporting countries, the highest rates were
reported by Ukraine (39.4), Estonia (24.6) and Moldova
(17.3), Latvia (16.8), Belarus (14.6) and Kazakhstan
(13.0). In Russia, the rate per 100 000 population was
55.6 in 2013 [1].
The majority of new HIV diagnoses (36%) were reported
in the age group 3039 years old, while 10% were
5 Minus the 62 581 cases officially reported to ECDC/WHO by Russia in
2010.
4 No data available from Sweden.
6 No data available from Uzbekistan or Turkmenistan.
FigureA: Rate of new HIV diagnoses per 100 000 population, by year of diagnosis, in the EU/EEA and the WHO European
Region, 19842013
9
WHO European Region
Cases per 100 000 population
EU/EEA
7
6
5
4
3
2
1
0
1984
1986
1988
1990
1992
1994
1996
1998
2000
2002
2004
2006
2008
2010
2012
Year of diagnosis
Countries
reporting
15
25 27 36 36 39 42 42 42 42 44 43 45 48 48 47 47 49 46 50 52 52 52
Rates may increase in the coming years due to reporting delays

Data from Russia not included.
viii
51
52 52 53
51
51
50
SURVEILLANCE REPORT
reported among 1524 year-olds. The male-to-female

ratio was 2.2 (1.7 when Russia is included): lowest in
the East (1.3) (1.4 when Russia is included), higher in
the West (3.3) and highest in the Centre (4.9) (Table A).
Most frequently, reported cases were acquired through
heterosexual transmission (46%), although the picture
is more heterogeneous at sub-regional level. Sixteen
percent of the new HIV cases were infected through
injecting drug use, 24% through sex between men and
0.9% were due to mother-to-child transmission (MTCT).
For 13% of cases, the transmission mode was reported
as unknown. When data for Russia are considered, the
percentages change as presented in Table A but the
overall distribution of transmission modes remains
unchanged.
In the West, sexual transmission between men remained
the main transmission mode (43% of new diagnoses),
followed by heterosexual transmission (34% of new
diagnoses). In the Centre, the main transmission mode
was through sex between men (30%) whereas heterosexual contacts accounted for 25% of new cases. In the
East, heterosexual contact (accounting for 63% of new
cases, 30% when Russia is included), followed by injecting drug use (31% of new cases, 26% when Russia is
included), were the predominant modes of transmission
while transmission through sex between men remained
very low in absolute terms (2% of cases, 0.8% when
Russia is included).
Between 2004 and 2013, the rate of newly diagnosed HIV
infections per 100 000 population increased by 81% from
8.7 in 2004 (75 812 cases) to 15.7 in 2013 (136 235 cases)
in 51 countries7 (Russia included [1]) which corresponds
to an 80% increase in the absolute number of cases.
The increase is mainly driven by an upward trend in the
East where the rate increased by fully 144%, from 16.9 in
2004 (47 332 cases) to 41.2 in 2013 (105 222 cases), corresponding to a 122% increase in the absolute number
of cases. In the 50 countries that provided official data
(Russia excluded), the regional rate increased by 16%,

from 6.7 (42 405 cases) to 7.8 (56 507 cases), whereas in
the East it increased by 80%, from 12.6 in 2004 (13 925
cases) to 22.7 in 2013 (25 494 cases). In the Centre, the
rate increased by 175%, from 0.8 (1 577 cases) to 2.2
(4 166 cases), whereas it decreased by 20%, from 7.9
(26 903 cases) to 6.3 (26 847), in the West (Figure M).
Trends by transmission mode in the WHO European
Region show increases in infections acquired due to
heterosexual contact (30% increase), sex between
men (40% increase) and mother-to-child transmission
(32% increase), whereas infections due to injecting
drug use decreased by 3% (Table 8) (Russia excluded).
When data for Russia are included, the number of cases
in each transmission category increased by 69% for
heterosexual transmission (from 22 811 to 38 439), by
42% for injecting drug use (from 20 178 to 28 590), by
43% for sex between men (from 7108 to 10 168) and by
144% for unknown transmission (from 19 941 to 48 565)
whereas it decreased by 15% for MTCT (from 988 to
839). In the East, sexual transmission (both heterosexual and through sex between men) increased, two-fold
and fourteen-fold, respectively, whereas transmission
through injecting drug use remained fairly stable in
comparison with 2004 following a period of much higher
levels during 20062010. At the same time, the number
of women newly infected almost doubled between 2004
and 2013 (Table 3). When data for Russia are included,
the number of cases in each transmission category in
the East increased by 207% for heterosexual transmission (from 10 225 to 31 424), by 48% for injecting drug
use (from 18 632 to 27 596), by 427% for sex between
men (from 166 to 875) and by 160% for unknown transmission (from 17 076 to 44 346) whereas it decreased by
5% for MTCT (from 671 to 635). In the West, transmission through male-to-male sex increased by 26% and
heterosexual transmission decreased by 47%. In the
Centre, infections acquired through sex between men
increased three-fold, heterosexual transmission by 64%
and IDU-related transmission four-fold mainly due to an
7 Data from Turkmenistan and Uzbekistan not included.
FigureB: Cumulative number of new HIV diagnoses in the EU/EEA and other countries of the WHO European Region,
19842013
10
EU/EEA
Number of cases (100 000s)
Other countries of the WHO European Region

8
2
0
1985
1990
1995
2000
2005
2010
Year of diagnosis
Data from Russia not included
ix
outbreak in Romania that started in 2011 and peaked in

2012 (Table8).
In 2013, 35 countries in the WHO European Region
provided information on CD4 cell count at the time of
diagnosis for 35 383 (48%) cases (Table 14). Of these
cases, 49% were reported as late presenters (CD4 cell
count <350/mm3), including 27% of cases with advanced
HIV infection (CD4 <200/mm3). The percentage of late
presenters varied across transmission categories and
geographical areas and was highest among people
infected through injecting drug use in the East (68%)
(Table14).
In 2013, 15 789 AIDS cases were diagnosed in 49 countries of the WHO European Region8, corresponding to a
rate of 2.2 per 100 000 population. Seventy-two percent
(11 292 cases) were reported by countries in the East,
23% (3 606 cases) in the West and 6% (891 cases) in the
Centre of the Region. The number of cases per 100 000
population was 10.0 in the East, eleven times higher
than in the West (0.9 per 100 000) and 20 times higher
than in the Centre (0.5 per 100 000) (Table15).
Between 2004 and 2013, the rate of new AIDS cases per
100 000 population increased by 10%, from 2.0 in 2004
(12 952 cases) to 2.2 in 2013 (15 789 cases) in the 50 countries with consistent AIDS data. There was, however,
substantial variation at sub-regional level with a threefold increase in rates in the East from 3.2 per 100 000
(3 275 cases) to 10.0 (11 292 cases), a 64% decrease in
the West from 2.5 per 100 000 (8 915 cases) to 0.9 (3 606
cases) and a 25% increase in the Centre from 0.4 (762
cases) to 0.5 (891 cases).
Conclusions
HIV infection remains of major public health importance
in Europe. A total of 136 235 new HIV infections were
diagnosed in 51 of 53 countries in 2013, giving a rate
of 15.7 per 100 000 population. The most recent surveillance data indicate that, despite significant efforts
dedicated to the prevention and control of HIV, the rate
of new HIV diagnoses has not declined in the EU/EEA
and has increased substantially over the last decade in
the European Region. HIV is mainly concentrated in key
populations at higher risk of HIV infection such as men
who have sex with men, people originating from generalised epidemic countries (mainly sub-Saharan Africa)
and other migrants, and PWID and their sexual partners.
At the same time cases among people originating from
countries with generalised HIV epidemics appear to be
decreasing. People infected through heterosexual transmission in the East, notably women, are increasingly
affected. Recent increases of HIV among PWID in some
countries in the EU/EEA and West indicate that even low
numbers can rapidly evolve into an outbreak when public health interventions are insufficient [3].
The proportion of late diagnoses is high in all countries reporting data on CD4 cell count at diagnosis. This
SURVEILLANCE REPORT
indicates a delay in HIV testing with nearly half of cases

already eligible for treatment when they are diagnosed,
based on 2010 WHO criteria of when to initiate ART; this
has since been revised to recommend ART initiation at
CD4 cell count <500/mm3 [2]. The high and increasing
number of AIDS cases in the East is also indicative of late
HIV diagnosis, low treatment coverage and delayed initiation of life-saving HIV treatment. The wide availability
of treatment and recommendations for earlier initiation
[2] have widened the scope of HIV surveillance to include
monitoring of access to care and treatment. Improved
access to and earlier initiation of treatment, particularly
for key populations, is of importance throughout Europe
but increasingly needs to be urgently addressed in the
East.
In order to decrease the number of late diagnoses, the
current organisation of HIV counselling and testing
services need to be reconsidered, including innovative
approaches and services (such as routine offers of counselling and testing in clinical settings, rapid testing and
community-based testing [2]), to reach people that are at
higher risk. These services should be accessible and targeted toward key populations in order to ensure earlier
diagnoses and initiation of HIV treatment and linkage to
care. This will result in improved treatment outcomes,
reduced morbidity and mortality and will contribute to
preventing or further reducing onward HIV transmission. Equal access to HIV prevention, testing, treatment
and care for all population groups should be ensured in
order for countries to reach the global targets of 90% of
people living with HIV diagnosed and enrolled in care;
90% of those diagnosed retained in care; and 90% of
people in care being virally suppressed [4].
Interventions to control the epidemic need to be based
on evidence and adapted to national and local epidemiology. From the surveillance data presented in this
report, the following can be concluded:
For the countries in the EU/EEA and West, interventions to prevent and control HIV among MSM are the
cornerstones of the HIV response. Given the persistent
increase in cases diagnosed in this key population
over the last decade, it would appear that current prevention and control efforts are not yet being delivered
with sufficient effect and would need to be significantly strengthened. In addition, as about 30% of
all new infections in the EU/EEA are reported among
migrants and about one third of the heterosexually
acquired HIV cases were reported as originating from
high-endemic countries, countries need to ensure that
interventions for prevention, treatment and care are
accessible to migrants. The observed increase in HIV
cases among people who inject drugs in a number of
countries [3] in recent years demonstrates the need to
maintain or scale up harm reduction programmes in
some settings.
For the countries in the Centre, as the epidemic among
MSM is increasing, the priority is to strengthen interventions to prevent, test and treat HIV in this group.
Stigma reduction efforts will be key to achieving this.
SURVEILLANCE REPORT
For the countries in the East, there is a need to scale

up targeted interventions and deliver effective, highquality, integrated services through well-functioning
health systems that address the social determinants
of health. Comprehensive coverage with effective
prevention, early and targeted testing, and access to
counselling and integrated care should be provided to
all in need. Access to antiretroviral therapy should be
used strategically to treat and prevent HIV transmission and reduce the growing number of AIDS cases.
Evidence-based policies targeting key populations,
particularly people who inject drugs, including harm
reduction programmes and early access to treatment,
need to remain the cornerstones of the HIV response.
In couples where one of the partners is engaged in a
high-risk behaviour, including but not limited to injecting drug use, bolder prevention interventions should
address the risk of heterosexual transmission [5].
Finally, robust surveillance data are critical to monitor
and inform the public health response to the European
HIV epidemic in an accurate and timely fashion. The
number of countries conducting enhanced HIV surveillance and reporting surveillance data at European level
has gradually increased over time; in 2013, 50 of the
53 countries submitted data. Data quality and completeness of key variables such as transmission mode
and CD4 cell count at time of diagnosis can be further
improved, as can measures of access to, uptake of,
and retention in care following diagnosis. In 2014, HIV
surveillance will undergo revision in order to be more
fit-for-purpose, combining the surveillance of HIV and
AIDS and increasing the possibilities for longer-term
monitoring of continuum of care outcomes such as linkage to care, treatment, and viral suppression following
HIV diagnosis.
References
1
Federal Scientic and Methodological Center for Prevention and

Control of AIDS. Reference: HIV-infection bulletin number 39.
Moscow: The Federal Service for Surveillance of Consumer Rights
Protection and human well-being; 2014.
World Health Organization. Consolidated guidelines on the use

of antiretroviral drugs for treating and preventing HIV infection.
Recommendations for a public health approach. Geneva: World
Health Organization; 2013.
Hedrich D, Kalamara E, Sfetcu O, Pharris A, Noor A, Wiessing L, et

al. Human immunodeciency virus among people who inject drugs:
Is risk increasing in Europe? Euro Surveill. 2013;18(48):pii=20648.
Available online: http://www.eurosurveillance.org/ViewArticle.
aspx?ArticleId=20648
UNAIDS. Ambitious treatment targets: Writing the nal

chapter of the AIDS epidemic. Geneva; 2014. Available
online:
http://www.unaids.org/en/media/unaids/conte n t a s s e t s/d o c u m e n t s/u n a i d s p u b l i c a t i o n/20 1 4/
JC2670_UNAIDS_Treatment_Targets_en.pdf
World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Geneva:
World Health Organization; 2014.
xi
xii
SURVEILLANCE REPORT
SURVEILLANCE REPORT

/

-

1. 2013 . 51 53

136 235 -.
ECDC/
56 507
-, 29 157
(/)2, 79 728

[1].
, - 7,8
100 000 5,7 100 000
/ ().

- 15,7 100 000
.
,
( ). ,

- .
. /
,
-
.
2013 . 49
15 789 ,
2,2 100 000 0,9
100 000 /3.

/,
2004 . .
2013 . 30 / 29 157
-, 5,7
100 000 ( 1). 2013 .
-
(24,6), (16,8),
(10,4), (10,0) (9,9).
-
(1,5) (2,0).

-, / 504 455 - 361 524
139 527 (
1 3), 3 404 .
2013 .
3,3 ( ).
15 24 11% -,
1 .
2 (.
5).
3 , , .
A: -, ,
/ , 2013

, /
-
100 000
1524

, ()
-
*
50/53 (51/53)
56 507 (136 235)
7.8 (15.7)
10.2%
2.2 (1.7)
23/23
26 847
6.3
10.3%
3.3
15/15
4166
2.2
14.4%
4.9
12/15 (13/15)
25 494 (105 222)
22.7 (41.2)
9.5%
1.3 (1.4)
30/31
29 157
5.7
10.9%
3.3
23.6% (10.1%)
46.1% (30.6%)
16.2% (21.3%)
0.9% (0.6%)
13% (37.3%)
43.1%
33.6%
4.1%
0.7%
18.2%
30.1%
24.8%
5.9%
1.1%
37.9%
2% (0.8%)
62.7% (30.0%)
30.6% (26.3%)
1.1% (0.6%)
3.6% (42.2%)
41.9%
32.4%
5.0%
0.7%
19.7%
, . , ECDC,
(TESSy) , -
[1]
* , ,
xiii
SURVEILLANCE REPORT
6%
25% ( E).
,
-
, () (42%),
-
(32%),
(33%) -
-.

5% -, 20%
-
( ).
, -,
- 100 000 ,
-, ,
. , 2004 . 6,5 100 000 (28 259 ),
2013 . 6,2 100 000 (31 977
) ( 1, 6).

, 2004 .
- ,
, 33% (8)
, / (4).
, (), -
, , 36% (8).
2011 2012 .

( 5).

-, , 45%.

- ( 8, K).
-

2004 2013
. 1% - (8)
2013 . CD4
-
21 17 526 (61% ,
2013 .) ( 14).
(47%) ( CD4 <350/
), 27%
- ( CD4 <200/).
, ,

- (59%) (52%).
-, ,
(37%)
(26%) ( 14, I).
-,

( J).
2013 . 29 /4
4 369 , 0,9 100 000 ( 15).

(6,6) (3,1). 1990-
4 .
FigureA: - 100 000 ,

, / , 19842013 .

9

100 000
7
6
5
4
3
2
1
0
1984
15
1986
1988
1990
1992
1994
1996
2000
2002
2004
2006
25 27 36 36 39 42 42 42 42 44 43 45 48 48 47 47 49 46 50 52 52 52
- .
.
xiv
1998
2008
2010
2012

51
52 52 53
51
51
50
SURVEILLANCE REPORT
. / .
-
100 000 2013 . 55,6 [1].
- (36%)
3039
. 1524 10%.
2,2 (1,7
) (1,3) (1,4
),
(3,3)

(4,9) ( ). (46%),
,
- . 16%
-
, 24%

0,9%
(). 13%
.
( ),

.
136 235 -,
2013 .,
, , 1 715 344, 914 813
5, ECDC
, ( B)
800 531 ,
[1]. 136 235 -
51 53
6, 15,7 100 000
2013 . 56 507
ECDC/ 50 (
7,8 100 000 ), 79 728 ,
[1]. ,
, -
45% (25 494) , 48%
(26 847) 7% (4 166) ;
( 100 000 ) (22,7),
,
(6,3 100 000) 10 ,
(2,2 100 000) ( 1).
: 77% -
, 20% 3%
, 41,2.
, ,
(39,4), (24,6), (17,3), (16,8),
(14,6) (13,0).
5 ,
ECDC/
2010 . (62 581).
6 .

-
(43% ),
(34%
).
-
(30% ),

(25%).
(63% , 30%
)
(31% 26% ),
B: - /
, 19842013
10
(100 000)
2
0
1985
1990
1995
2000
2005
2010
xv

(2% 0,8%
).
2004 2013 ,
- 100 000
81% 8,7 2004 (75 812 ) 15,7 2013
. (136 235 ) 51 7 ( [1]),

80%. ,
,
,
144% 16,9 2004 . (47 332 ) 41,2 2013
. (105 222 ) 122%
. 50 ,
( ),
16% 6,7 (42 405 ) 7,8 (56 507 ),
80% 12,6 2004 . (13 925 )
22,7 2013 . (25 494 ).
175% 0,8
(1 577 ) 2,2 (4 166 ),
20%
7,9 (26 903 ) 6,3 (26 847 ) ( M). -

30%, 40% 32%
,
. ,
3% (
). ,
69% (
22 811 38 439), 42% ( 20 178 28 590), 43%
( 7108 10 168) 144%
( 19 941
48 565),
15% ( 988 839
).
-,
(
, )
, ,
, -

2004

20062010 . -
2004 2013 . (3).

207%
( 10 225 31 424), 48% ( 18 632 27 596),
7 .
xvi
SURVEILLANCE REPORT
427% ( 166 875)

160% (
17 076 44 346), 5% (
671 635 ). -
26%,

47%. ,
, ,
64%

( ,
, 2011 .
2012 .) (8).
2013 . 35 CD4
-
35 383 (48%) ( 14). 49%
, ( CD4 <350/
), 27%
- ( CD4 <200/).
, ,
.
,
(68%) (14).
2013 . 49 -
8, 15 789
, , ,
2,2 100 000 .
(11 292)
, 23%
(3 606) 6% (891)
. 100 000
10,0.

, (0,9 100 000)
20 , (0,5
100 000) (15).
2004 2013 . 50 ,
,
100 000
10% 2,0 2004 . (12 952 )
2,2 2013 . (15 789 ). ,
:

3,2 100 000 (3 275 ) 10,0 (11 292 );
64%
2,5 100 000 (8 915 ) 0,9 (3 606 );
25%
0,4 (762 ) 0,5 (891 ).
8 , , .
SURVEILLANCE REPORT
- .
2013 . 51 53 -
136 235 -, 15,7
100 000 . , ,
-,
- / ,

.
, ,
,
, (
)
, .

-,
-, . ,

-, , .
- /

,
-,
[3].
,
CD4 ,
.

. ,
2010 .,
,
CD4-
500/3 [2].
, ,

-, - ,
-, , .

- [2]
-,

.
,
.
.
,
,
, (,
,
,
, -,
[2]).
,

- -.
,
, .

, ,
-,
,
: 90% ,
,
; 90%
; 90% ,
, [4].

. , ,
:
/
- .
,
, -,
, -

. 30%
- /
-,
,
,
, ,
- .
[3]
- , ,

.
,
,
, (
xvii
) -
.

.

,
,
.
,
.
,
-
. -
-
-
, ,
, ,
.
,

( ..),

[5].
, ,

, ,

- .
,
- , . 2013
. 50
53 .
,
CD4 ,
. ,
,

. 2014 .
- ,
-

-, ,
xviii
SURVEILLANCE REPORT

-
.
1.
-
, : HIV-infection
Newsletter number 39 [ 39]. :
; 2014 .
2.

-.
. :
, 2013 .
3.

Is risk increasing in Europe? Euro Surveill. 2013;18(48):pii=20648.
Available online [ ]: http://www.eurosurveillance.
org/ViewArticle.aspx?ArticleId=20648
UNAIDS. Ambitious treatment targets: Writing the nal chapter of the AIDS epidemic. Geneva; 2014. Available online
[
]:http://www.unaids.org/en/media/
unaids/contentasset s/document s/unaidspublication/201 4/
JC2670_UNAIDS_Treatment_Targets_en.pdf
World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations [
, ,
- ].
Geneva: World Health Organization; 2014.
SURVEILLANCE REPORT
Abbreviations
AIDS
Acquired immunodeficiency syndrome
ART
Antiretroviral therapy
ECDC
European Centre for Disease Prevention and Control
EEA
European Economic Area
EU
European Union
HIV
Human immunodeficiency virus
ICJ
International Court of Justice
IDU
Injecting drug use
MSM
MTCT
PWID
People who inject drugs
TESSy
The European Surveillance System
UN
United Nations
UNAIDS Joint United Nations Programme on HIV/AIDS

UNSCR
United Nations Security Council Resolution
WHO
World Health Organization
xix
SURVEILLANCE REPORT
1 HIV and AIDS in the European Union and

European Economic Area
1.1 HIV diagnoses
For 2013, 29 157 HIV diagnoses were reported by 30 EU/
EEA countries1 giving a rate of 5.7 per 100 000 population (Table 1). The highest rates were observed in
Estonia (24.6; 325 cases), Latvia (16.8; 340 cases),
Portugal (10.4; 1093 cases), Belgium (10.0; 1 115 cases)
and Luxembourg (9.9; 53 cases). The lowest rates were
reported by Slovakia (1.5; 83 cases) and Croatia (2.0; 85
cases).
The overall rate for men in the EU/EEA was 8.9 per
100 000 population (Table 2) and for women, 2.6 per
100 000 population (Table3). The overall male-to-female
ratio was 3.3. The ratio was highest in Hungary (11.1),
Croatia (9.6), the Czech Republic (8.8) and Greece (8.7)
(Figure C). The predominant mode of transmission in
these countries was sex between men.
Most HIV diagnoses were in the age category 3039
years (33%). The 3039-year-olds accounted for most
HIV diagnoses among IDU (41% of cases), MSM (34%),
heterosexuals from countries with generalised HIV epidemics (39%), and other heterosexual cases (29%).
However, MSM tended to predominate in the younger
(2029-year-old) age categories while heterosexuals
were the predominant group among those diagnosed
over 50 years of age (Figure D).
Young people 15 to 24 years of age comprised 12% of
the EU/EEA population and 11% of HIV diagnoses in
2013. Romania, Cyprus, Iceland, Slovakia, Bulgaria and
Lithuania reported more than 15% of their HIV diagnoses
among young people (FigureE). In eleven countries, this
proportion was lower than 10%.
Data on transmission mode provide information on the
groups that are most affected by HIV in the EU/EEA
(Table12a, Tables 47):
Sex between men is the predominant mode of HIV
transmission in EU/EEA countries, accounting for 42%
(12 228) of HIV diagnoses in 2013 (Table 4), and 52%
of HIV diagnoses where the route of transmission
was known (Figure F). Among those with known route
of HIV transmission, MSM accounted for more than
half of new diagnoses in fifteen countries (Austria,
Belgium, Croatia, Cyprus, the Czech Republic,
Denmark, Germany, Hungary, Malta, the Netherlands,
Poland, Slovakia, Slovenia, Spain, and the United
Kingdom) (FigureF).
Heterosexual contact is the second most commonly
reported mode of transmission in the EU/EEA, accounting for 9 449 diagnoses (32%) (Table 6). One third
1 Liechtenstein did not report data in 2013 (see country-specific

comments in Annex 5).
(33%; 3 160) of newly diagnosed cases among heterosexuals originate from countries with generalised HIV
epidemics. The highest proportions of heterosexually
transmitted cases originating from countries with generalised epidemics were observed in Belgium (52%),
France (50%), Ireland (53%), Luxembourg (58%) and
Sweden (58%) (FigureG).
Five percent (1 455 cases) of HIV diagnoses were
reported among PWID (Table 5). Injecting drug use
accounted for more than one quarter of cases in
Greece (31%), Lithuania (35%) and Romania (29%).
Of the remainder, 218 (0.7%) diagnoses were reported
as mother-to-child transmission (Table 7); 25% of
those cases originated from countries with generalised HIV epidemics. Forty-seven diagnoses were
reported to be due to transfusion of blood and its
products, and 19 cases were hospital-acquired infections (Table12a).
Transmission mode was reported as unknown for
5 741 diagnoses (20%) with a wide variation between
countries: less than 5% of diagnoses reported
as unknown in Croatia, Cyprus, Czech Republic,
Denmark, Luxembourg, Norway, Portugal and Slovakia
and more than 60% reported as unknown in Iceland
and Poland.
In 2013, 28 EU/EEA countries provided information on
the country of birth, country of nationality, or region
of origin. In the EU/EEA, 3 784 diagnoses (15% of those
with known information on region of origin), irrespective
of transmission mode, were among persons originating
from countries with generalised HIV epidemics in 2013
(FigureH, Table11). An additional 20% of new diagnoses
with known information on region of origin (5 248 cases)
were among persons originating outside of the country
of report, but not from a generalised epidemic country.
Countries with more than half of new HIV diagnoses
among persons originating from outside of the country
of report are Belgium (52%), Denmark (52%), Ireland
(55%), Luxembourg (70%), Malta (77%), Norway (63%),
Sweden (74%), and the United Kingdom (54%) (FigureH).
In 2013, 27 EU/EEA countries were able to provide information on the probable source of infection when the
infection was acquired through heterosexual contact
(Table 10). This information was reported for 39% of
heterosexual cases (3 731). Among those, HIV diagnoses
were reported in 776 individuals with a partner originating from a country with a generalised epidemic, 71
with a partner who injects drugs and 26 with a bisexual
partner.
Information on CD4 cell count at the time of HIV diagnosis was provided by 21 countries (Table14) for 17 526 HIV
diagnoses (61%) in adults and adolescents. All countries
SURVEILLANCE REPORT
FigureC: Male-to-female ratio in HIV diagnoses, by country, EU/EEA, 2013 (n=29 086)
Hungary
Croatia
Czech Republic
Greece
Slovenia
Netherlands
Poland
Slovakia
Cyprus
Spain
Luxembourg
Austria
Malta
Germany
Bulgaria
Italy
EU/EEA
Denmark
Ireland
United Kingdom
Iceland
Portugal
Lithuania
Romania
Belgium
Norway
France
Finland
Sweden
Estonia
Latvia
0
10
12
FigureD: Percentage of new HIV diagnoses, per age group, by transmission mode, EU/EEA, 2013 (n=22 472)
50
Sex between men
40
Heterosexual, excluding countries with

generalised HIV epidemics
Percentage
Heterosexual from countries with generalised

HIV epidemics
30
Injecting drug use
20
10
0
15-19
20-24
25-29
30-39
40-49
50+
Age category (years)

Data from persons <15, other/unknown transmission, mother-to-child transmission, transfusion-related transmission, and nosocomial transmission not shown here.
Data from Estonia and Poland excluded.
SURVEILLANCE REPORT
FigureE: Percentage of new HIV diagnoses in people between 15 and 24 years old, by country, EU/EEA, 2013 (n=29 157)
Romania
Cyprus
Iceland
Slovakia
Bulgaria
Lithuania
Estonia
Poland
United Kingdom
Sweden
Austria
Hungary
Czech Republic
Ireland
Germany
Malta
EU/EEA
Spain
Netherlands
Greece
Belgium
France
Latvia
Portugal
Finland
Croatia
Luxembourg
Italy
Denmark
Slovenia
Norway
0
10
15
20
25
Percentage
FigureF: Percentage of new HIV diagnoses acquired through sex between men out of all reported HIV diagnoses with
known mode of HIV transmission, by country, EU/EEA, 2013 (n=23 416)
Hungary
Croatia
Czech Republic
Slovenia
Netherlands
Slovakia
Germany
Poland
Cyprus
Spain
Malta
United Kingdom
Austria
EU/EEA
Denmark
Belgium
Ireland
Luxembourg
Greece
Italy
France
Norway
Bulgaria
Sweden
Finland
Portugal
Lithuania
Romania
Latvia
Estonia
0
20
40
60
80
100
Percentage
No cases with sex between men as transmission mode were reported in Iceland
SURVEILLANCE REPORT
FigureG: Percentage of new HIV diagnoses among persons originating from countries with generalised HIV epidemics
out of all cases reported as heterosexually acquired, EU/EEA (n=9 449)
Sweden
Luxembourg
Ireland
Belgium
France
Germany
United Kingdom
Norway
Malta
Denmark
EU/EEA
Netherlands
Bulgaria
Portugal
Austria
Finland
Spain
Italy
Hungary
Slovenia
Greece
Cyprus
Slovakia
Czech Republic
0
10
20
30
40
50
60
70
Percentage
No cases reported among persons originating from countries with generalised HIV epidemics in Croatia, Estonia, Latvia, Lithuania, Poland or Romania
FigureH: Percentage of new HIV diagnoses among migrants out of all reported diagnoses with known region of origin,
by country of report, EU/EEA, 2013 (n=25 568)
New diagnoses among persons
originating from countries with
Malta
Sweden
Luxembourg
Norway
Ireland
United Kingdom
Belgium
Denmark
Finland
France
Iceland
Austria
EU/EEA
Germany
Spain
Netherlands
Czech Republic
Portugal
Cyprus
Italy
Greece
Bulgaria
Slovenia
Hungary
Slovakia
Lithuania
Estonia
Romania
New diagnoses among persons

originating from other countries
10
20
30
40
Percentage
There were no cases reported among migrants in Croatia, Latvia or Poland.
50
60
70
80
SURVEILLANCE REPORT
providing this data, with the exception of Estonia, were

able to provide CD4 cell counts for more than 50% of
their reported cases. Nearly half (47%) of all cases were
late presenters with a CD4 cell count less than 350/mm3,
including 27% of cases with advanced HIV infection (CD4
<200/mm3). The percentage of late diagnoses (CD4 <350/
mm3) was higher than 50% in eight countries: Estonia
(52%), Finland (57%), Greece (55%), Italy (58%), Latvia
(54%), Luxembourg (55%), Portugal (58%), and Slovenia
(58%).
When analysing CD4 cell count by transmission mode,
the highest proportion of late diagnoses was observed
among heterosexually acquired cases, especially among
those originating from countries with generalised HIV
epidemics (59%) (Figure I). The lowest proportion with
CD4 less than 350/mm3, as well as CD4 less than 200/
mm3, was observed among cases due to mother-to-child
transmission (26% and 14%) and MSM (37% and 18%)
(FigureI). Nine countries reported late diagnosis in more
than half of the cases acquired through injecting drug
use and two countries for more than half of the cases in
MSM (Table14).
When analysing CD4 count by age category, there is a

clear age gradient with increased proportions of late
diagnosis among older age categories. Among those 50
years of age and older, 63% were diagnosed with CD4
<350/mm3 and 44% with CD4 <200/mm3 (FigureJ).
1.2 Trends in HIV diagnoses

The trend of reported HIV diagnoses for the period
20042013 remains relatively stable, although the
overall rate of HIV diagnoses per 100 000 population
decreased slightly from 6.5 per 100 000 in 2006 (28 259
cases) to 5.7 per 100 000 (29 157 cases) in 2013 (when
not adjusted for the reporting delay in a number of countries (Table 1)). However, comparing with the estimated
adjusted rate for 2013 that is 6.2 per 100 000 population
(31 977 cases) shows less apparent decline, (see Annex1
for methods; Annex 6 for results). In the previous HIV/
AIDS surveillance report [1], 29 381 HIV diagnoses were
reported for 2012, but this number has now increased
by over 3 000 cases and may still increase further in the
coming one to two years.
FigureI: Percentage of reported cases with a CD4 cell count <350/mm3 and <200/mm3 at presentation, by transmission
mode, EU/EEA, 2013 (n=17 526)
< 200
Transmission mode
< 350
Sex between men
Injecting drug use
Other heterosexual contact

Heterosexual cases from
countries with generalised
HIV epidemics
0
10
20
30
40
50
60
70
Percentage
FigureJ: Percentage of reported cases with a CD4 cell count <350/mm3 and <200/mm3 at presentation, by age category,
EU/EEA, 2013 (n=17 526)
80
< 200
70
< 350
Percentage
60
50
40
30
20
10
0
15-19
20-24
25-29
30-39
40-49
50+
Age category (years)
SURVEILLANCE REPORT
Over the past decade, trends at national level have varied widely. Since 2004, rates of HIV diagnoses have
more than doubled in Bulgaria, the Czech Republic,
Hungary, Iceland, Malta, Romania and Slovakia and
have increased by more than 50% in Croatia, Cyprus,
Greece, Lithuania, Poland and Slovenia. The rate of new
HIV diagnoses decreased in thirteen countries between
2004 and 2013, with decreases in the rate of new HIV
diagnoses of more than 25% observed in Denmark,
Estonia, France, Italy, Luxembourg, Portugal, Spain and
the United Kingdom (Table1).
The number of HIV diagnoses among PWID has

declined by 36% since 2004 (1 628 cases to 1 037
cases). An increase in overall numbers for the EU/
EEA was observed in 2011 and 2012 due to localised
outbreaks in Greece and Romania. In Greece, cases
diagnosed increased from 14 in 2004 to 513 cases
in 2012 and 248 cases in 2013. In Romania, cases
increased from 1 in 2004 to 116 in 2011, 170 in 2012
and 149 in 2013. Bulgaria has also seen an increase,
though less dramatic, in cases among PWID from 7 in
2004 to 74 in 2009 and then 33 in 2013 (Table5).
Since 2004, 26 EU/EEA countries have consistently

reported data on transmission mode. Data from Estonia
and Poland were excluded from this analysis because
more than 50% of their data on transmission mode was
missing. Data from Spain and Italy were also excluded
because coverage of the surveillance system increased
over this time period. Data on transmission mode from
the countries consistently reporting indicate the following (Table 8a, FigureK):
The number of diagnoses of HIV transmitted from

mother to child decreased by 37%, from 305 in 2004
to 193 in 2013.
The number of HIV diagnoses among MSM increased

by 33% from 6 682 cases in 2004 to 8 864 cases
in 2013, with a peak of 9 469 cases in 2012; when
adjusted for reporting delay, HIV cases among MSM
increased by 43% between 2004 and 2013. Between
2004 and 2013, increases of more than 100% were
observed in Bulgaria, Croatia, Cyprus, the Czech
Republic, Hungary, Ireland, Latvia, Lithuania, Malta,
Romania and Slovakia. Increases of more than 50%
were observed in Belgium, Germany and Slovenia.
(Table 4).
The number of heterosexually acquired cases
decreased by 45% from 12 027 in 2004 to 6 660 in
2013, with a consistently decreasing trend. This was
mainly due to a 61% decrease among cases originating from countries with generalised HIV epidemics
(6 922 in 2004, 2 732 in 2013).
The number of HIV diagnoses due to nosocomial infection has remained stable with 23 cases in 2004 and
19 in 2013. The number of cases due to transfusion of
blood and its products has decreased by 55%, from 89
in 2006 to 40 cases in 2013.
The number of cases reported to have an unknown
mode of transmission has increased consistently
since 2004. Over the period in question, there was an
increase of 48%, from 2 740 in 2006 to 4 044 cases
in 2013. This increase is an underestimate as some
countries reporting higher rates of incomplete data on
transmission mode were excluded.
Reporting delays differ significantly between transmission categories for some countries. When adjustments
for reporting delay were made, it increased the number
of reported HIV cases in all transmission categories
by between 8% and 19%, depending on the category.
Figure K shows the adjusted trends.
1.3 AIDS cases, morbidity and

mortality
For 2013, 4 369 diagnoses of AIDS were reported by 29
EU/EEA countries (no data from Sweden), resulting in a
FigureK: New HIV diagnoses, by transmission mode and year of diagnosis, adjusted for reporting delay, EU/EEA,
20042013
10000
Heterosexual, excluding cases originating

from countries with generalised HIV epidemics
Heterosexual, originating from countries with
Number of cases
8000
Sex between men

6000
Injecting drug use

4000
Other/undetermined
2000
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Year of diagnosis
Cases from Estonia and Poland excluded due to incomplete reporting on transmission mode during the period; cases from Italy and Spain excluded due to increasing
national coverage over the period
SURVEILLANCE REPORT
rate of 0.9 cases per 100 000 population (Table15). The

highest rates were reported by Latvia (6.6, 133 cases)
and Portugal (3.1, 322 cases). In the EU/EEA during the
last decade, the rate of reported AIDS cases has halved
from 2.1 per 100 000 (9 455 cases) reported in 2004.
However, since 2004, an increase of 100% or more in
the rate of AIDS diagnoses was reported in Bulgaria, the
Czech Republic, Hungary and Lithuania. The number of
cases also increased in Croatia, Greece and Latvia.
HIV surveillance data suggest that the epidemic in EU/

EEA countries remains constant overall, with little fluctuation in the rate of diagnoses per 100 000 population
over the last decade. While the actual 2013 rate of 5.7
per 100 000 population is lower than previous years, it
is expected to increase in future reporting cycles due to
reporting delay which is common for HIV generally, and
in some countries in the EU/EEA in particular.
Despite the stable rate of HIV in the region, these data
provide evidence of important changes in the epidemiology of HIV during the past decade. There has been a
sustained increase in HIV diagnoses among men who
have sex with men, and this is the population in the EU/
EEA that accounts for most new HIV diagnoses. During
the past decade, HIV increases among men who have
sex with men were observed in all but four EU/EEA countries, and significant increases were seen in countries
with overall low rates of HIV such as Croatia, Cyprus, the
Czech Republic, Hungary, Malta, Romania and Slovakia.
In the EU/EEA, the most common AIDS-indicative diseases diagnosed in 2013 were Pneumocystis pneumonia
(20%), oesophageal candidiasis (10%), wasting syndrome due to HIV (8%) and pulmonary tuberculosis (8%)
(Table 24). The most common indicative diseases for
MSM were Pneumocystis pneumonia, Kaposis sarcoma
and oesophageal candidiasis; for PWID, pulmonary
tuberculosis, Pneumocystis pneumonia and HIV wasting
syndrome; for cases due to heterosexual transmission,
Pneumocystis pneumonia, oesophageal candidiasis and
pulmonary tuberculosis (FigureL).
There has been a substantial decrease in the number

of heterosexually acquired HIV infections during the
past decade; however, heterosexual transmission still
remains the second most common mode of HIV transmission in the EU/EEA. Part of the decline in heterosexual
cases is due to the 61% decline during the last decade in
the number of heterosexually acquired cases originating
from countries with generalised HIV epidemics. Further
exploration is required to understand whether these
trends are driven by decreased incidence of HIV in these
populations, decreased testing, migration or a combination of factors.
In the EU/EEA, 27 countries reported data on deaths

among individuals diagnosed with AIDS (Finland, Italy,
and Sweden did not provide this data). Overall, 997 individuals with AIDS were reported to have died during 2013
(Table25). This figure has been consistently decreasing
since 2004 (3 067 reported deaths among the same 27
countries reporting deaths in 2013), although delays in
reporting affect the latest figures. From the beginning of
the HIV epidemic to the end of 2013, a cumulative total
of 341 625 individuals had been diagnosed with AIDS
in the EU/EEA (Table 15). The cumulative total of cases
reported as known to have died by the end of 2013 was
183 953 (Table25).
Both among heterosexual cases and within other transmission groups, migrants, or persons originating from
outside of the reporting country, still constitute a considerable proportion (35%) of new HIV diagnoses in the
EU/EEA. There is increasing evidence that a proportion
of migrants acquire HIV after arrival in the EU/EEA [2, 3].
1.4 Conclusions
In 2013, for the first time, HIV surveillance data have
national coverage from all participating EU/EEA countries due to increased coverage of the HIV surveillance
systems in Italy and Spain in recent years. The 2013
MSM
FigureL: Percentage and number of the most common AIDS-indicative diseases per transmission mode, EU/EEA, 2013
(n=4 369)
Pneumocystis pneumonia
393
Kaposi's sarcoma
222
Candidiasis, oesophageal
131
IDU
Mycobacterium tuberculosis, pulmonary
152
129
Hetero
Wasting syndrome due to HIV
116
500
269
199
0
10
15
20
25
30
Percentage
MSM: Men having sex with men; IDU: injecting drug use; Hetero: heterosexual transmission.
Transmission among people who inject drugs remains

at a low level in most countries in the EU/EEA. However,
increases have been observed during recent years in
Romania and Greece, countries with previously very
low levels of HIV among PWID [4, 5], illustrating that
patterns can change quickly in the absence of effective
prevention delivered at scale.
The decreasing number of cases infected through
mother-to-child transmission indicate that antenatal
screening programmes are operating effectively and that
prophylactic treatment is available in most countries in
the EU/EEA. Still, strengthened efforts are needed to
address the few preventable cases of mother-to-child
transmission that still occur in some EU/EEA countries.
Despite increasing evidence of the benefits of early
treatment for the infected individual, 47% of newly
reported HIV cases with information on CD4 cell count
are diagnosed as late presenters or with indication of
advanced infection, i.e. with unacceptably low CD4 cell
counts. This suggests persistent problems with access
to, and uptake of, HIV testing and counselling by those
most at risk in many countries. There is strong evidence
that delayed initiation of antiretroviral treatment leads
to increased morbidity and mortality for the person
diagnosed. In addition to the clinical and personal benefits to the individual diagnosed, early diagnosis and
treatment can also benefit sexual and injecting partners
by inhibiting onward HIV transmission.
The changes in the pattern of HIV infections observed in
the EU/EEA over the last decade indicate that it is crucial
to sustain evidence-based HIV prevention interventions
that are tailored to the local epidemiological context and
targeted at those most at risk. Prevention and control of
HIV infection adapted appropriately to key populations,
such as MSM, are the cornerstones of HIV prevention
in most EU/EEA countries. Migrants, both those from
high-endemic countries and other countries, are also a
key population for prevention and control efforts in the
majority of EU/EEA countries. Given the increasing evidence of post-migration HIV acquisition, it is important
that migrant-sensitive services for HIV testing, combined with policies which promote and ensure linkage to
and access to care are delivered in all countries across
the EU/EEA. Finally, harm reduction programmes among
people who inject drugs and their sexual partners are
crucial and should be maintained and scaled up in many
countries where HIV incidence is high in this population
and where service coverage is low.
References
1
European Centre for Disease Prevention and Control/WHO Regional

Oce for Europe. HIV/AIDS surveillance in Europe 2012. Stockholm:
ECDC; 2013.
Rice BD, Elford J, Yin Z, Delpech VC. A new method to assign country
of HIV infection among heterosexuals born abroad and diagnosed
with HIV. AIDS 2012; 26(15):1961-1966.
European Centre for Disease Prevention and Control. Migrant

health: Sexual transmission of HIV within migrant groups in the EU/
EEA and implications for e ective interventions. Stockholm: ECDC;
2013.
SURVEILLANCE REPORT

Is risk increasing in Europe?. Euro Surveill. 2013;18(48):pii=20648.
Available online: http://www.eurosurveillance.org/ViewArticle.
aspx?ArticleId=20648
Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Antoniadou

A, Lazanas M, et al. HIV-1 outbreak among injecting drug
users in Greece, 2011: a preliminary report. Euro Surveill.
2011;16(36):pii=19962. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19962
SURVEILLANCE REPORT
2 HIV and AIDS in the WHO European Region

2.1 HIV and AIDS diagnoses in
the WHO European Region
HIV diagnoses
With inclusion of 136 235 new HIV diagnoses reported
in 2013, the cumulative number of infections diagnosed
in the WHO European Region increased to 1 715 344,
including 914 8132 officially reported to ECDC and the
WHO Regional Office for Europe (Figure B) and 800 531
diagnoses were reported by Russia [1]. The 136 235 new
HIV diagnoses were reported by 51 of the 53 countries of
the WHO European Region3, corresponding to a rate of
15.7 per 100 000 population for 2013, and include 56 507
cases officially reported to ECDC/WHO Regional Office
for Europe by 50 countries, a rate of 7.8 per 100 000 population; and 79 728 cases from Russia [1].
For men, the rate of new cases was 10.8 per 100 000
population (Table 2) and for women, 4.8 per 100 000
population (Table 3) (Russia not included). Forty-five
percent of newly diagnosed infections (25 494 cases)
were reported in the East, 48% (26 847 cases) in the West
and 7% (4 166 cases) in the Centre of the Region, while
the rate of cases per 100 000 population was highest in
the East (22.7 per 100 000), over three times higher than
in the West (6.3 per 100 000) and ten times higher than
in the Centre (2.2 per 100 000) (Table 1). When data for
Russia are included, 77% of new cases were reported in
the East, 20% in the West and 3% in the Centre while the
rate in the East increases to 41.2 per 100 000 population.
Rates of HIV infections diagnosed in 2013 also varied
widely across countries in the WHO European Region.
In Russia the rate was 55.6 per 100 000 population
in 2013 [1]. Among reporting countries, the highest
rates were reported by Ukraine (39.4), Estonia (24.6),
Moldova (17.3), Latvia (16.8), Belarus (14.6), Kazakhstan
(13.0), Georgia (10.7), Tajikistan (10.1) and Belgium
(10.0) while the lowest rates were reported by Bosnia
and Herzegovina (0.7), the former Yugoslav Republic of
Macedonia (0.7), Slovakia (1.5), Montenegro (1.6) and
Turkey (1.7). Monaco and San Marino reported zero
cases in 2013. (Table1).
Among HIV infections diagnosed in 2013 (Russia
excluded), the majority (36%) were in the age group
3039 years (42% with Russia included), while 10%
were 1524-year-olds (Table 9, Table A). The male-tofemale ratio was 2.2 (1.7 with Russia included), lowest
in the East (1.3) (1.4 with Russia included), higher in the
West (3.3) and highest in the Centre (4.9) (Table A). At
country level, the highest male-to-female ratios were
2 Minus the 62 581 cases officially reported to ECDC/WHO by Russia in
2010.
observed in Serbia (11.3), Hungary (11.1), Croatia (9.6),

the Czech Republic (8.8), Greece (8.7) and Slovenia (7.8)
and the lowest in Belarus (1.1), Moldova (1.2), Ukraine
(1.3), Kazakhstan (1.3), Kyrgyzstan (1.4), and Latvia (1.5)
(FiguresC, P, S).
Data on transmission mode for 2013 indicate the following (TableA, Tables47):
Forty-six percent of cases newly diagnosed were
infected through heterosexual transmission (26 047
cases), although the picture is more heterogeneous
at sub-regional level (Table 6, Table A). Among cases
reported as infected through heterosexual contact,
13% were in persons originating from countries with
generalised epidemics (data not shown).
Twenty-four percent were infected through sex
between men (13 348 cases) (Table4).
Sixteen percent of newly diagnosed HIV infections
were acquired through injecting drug use (9 135)
(Table5).
Of the remaining cases, 0.9% (509 cases) were
infected through mother-to-child transmission
(Table7) and 0.2% (94 cases) through other transmission routes (nosocomial infection, transfusion or use
of other blood products). Seventeen percent of children infected through MTCT originated from countries
with generalised epidemics (data not shown).
Transmission mode was reported as unknown or missing for 13% (7 374 cases).
When data for Russia are included, the percentages and
numbers of cases by transmission category change to
31% (41 656 cases) for heterosexual transmission, 21%
(29 010 cases) for injecting drug use, 10% (13 719 cases)
for sex between men, 0.6% (875 cases) for MTCT and
37% (50 862 cases) for unknown transmission mode.
Information about probable country of infection was
reported by 27 of the 50 countries, covering 19% of new
diagnoses (10 981 cases). Of the cases for whom HIV
infection was reported as acquired abroad (1 912 cases)
34% were infected in sub-Saharan Africa (658 cases),
32% in central and eastern Europe (611 cases) and 11%
in south and south-east Asia (209 cases) (Table13).
In 2013, 35 countries (15 in the West, 12 in the Centre
and eight in the East) provided information on CD4 cell
count at the time of HIV diagnosis for 35 383 cases (covering 48% of all new cases) (Table 14). Close to half
(49%) of these cases were late presenters with CD4 cell
counts below 350/mm3, including 27% with advanced
HIV infection (CD4<200/mm3). CD4 cell count data were
available for more than 50% of the reported cases in
30 countries. The percentage of late presenters varied
3 No data available from Lichtenstein, Uzbekistan or Turkmenistan.
SURVEILLANCE REPORT
FigureM: Rates of new HIV diagnoses, by geographical area and year of diagnosis, WHO European Region, 20042013
Arithmetic scale
25
West
Centre
East
20
WHO European Region

15
10
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Year of diagnosis
Logarithmic scale
100
West
Centre
East
WHO European Region
10
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Year of diagnosis
Cases from Russia, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period
FigureN: New HIV diagnoses, by transmission mode and year of diagnosis, WHO European Region, 20042013
25000
Heterosexual
Sex between men
Injecting drug use
Number of cases
20000
Other/undetermined
15000
10000
5000
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Year of diagnosis
Cases from Russia, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period; cases from Estonia, Poland and Turkey excluded due to
incomplete reporting on transmission mode during the period; cases from Italy and Spain excluded due to increasing national coverage over the period. Data are not
adjusted for reporting delays and numbers of cases reported for recent years are likely to increase in future reports.
10
SURVEILLANCE REPORT
across transmission categories and were highest for

people infected through heterosexual contact (57%) and
injecting drug use (56%) and lower for people infected
through sex between men (37%).
Trends in HIV diagnoses

Between 2004 and 2013, the rate of newly diagnosed HIV
infections per 100 000 population increased by 81%, from
8.7 in 2004 (75 812 cases) to 15.7 in 2013 (136 235 cases)
in 51 countries4 (Russia included) which corresponds to
an 80% increase in the absolute number of cases. The
increase is mainly driven by an upward trend in the East
where the rate increased by fully 144% from 16.9 in 2004
(47 332 cases) to 41.2 in 2013 (105 222 cases). In the 50
countries that provided official data to ECDC and WHO
(Russia excluded), the regional rate increased by 16%,
from 6.7 per 100 000 (42 405 cases) to 7.8 (56 507 cases),
whereas the rate in the East increased by 80% from 12.6
in 2004 (13 925 cases) to 22.7 in 2013 (25 494 cases) for
those countries consistently reporting for the period. In
the Centre, the rate increased by 175%, from 0.8 (1 577
cases) to 2.2 (4 166 cases) whereas it decreased in the
West by 20%, from 7.9 (26 903 cases) to 6.3 (26 847),
not adjusting for reporting delay (Figure M, Table 1).
Presenting the data on a logarithmic scale, allowing better comparison of rates of change regardless of starting
point, visually shows that the highest relative increase
in rates occurred in the Centre (FigureM).
A total of 14 395 148 HIV tests performed for diagnostic purposes were reported by 33 countries for 2013. A
majority of countries reported increasing numbers of
HIV tests during the period 20042013, notably in the
East. Higher testing rates were reported by countries
in the East, lower rates by countries in the Centre while
data from countries in the West showed varying levels
and trends (Table 27). The total number of tests performed in the 32 countries with data for both 2004 and
2013 increased by 41%, from 10 106 310 to 14 244 551.
Among the 46 countries consistently reporting data on
transmission mode for the period 20042013 (Table 8,
Figure N), not considering variations at sub-regional
level:
the number of heterosexually acquired infections
(including cases originating from countries with generalised epidemics) increased by 30% from 17 620 in
2004 to 22 830 in 2013;
the number of cases infected through sex between
men increased by 40% from 6 975 in 2004 to 9 797 in
2013;
the number of cases infected through injecting drug
use decreased by 3% from 8 987 in 2004 to 8 713 in
2013;
the number of children infected through mother-tochild transmission increased by 32%, from 357 cases
in 2004 to 473 in 2013;
Data from Turkmenistan and Uzbekistan not included.
of the number of HIV infections transmitted through

other means, nosocomial transmission increased
by 39% from 23 cases in 2004 to 32 cases in 2013,
whereas transmission due to transfusion of blood and
its products decreased by 54% from 105 in 2004 to 48
in 2013; and
the number of infections reported with unknown risk
factors increased by 48%, from 3 372 in 2004 to 5 001
in 2013.
When data for Russia are included, the number of cases
in each transmission category increases by 69% for heterosexual transmission (from 22 811 to 38 439), by 42%
for injecting drug use (from 20 178 to 28 590), by 43% for
sex between men (from 7 108 to 10 168) and by 144% for
unknown transmission (from 19 941 to 48 565) whereas
it decreased by 15% for MTCT (from 988 to 839 cases).
AIDS cases, morbidity and mortality

Since the beginning of the epidemic, at least 472 358
AIDS cases have been diagnosed in the WHO European
Region. In addition to the 437 885 cases officially
reported to ECDC/WHO by 52 countries, this figure
includes cumulative 34 473 AIDS cases diagnosed in
Russia as of 31 December 2013 [1].
In 2013, 15 789 new AIDS cases were diagnosed in 49
countries of the WHO European Region5 and the rate of
new diagnoses per 100 000 population was 2.2 (Table15).
Of the new AIDS diagnoses, 72% (11 292 cases) were
reported by countries in the East, 23% (3 606 cases) in
the West and 6% (891 cases) in the Centre of the Region.
The number of cases per 100 000 population was 10.0 in
the East, eleven times higher than in the West (0.9 per
100 000) and 20 times higher than in the Centre (0.5 per
100 000).
The rate of new AIDS diagnoses varied widely between
countries. The highest rates were reported in Ukraine
(20.6), Georgia (6.8), Latvia (6.6), Moldova (5.7), Belarus
(4.7) and Armenia (4.4) and the lowest rates (0.3 or less)
were reported in Bosnia and Herzegovina, Cyprus, the
Czech Republic, Germany, Iceland, Malta, Slovakia and
Turkey. Monaco and San Marino reported zero cases.
Between 2004 and 2013, the rate of new AIDS cases
per 100 000 population increased by 10%, from 2.0
in 2004 (12 952 cases) to 2.2 in 2013 (15 789 cases) in
the 50 countries with consistent AIDS data (Figure O).
Reporting delays affect the number of cases reported in
2013, reinforcing the recent apparent decrease.
AIDS trends vary greatly at sub-regional level. In the
East, the rate increased by 213% from 3.2 (3 275 cases)
in 2004 to 10.0 (11 292 cases) in 2013, whereas in the
West, the steady downward trend continued with a rate
decrease of 64%, from 2.5 (8 915 cases) in 2004 to 0.9
(3 606 cases) in 2013. In the Centre there was a 25%
increase from 0.4 (762 cases) in 2004 to 0.5 (891 cases)
in 2013. Trends in AIDS cases by mode of transmission
11
SURVEILLANCE REPORT
FigureO: Rate of AIDS cases per 100 000 population, by geographical area and year of diagnosis, 20042013
12
West
Centre
10
East
WHO European Region
8
6
4
2
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Year of diagnosis
Cases from Sweden, Russia, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period
FigureP: Male-to-female ratio in new HIV diagnoses and heterosexually infected cases, by country, East, 2013
(n=25 494)
All cases
Georgia
Cases infected through heterosexual

transmission
Lithuania
Armenia
Azerbaan
Tajikistan
Estonia
Latvia
Kyrgyzstan
East average
Ukraine
Kazakhstan
Moldova
Belarus
0.0
0.5
1.0
1.5
2.0
12
2.5
3.0
3.5
SURVEILLANCE REPORT
in the West, Centre and East are presented in Figure 1

on page82.
by the countries for 2013 indicates the following (TableA,

Tables47):
The cumulative number of people with AIDS reported to

have died in the Region by the end of 2013 is 258 631,
including 230 370 officially reported to ECDC/WHO and
28 261 in Russia [1]. Some 5 037 deaths among AIDS
cases were reported by 47 countries6 in 2013 (Table25).
In those countries, the number of deaths decreased by
4%, from 5 269 in 2004.
The majority of new infections were acquired through

heterosexual contact, accounting for 63% of new HIV
infections (15 984 cases).

the East
HIV diagnoses in the East
In 2013, 12 of the 15 countries in the East reported 25 494
newly diagnosed HIV infections, corresponding to a rate
of 22.7 per 100 000 population (Table1), the highest rate
of the three geographical areas and the highest in the
East during the past ten years for those 12 countries. An
additional 79 728 new HIV diagnoses were reported in
Russia [1], increasing the total number of cases in the
East to 105 222, giving a rate of 41.2 cases per 100 000
population.
In Russia the rate of diagnoses per 100 000 population
was 55.6 in 2013 [1]. Among reporting countries, the
highest rates in 2013 were reported by Ukraine (39.4),
Estonia (24.6), Moldova (17.3), Latvia (16.8), Belarus
(14.6), Kazakhstan (13.0), Georgia (10.7 and Tajikistan
(10.1) and the lowest rates were reported by Azerbaijan
(5.5), Lithuania (6.0) and Armenia (7.3). Among cases
with information about age and gender, the majority
(40%) were reported in the age group 3039 years (45%
when Russian data are included), while 10% were aged
1524 years (TableA).
The male-to-female ratio was 1.3 (1.4 when Russia is
included), the lowest of the three geographical areas,
translating into 43% of new cases being women in the
East. The number of women newly diagnosed doubled
between 2004 and 2013 in countries with consistent
data7, from 5 357 to 10 938 (Table3). Looking only at cases
infected through heterosexual transmission, the male-tofemale ratio drops to 0.7 corresponding to 57% of people
infected heterosexually being female (FigureP). However,
in two countries (Armenia and Georgia) the ratio remains
above one, indicating that men remain more affected
even among cases infected heterosexually. In the West
and the Centre, the average male-to-female ratio among
cases infected through heterosexual transmission is 1.0
and 2.0, respectively (data not shown), suggesting that
the proportion of women among heterosexually infected
cases is highest in the East.
In the East, heterosexual contact, followed by injecting
drug use, was the predominant mode of HIV transmission. Information about transmission modes as reported
6 No data available from Finland, Italy, Russia, Sweden, Turkmenistan

or Uzbekistan.
Injecting drug use was the second most common

mode of transmission, contributing 31% of new HIV
infections (7 791cases).
Just 2% of cases were acquired through sex between
men (510 cases).
1% of new infections were due to mother-to-child
transmission (271 cases).
Transmission mode was unknown for 4% of the new
diagnoses (922 cases).
When data for Russia are included, the percentages
and numbers of cases by transmission mode change to
30% (31 593 cases) for heterosexual transmission, 26%
(27 666) for injecting drug use, 0.8% (881 cases) for
sex between men, 0.6% (637 cases) for MTCT and 42%
(44 435 cases) for unknown transmission mode.
In 2013, only five countries in the East provided information on the probable source of infection when the case
was infected through heterosexual contact (Armenia,
Azerbaijan, Estonia, Georgia and Latvia), and even
in those countries, the information was reported as
unknown for 86% (833) of the 973 cases (Table 10).
Among the cases that did have information, the probable source of infection was reported to be sexual
contact with a person who injects drugs for 75% of
cases and sexual contact with a person from a generalised epidemic country in 21% of cases. This variable,
if well reported, could provide important information
on the extent to which the increasing numbers of new
cases reported as heterosexually acquired are occurring
among sexual partners of people who inject drugs or
other high risk groups.
Nine countries provided information about the probable country of infection for 4 654 cases diagnosed in
2013 (18% of cases in the East). In that sample, 10% of
cases were reported as acquired abroad of which 90%
were acquired in other countries of central and eastern
Europe.
Trends in HIV diagnoses in the East

In the 13 countries in the East with consistent data for
20042013 the rate of reported HIV diagnoses increased
by 80% from 12.6 per 100 000 in 2004 to 22.7 per
100 000 in 2013 (Table1, FigureM). When data for Russia
are considered, the rate increased by 144%, from 16.9
in 2004 (47 332 cases) to 41.2 in 2013 (105 222 cases),
corresponding to a 122% increase in the absolute number of cases. Since 2004, all countries with consistent
data, except Estonia where rates decreased from 54.4 to
24.6, have reported increasing numbers and rates of HIV
diagnoses. Rates of diagnoses per 100 000 population
increased more than fourfold in Armenia and Azerbaijan,
7 Russia, Turkmenistan and Uzbekistan excluded.
13
SURVEILLANCE REPORT
FigureQ: New HIV diagnoses, by transmission mode and year of diagnosis, East, 20042013
Arithmetic scale
20000
Heterosexual
Sex between men
Injecting drug use
Number of cases
15000
Other/undetermined
10000
5000
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Year of diagnosis
Logarithmic scale
100000
Heterosexual
Sex between men
Number of cases
10000
Injecting drug use

Other/undetermined
1000
100
10
1
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Year of diagnosis
Cases from Russia, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period; cases from Estonia excluded due to incomplete reporting
on transmission mode during the period
FigureR: Distribution of the three most common AIDS-indicative diseases per transmission mode, East, 2013
MSM
IDU
296
160
Hetero
Mycobacterium tuberculosis, extrapulmonary
121
252
184
162
0
10
15
Percentage
MSM: Men having sex with men; IDU: injecting drug use; Hetero: heterosexual transmission.
14
20
25
30
SURVEILLANCE REPORT
more than threefold in Tajikistan and more than doubled

in Georgia, Kazakhstan and Kyrgyzstan (Table1).
(FigureO), corresponding to a 245% increase in the number of cases.
During the same period, the number of HIV tests doubled

in the 12 countries with consistent data, from 3 300 898
in 2004 to 6 818 803 in 2013 (Table27).
The most common AIDS-indicative diseases diagnosed

in 2013 were pulmonary tuberculosis (24% of all disease
events reported), wasting syndrome due to HIV (14%)
and oesophageal candidiasis (13%) (Table24). By transmission mode, the most common diseases in people
infected through heterosexual contact and sex between
men were pulmonary tuberculosis, wasting syndrome
and oesophageal candidiasis; while for people infected
through injecting drug use, pulmonary tuberculosis,
wasting syndrome due to HIV and extrapulmonary tuberculosis were the most frequent diagnoses (FigureR).
Information on transmission mode in 12 countries in the

East with consistent data since 20048 indicates the following (Table8b, FigureQ):
The number of infections acquired through injecting
drug use remained fairly stable with 7 441 cases in
2004 and 7 719 in 2013 following a period of higher
levels during 20062010, although increasing numbers were reported in some countries.
The number of HIV infections acquired through heterosexual contact tripled from 5 034 cases in 2004 to
15 815 in 2013. In Armenia, Azerbaijan, Kazakhstan,
Kyrgyzstan and Tajikistan the number increased by
more than five times.
The number of HIV infections acquired through sex
between men has increased by more than fifteen
times, from 33 in 2004 to 504 in 2013.
A cumulative 66 606 people with an AIDS diagnosis

were reported to have died by the end of 2013 in the
East: 38 345 officially reported to ECDC/WHO and 28 261
from Russia [1]. In the East, 4 096 deaths among cases
diagnosed with AIDS were reported for 2013 (Table 25).
Assessing the change between 2004 and 2013 in countries with complete reporting 10, a 98% increase in the
number of deaths is observed (from 2 067 in 2004 to
4 096 in 2013).
The number of children infected through mother-tochild transmission has increased by 19%, from 226 in
2004 to 269 in 2013.

the Centre
The number of cases for which the mode of transmission was unknown increased by 34%, from 633 in
2004 to 846 in 2013.
HIV diagnoses in the Centre
Considering data for Russia, the number of cases in

each transmission category increased by 207% for heterosexual transmission (from 10 225 to 31 424 cases),
48% for injecting drug use (from 18 632 to 27 596 cases),
427% for sex between men (from 166 to 875) and 160%
for unknown transmission (from 17 076 to 44 346 cases)
whereas it decreased by 5% for MTCT (from 671 to 635
cases).
On a logarithmic scale allowing comparison of rates
of change regardless of starting point, the data reveal
the dramatic relative increase in the rate of infections
reported as acquired through sex between men and
shows this increase to be much steeper than that of
other transmission modes (FigureQ).
AIDS cases, morbidity and mortality in the East

In 2013, 11 292 cases of AIDS were diagnosed in 12 of
the 15 countries in the East 9 which corresponds to a
rate of 10.0 per 100 000 population. In 2013, the highest rates were reported by Ukraine (20.6), Georgia (6.8),
Latvia (6.6), Moldova (5.7) and the lowest by Tajikistan
(1.1), Kyrgyzstan (1.2), Lithuania (1.5), Kazakhstan (1.6)
and Estonia (1.8) (Table 15). Between 2004 and 2013
the rate increased by 213%, from 3.2 cases per 100 000
population in 2004 (3 275 cases) to 10.0 in 2013 (11 292
cases) for countries reporting consistently for the period
The HIV epidemic in the Centre remains at a low and

stable level although there is evidence of increasing
transmission in many countries, especially through
sexual contact between men. In 2013, 4 166 new infections were reported from 15 countries; a rate of 2.2 per
100 000 population (Table 1). The highest rates were
reported by Cyprus (6.2), Albania (4.1), Poland (2.8) and
Bulgaria (2.7) and the lowest by Bosnia and Herzegovina
(0.7), the former Yugoslav Republic of Macedonia (0.7),
Slovakia (1.5), Montenegro (1.6) and Turkey (1.7).
Among cases newly diagnosed in 2013, the most affected
age group was the 3039-year-olds with 36% of cases,
whereas 14% were diagnosed among 1524-year-olds
(TableA). The male-to-female ratio was 4.9, the highest
male-to-female ratio of the three geographical areas in
the WHO European Region. The highest male-to-female
ratios were observed in Serbia (11.3), Hungary (11.1),
Croatia (9.7), the Czech Republic (8.8) and Slovenia (7.8)
(Figure S). Information on transmission modes for 2013
indicates the following (TableA, Tables47):
Men having sex with men accounted for 30% of new
diagnoses (1 256 cases).
Twenty-five percent of HIV infections were acquired
through heterosexual contact (1 032 cases).
Six percent were infected through injecting drug use
(244 cases).
Mother-to-child transmission accounted for 1.1% (47
cases).
8 Data from Estonia, Russia and Uzbekistan not included.

9 No data reported by Russia, Turkmenistan or Uzbekistan.
10 Russia, Turkmenistan and Uzbekistan not included.
15
SURVEILLANCE REPORT
FigureS: Male-to-female ratio in new HIV diagnoses, by country, Centre, 2013 (n=4 166)
Serbia
Hungary
Croatia
Czech Republic
Slovenia
Poland
Slovakia
Cyprus
Turkey
Bulgaria
Bosnia and
Herzegovina
Romania
Albania
0
10
12
Montenegro and the former Yugoslav Republic of Macedonia did not report any female cases in 2013
FigureT: New HIV diagnoses, by transmission mode and year of diagnosis, Centre, 20042013
1000
Heterosexual
Sex between men
Injecting drug use
Number of cases
800
Other/undetermined
600
400
200
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Year of diagnosis
Cases from Poland and Turkey excluded due to incomplete reporting on transmission mode during the period
16
SURVEILLANCE REPORT
Transmission mode was unknown for 38% of the new

diagnoses (1 579 cases).
In 2013, sex between men remained the predominant
reported mode of transmission in an increasing majority
of countries: Bosnia and Herzegovina, Bulgaria, Croatia,
Cyprus, the Czech Republic, the former Yugoslav
Republic of Macedonia, Hungary, Montenegro, Poland,
Serbia, Slovakia and Slovenia; whereas heterosexual
transmission was the main mode of transmission in
Albania, Romania and Turkey.
Trends in HIV diagnoses in the Centre

In the 15 countries in the Centre, the rate of new HIV
diagnoses increased by 175% between 2004 and 2013,
from 0.8 per 100 000 population in 2004 (1 577 cases) to
2.2 in 2013 (4 166 cases) (Figure M). Rates increased in
all 15 countries and more than tripled in seven: Albania,
Bulgaria, Czech Republic, Hungary, Montenegro,
Slovakia and Turkey.
Reported data suggest some increase in HIV testing
activities, with a reported 30% increase in the number
of tests performed in 2013 compared with 2004 in the
twelve countries with data for both years (Table 27).
Since 2004, information on transmission mode from 13
countries with consistent data (Poland and Turkey not
included) shows the following (Table8b, FigureT):
The number of cases infected through sex between
men more than quadrupled, from 179 in 2004 to 809
in 2013.
The number of cases infected through heterosexual
transmission increased by 64% (from 318 cases in
2004 to 522 cases in 2013).
The number of cases infected through injecting drug
use increased by more than five times (by 458%), from
36 in 2004 to 201 in 2013, mainly due to an outbreak in
Romania that started in 2011.
The number of HIV infections transmitted from mother
to child increased by 129%, from 14 children in 2004 to
32 in 2013. Four countries contributed to this increase:
Albania, Bulgaria, Romania and Serbia.
The number of new cases reported with unknown
transmission mode increased by 41% from 141 cases
in 2004 to 199 in 2013.
AIDS cases, morbidity and mortality in the

Centre
In 2013, 891 AIDS diagnoses were reported by the 15 countries in the Centre, a rate of 0.5 per 100 000 population
(Table 15). The highest rates were reported by Albania
(2.0), Romania (1.7), Montenegro (1.1) and Bulgaria (1.0).
In the other countries, AIDS rates remained at or below
0.5 per 100 000 population.
The rate of new AIDS cases increased by 25%, from 0.4
per 100 000 (762 cases) in 2004 to 0.5 per 100 000 (891
cases) in 2013 (Figure O). At country level trends were
heterogeneous. Of the seven countries reporting more

than 30 AIDS cases in 2013, the number increased in
four: Albania (from 11 to 56), Bulgaria (from 22 to 71),
Hungary (from 23 to 42) and Turkey (from 55 to 93); and
decreased slightly in three: Poland (from 176 to 160),
Romania (from 366 to 338) and Serbia (from 58 to 44)
(Table15).
in 2013 were wasting syndrome due to HIV (18%), pulmonary tuberculosis (11%) and Pneumocystis pneumonia
(10%) (Table 24). By transmission mode, the most common diseases for people infected through sex between
men are Pneumocystis pneumonia, wasting syndrome
due to HIV and Kaposis sarcoma; for people infected
through injecting drug use, pulmonary tuberculosis,
wasting syndrome due to HIV and Pneumocystis pneumonia; and for heterosexuals, wasting syndrome due to
HIV, pulmonary tuberculosis and Pneumocystis pneumonia (FigureU).
A total of 202 individuals diagnosed with AIDS were
reported to have died during 2013 in the Centre
(Table25); a 45% decrease from 365 individuals in 2004.

the West
HIV diagnoses in the West
In the West, 26 847 newly diagnosed HIV infections were
reported in 2013 from the 23 countries, giving a rate of
6.3 per 100 000 population, without adjusting for reporting delay (Table 1, Table A). The reported data suggest
that sexual transmission between men remains the main
transmission mode, followed by heterosexual transmission, together accounting for 77% of new diagnoses. Of
newly diagnosed HIV infections in 2013, the majority
(32%) were 3039-year-olds, 10% were 1524-year-olds
and the male-to-female ratio was 3.3 (TableA).
The distribution by transmission mode is, as in previous
years, influenced by the number of infections diagnosed
in individuals originating from countries with generalised epidemics, especially for heterosexually acquired
infections. Epidemic patterns by country of origin and
mode of transmission largely correspond to those of the
EU/EEA and are described in Chapter 1.2.
Information about transmission mode for 2013 indicates
the following (TableA, Tables47):
Sex between men accounted for 43% of new diagnoses (11 582 cases).
Thirty-four percent of the HIV infections were acquired
through heterosexual contact (9 031 cases).
Four percent of HIV infections were acquired through
injecting drug use (1 100 cases).
Mother-to-child transmission accounted for 0.7% of
diagnoses (191 cases).
17
SURVEILLANCE REPORT
FigureU: Distribution of the three most common AIDS-indicative diseases per transmission mode, Centre, 2013
MSM
36
36
Kaposi's sarcoma
20
IDU
41
31
13
Hetero
72
38
31
0
10
15
20
25
Percentage
MSM: Men having sex with men; IDU: injecting drug use; Hetero: heterosexual transmission
FigureV: New HIV diagnoses, by transmission mode and year of diagnosis, West, 20042013
10000
Heterosexual, excluding cases originating

from countries with generalised HIV epidemics
Heterosexual, originating from countries with
Number of cases
8000
Sex between men

6000
Injecting drug use

4000
Other/undetermined
2000
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Year of diagnosis
Cases from Italy and Spain excluded due to increasing national coverage of reporting during the period. Data are not adjusted for reporting delays and numbers of
cases reported for recent years are likely to increase in future reports.
MSM
FigureW: Distribution of the three most common AIDS-indicative diseases per transmission mode, West, 2013
378
Kaposi's sarcoma
209
123
IDU
114
90
Hetero
78
484
263
163
0
10
15
Percentage
MSM: Men having sex with men; IDU: injecting drug use; Hetero: heterosexual transmission
18
20
25
30
SURVEILLANCE REPORT
Transmission mode was unknown for 18% of infections (4 873 cases).
Trends in HIV diagnoses in the West

Between 2004 and 2013 in the 23 countries in the West
with consistent data, the average rate of newly diagnosed HIV infections declined by 20%, from 7.9 per
100 000 population (26 903 cases) in 2004 to 6.3 (26 847
cases), not taking into account reporting delay for the
most recent years.
Rates increased in eight and decreased in 15 countries.
However, the decreases may be influenced by reporting delays in several countries. The highest rates were
reported by Portugal (10.4), Belgium (10.0), Luxembourg
(9.9), and the United Kingdom (9.4); and the lowest by
Finland (2.9), Austria (3.1), Iceland (3.4), Sweden (3.7)
and Denmark (4.2).
Since 2004, information on transmission mode in 21
countries (data not included from Italy or Spain) indicates the following (Table8b, FigureV):
The number of heterosexually acquired infections
decreased by 47% (from 12 268 cases in 2004 to 6 493
cases in 2013), with the steepest decline among cases
originating from countries with generalised epidemics
(see Chapter1.2 and FigureV).
The number of HIV diagnoses among MSM increased
by 26% from 6 760 in 2004 to 8 484 in 2013.
New diagnoses of cases infected through injecting
drug use decreased by 47%, from 1 510 in 2004 to 793
in 2013.
Newly diagnosed HIV infections due to mother-to-child
transmission decreased by 43% from 303 in 2004 to
172 in 2013.
The number of cases with unknown transmission
mode has increased by 49%, with 2 706 cases in 2004
and 4 019 in 2013.
The presentation of trends by transmission group
largely mirrors the pattern for the EU/EEA as described
in Chapter1.2.
AIDS cases, morbidity and mortality in the

West
For 2013, 3 606 AIDS diagnoses were reported by 20 of
the 23 countries in the West 11, giving a rate of 0.9 per
100 000 population (Table15). Between 2004 and 2013,
the rate of new AIDS cases decreased by 64%, from 2.5
(8 915 cases) in 2004 to 0.9 (3 606 cases) in 2013 for
countries consistently reporting.
in the West in 2013 were Pneumocystis pneumonia
(23%) and oesophageal candidiasis (11%) (Table24). By
transmission mode, the most common AIDS-indicative
diseases for men infected through sex with men were
Pneumocystis pneumonia, Kaposis sarcoma and

oesophageal candidiasis; for people who inject drugs
and heterosexually infected cases it was Pneumocystis
pneumonia, oesophageal candidiasis and pulmonary
tuberculosis (FigureW).
In the West, 739 individuals diagnosed with AIDS were
reported to have died during 2013 (Table25), continuing
the decreasing trend from 2 837 deaths in 2004 in countries with consistent data (a 74% decrease).
2.5 Number of HIV tests

performed
The numbers of HIV tests performed annually for diagnostic purposes (i.e. excluding unlinked anonymous
tests and screening of blood donations) are presented
by country in Table27. In 2013, 32 countries reported a
total of 14 395 148 HIV tests performed. Higher testing
rates were generally reported by countries in the East,
lower rates by countries in the Centre while data from
countries in the West varied considerably.
The number of tests increased by 41%, from 10 106 310 in
2004 to 14 244 551 in 2013 in 32 countries with consistent data. The number of tests increased in 27 countries
and declined in five.
Data on the number of HIV tests can support the interpretation of trends in newly diagnosed HIV infections.
The presented data, however, are derived from different
sources, ranging from annual reports from national HIV
testing sites, to extrapolations from information systematically gathered in laboratory networks performing
HIV tests and to estimates based on national surveys. In
contrast to the East and the Centre, many countries in
the West do not systematically collect data on the number of HIV tests and in some cases only estimates are
available. When comparing the reported testing rates
across countries, these differences should be kept in
mind. Further, the data do not provide detailed information on who is being tested or to what extent testing is
targeted at high-risk populations.
2.6 Conclusions
HIV infection remains of major public health importance
in Europe. In 2013, 136 235 new HIV infections were diagnosed in 51of the 53 countries of the WHO European
Region, giving a rate of 15.7 per 100 000 population.
Of those, 56 507 were officially reported to ECDC/WHO
Regional Office for Europe by 50 countries, while data
for 79 728 cases were published by the Russian Federal
Scientific and Methodological Center for Prevention and
Control of AIDS [1].
The data suggest continuing HIV transmission in
many countries and that HIV remains concentrated in
key populations at higher risk, such as MSM, people
from countries with generalised epidemics and other
migrants, and people who inject drugs and their sexual partners. At the same time, cases among people
11 No data available from Finland, Italy and Sweden.
19
originating from countries with generalised HIV epidemics appear to be decreasing. People infected through
heterosexual transmission in the East are increasingly affected. Predominant transmission modes and
trends over time vary by country and geographical/
epidemiological area, illustrating the diversity of HIV
epidemiology in Europe. Recent increases of HIV among
PWID in the EU/EEA indicate that even low numbers of
infections can rapidly evolve into an outbreak when public health interventions are insufficient.
In the western part of the Region, the highest proportion of HIV infections continues to be diagnosed in MSM.
HIV responses in this part of Europe need to be based on
evidence-informed prevention interventions targeting
this key population. In addition, given the relatively high
numbers of HIV diagnoses among people originating
from countries with generalised epidemics, countries
should ensure equal access to prevention, testing, treatment and care services for migrant populations.
In the Centre, levels of HIV infection remain at a relatively low level. However, the relative increase in new
diagnoses is by far the highest in this part of the Region.
The epidemic in this part of Europe is diverse but
sexual transmission between men dominates over heterosexual transmission in the majority of countries and
recent increasing trends are mostly driven by increasing
numbers of diagnosed infections acquired through sex
between men.
In the East, the number and rate of newly diagnosed HIV
infections is the highest in the Region and the number
of cases continues to increase. Heterosexual contact,
followed by injecting drug use, is the dominant reported
mode of transmission (both including and not including
Russia). The amount of independent versus PWID-related
heterosexual transmission remains unclear as data
on the probable source of infection is missing for the
majority of heterosexually acquired cases. Information
about probable country of infection is poorly reported
too, leaving insufficient evidence regarding the extent
to which people become infected in their home country
or abroad, including during periods of labour migration to neighbouring countries. While men remain
disproportionally affected by the epidemic, the maleto-female ratio is lower in the East than in other parts
of the Region and women account for more than 40% of
new infections overall and for the majority of new cases
acquired through heterosexual transmission. HIV transmission from male PWID and males with other high risk
behaviours to their female partners likely contributes to
this epidemic pattern.
Curbing the HIV epidemic in the East will not be possible
without implementation of more comprehensive prevention strategies for people who inject drugs, including
harm reduction interventions. In couples where one of
the partners is engaged in high-risk behaviour, such
as injecting drug use, prevention interventions should
address the risk of heterosexual transmission [2].
20
SURVEILLANCE REPORT
It is a major concern that 49% of newly diagnosed HIV

infections with information on CD4 cell counts have a
low count (<350/mm3) at the time of diagnosis, including
27% with an even lower count of CD4 <200/mm3. These
so-called late presenters reflect the low access to, and
uptake of, HIV testing and counselling by those most
at risk. Delayed initiation of antiretroviral treatment
decreases the clinical benefits, as well as the impact of
treatment on preventing further HIV transmission. HIV
counselling and testing strategies need to be reconsidered, including through innovative approaches and
services such as routine offers of counselling and testing
in clinical settings, rapid testing and community-based
testing to reach people that are at higher risk and ensure
earlier diagnosis and initiation of HIV treatment and
linkage to care. This will result in improved treatment
outcomes and clinical benefits, as well as contribute to
preventing or reducing further HIV transmission.
The number of diagnosed AIDS cases continues to
decline throughout Europe, except in the East. The high
and increasing number of AIDS cases in the countries in
the East is indicative of late HIV diagnosis, low treatment
coverage and delayed initiation of life-saving HIV treatment. The wide availability of treatment broadens the
perspectives of HIV surveillance to include monitoring
of access to care and treatment in the future. Improved
access to and earlier initiation of treatment, particularly
for key populations, is needed throughout Europe but
particularly in the East.
The number of countries conducting enhanced surveillance for HIV in Europe has increased over recent
years. Enhanced HIV surveillance in Europe is essential
to provide the strategic information for monitoring the
epidemic and guiding the public health response to HIV.
Interventions to control the epidemic need to be based
on evidence and adapted to national and local epidemiology. In order to achieve this aim, surveillance data
should be of high quality and provide complete case
reports with information about key variables such as
transmission mode, CD4 cell count and probable country
and source of infection.
References
1
Russian Federal Scientic and Methodological Center for Prevention

and Control of AIDS. HIV-infection Bulletin number 39. Moscow: The
Federal Service for Surveillance of Consumer Rights Protection and
human well-being; 2014.
World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Geneva:
World Health Organization; 2014.
SURVEILLANCE REPORT
Tables
21
SURVEILLANCE REPORT
Table1: HIV diagnoses and rates per 100 000 population, by country and year of diagnosis (20042013) and cumulative
totals, in EU/EEA and other countries of the WHO European Region
Area
Country*
EU/EEA
West Austria
West Belgium
Centre Bulgaria
Centre Croatia
Centre Cyprus
Centre Czech Republic
West Denmark
East
Estonia
West Finland
West France
West Germany
West Greece
Centre Hungary
West Iceland
West Ireland
West Italy
East
Latvia
East
Lithuania
West Luxembourg
West Malta
West Netherlands
West Norway
Centre Poland
West Portugal
Centre Romania
Centre Slovakia
Centre Slovenia
West Spain
West Sweden
West United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre Bosnia and Herzegovina
Centre former Yugoslav Republic of Macedonia, the
East
Georgia
West Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West Monaco
Centre Montenegro
East
Russia***
West San Marino
Centre Serbia****
West Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
Total WHO European Region
Year of
start of
reporting
2004
2005
2006
2007
2008
Rate
Rate
Rate
Rate
Rate
1980
1985
1986
1985
1986
1985
1990
1988
1980
2003
1993
1983
1985
1983
1981
2004
1987
1988
1983
2001
1980
1984
1985
1983
1987
1985
1985
2003
1983
1981
338
1 004
50
53
25
72
306
743
124
5 774
2 224
493
75
4
358
1 666
323
135
68
16
1 183
251
669
2 201
245
15
24
1 687
437
7 696
28 259
4.2
9.7
0.6
1.2
3.5
0.7
5.7
54.4
2.4
9.3
2.7
4.5
0.7
1.4
8.9
8.7
14.2
4.0
15.0
4.0
7.3
5.5
1.8
21.3
1.1
0.3
1.2
9.7
4.9
13.0
6.5
324
1 070
83
68
43
90
264
621
134
5 985
2 508
537
106
8
325
1 490
299
120
53
15
1 221
219
707
2 026
228
21
38
1 648
396
7 888
28 535
4.0
10.2
1.1
1.6
5.9
0.9
4.9
45.7
2.6
9.5
3.1
4.8
1.1
2.7
7.9
7.6
13.3
3.6
11.5
3.7
7.5
4.8
1.9
19.6
1.1
0.4
1.9
9.3
4.4
13.2
6.6
328
1 018
91
57
35
91
245
668
191
5 698
2 666
503
81
11
353
2 017
299
100
53
24
1 129
276
818
2 057
187
27
33
1 779
397
7 437
28 669
4.0
9.7
1.2
1.3
4.7
0.9
4.5
49.5
3.6
9.0
3.2
4.5
0.8
3.7
8.4
8.4
13.4
3.0
11.3
5.9
6.9
5.9
2.1
19.9
0.9
0.5
1.6
9.9
4.4
12.4
6.5
345
1 072
126
49
46
121
306
633
187
5 680
2 800
555
119
13
391
2 206
350
106
44
14
1 232
248
802
1 963
173
39
37
2 747
488
7 344
30 236
4.2
10.1
1.7
1.1
6.1
1.2
5.6
47.1
3.5
8.9
3.4
5.0
1.2
4.2
9.0
7.1
15.8
3.3
9.2
3.5
7.5
5.3
2.1
19.0
0.8
0.7
1.8
11.3
5.4
12.1
6.7
359
1 092
123
71
37
148
285
545
147
5 764
2 850
609
145
10
404
2 463
358
95
59
28
1 307
299
841
2 050
259
53
48
3 310
426
7 220
31 405
4.3
10.2
1.6
1.7
4.8
1.4
5.2
40.7
2.8
9.0
3.5
5.4
1.5
3.2
9.1
6.6
16.3
3.0
12.2
6.9
8.0
6.3
2.2
19.8
1.3
1.0
2.4
11.8
4.6
11.8
6.8
1993
2004
1988
1987
1981
1986
1993
1989
1981
1987
1987
1987
1985
1989
2010
1985
1984
1985
1991
1985
1990
1987
1981
32
1
49
101
786
10
1
157
318
694
161
360
2
2
3
103
749
198
201
0
10 218
2 055
16 201
1
1.4
1.5
1.2
8
0.3
0
3.6
4.9
4.7
3.2
10
6.1
0.3
10.3
1.4
10.2
3
0.3
0.0
21.5
8
7.1
33
6
75
206
800
13
1
237
355
958
171
533
0
9
4
103
724
189
271
0
11 464
2 159
18 311
1.1
7.8
2.3
2.5
8.2
0.3
0
5.5
5.4
6.4
3.4
12.8
0
1.4
13.5
1.4
9.8
2.8
0.4
0.0
24.3
8.3
7.9
32
1
67
239
818
11
8
276
336
1 729
244
621
1
5
2
88
760
204
276
0
13 456
2 205
21 379
1
1.3
2.1
2.8
8.5
0.3
0.4
6.3
5
11.4
4.8
15
3
0.8
6.7
1.2
10.2
2.9
0.4
0.0
28.8
8.4
9.2
46
5
107
437
991
4
5
340
365
1 973
409
731
1
11
0
91
757
305
348
0
13 469
3 169
23 564
1.5
6.2
3.3
5.1
10.3
0.1
0.2
7.8
5.3
12.8
8
17.8
3
1.8
0
1.2
10.1
4.3
0.5
0.0
29
11.9
10.2
54
3
136
433
900
9
4
353
394
2 321
553
793
0
11
4
118
766
331
395
0
15 544
3 061
26 183
1.7
3.6
4.2
5
9.4
0.2
0.2
8.1
5.5
14.9
10.6
19.3
0
1.8
12.5
1.6
10.1
4.5
0.6
0.0
33.7
11.3
11.2
26 903
1 577
15 980
44 460
7.9
0.8
11.7
6.7
27 200
1 814
17 832
46 846
8
1
13
7
27 282
1 840
20 926
50 048
7.8
1
15.3
7.4
28 763
2 017
23 020
53 800
7.9
1.1
16.7
7.8
29 849
2 316
25 423
57 588
8
1.2
18.4
8.2
*
Country-specific comments are in Annex5
** Cumulative total is the total number of cases reported by country since the start of reporting
*** No official data were reported by Russia. Information about new and cumulative HIV diagnoses were published by the Federal Scientific and Methodological
Center for Prevention and Control of AIDS: 33 407 (2004), 35 401 (2005), 39 312 (2006), 45 099 (2007), 54 799 (2008), 58 142 (2009), 58 305 (2010), 62 385
(2011), 70 744 (2012), 79 728 (2013), 800 531 (cumulative as of 31 December 2013). Reference: HIV-infection bulletin number 39. Moscow: The Federal Service for
Surveillance of Consumer Rights Protection and human well-being; 2014.
**** Excluding a cumulative 89 cases from Kosovo, including 3 diagnosed in 2013 (without prejudice to positions on status, and in line with UNSCR 1244 and the ICJ
Opinion on the Kosovo Declaration of Independence)
22
SURVEILLANCE REPORT
2009
2010
2011
2012
2013
Cumulative Country*
total**
Rate
Rate
Rate
Rate
Rate
308
1 132
171
54
38
156
236
411
172
5 450
2 885
600
140
15
395
3 797
275
180
57
19
1 195
282
956
1 864
253
53
48
3 430
431
6 630
31 633
3.7
10.5
2.3
1.3
4.8
1.5
4.3
30.8
3.2
8.5
3.5
5.4
1.4
4.7
8.7
6.6
12.7
5.7
11.6
4.6
7.2
5.9
2.5
18.0
1.3
1.0
2.4
10.5
4.7
10.8
6.4
321
1 199
163
70
41
180
275
376
184
5 538
2 723
634
182
24
330
3 980
274
153
52
18
1 187
258
956
1 824
274
28
35
3 666
457
6 329
31 731
3.8
11.1
2.2
1.6
5.0
1.7
5.0
28.2
3.4
8.6
3.3
5.7
1.8
7.6
7.3
6.7
12.9
4.9
10.4
4.3
7.2
5.3
2.5
17.6
1.4
0.5
1.7
11.2
4.9
10.2
6.4
314
1 183
201
77
54
153
266
366
172
5 414
2 702
946
162
23
327
3 838
299
166
52
21
1 129
269
1 115
1 613
427
49
55
3 390
391
6 165
31 339
3.7
10.8
2.7
1.8
6.4
1.5
4.8
27.5
3.2
8.3
3.3
8.5
1.7
7.2
7.2
6.5
14.4
5.4
10.2
5.1
6.8
5.5
2.9
15.6
2.1
0.9
2.7
10.3
4.2
9.9
6.3
320
1 229
157
74
58
212
201
315
156
5 660
2 975
1 133
219
19
351
4 098
339
160
58
30
1 036
242
1 095
1 542
489
50
45
3 611
381
6 238
32 493
3.8
11.1
2.1
1.8
6.7
2.0
3.6
23.8
2.9
8.7
3.6
10.2
2.2
5.9
7.7
6.9
16.6
5.3
11.1
7.2
6.2
4.9
2.8
14.6
2.4
0.9
2.2
9.5
4.0
9.8
6.5
260
1 115
200
85
54
235
233
325
157
4 002
3 263
807
240
11
332
3 608
340
177
53
36
949
233
1 089
1 093
507
83
44
3 278
354
5 994
29 157
3.1
10.0
2.7
2.0
6.2
2.2
4.2
24.6
2.9
6.1
4.0
7.3
2.4
3.4
7.2
6.0
16.8
6.0
9.9
8.5
5.7
4.6
2.8
10.4
2.5
1.5
2.1
7.0
3.7
9.4
5.7
7 942
26 850
1 830
1 111
847
2 122
6 572
8 702
3 218
60 047
48 891
13 627
2 574
310
6 976
29 163
5 867
2 237
1 251
223
22 044
5 370
17 662
47 390
6 077
539
633
29 987
10 787
133 606
504 455
63
2
149
455
1 069
6
6
385
387
2 078
696
704
0
14
1
132
656
418
470
0
16 268
4 055
28 014
2
2.4
4.6
5.1
11.2
0.2
0.3
8.9
5.3
13.2
13.2
17.2
0
2.2
3.2
1.8
8.5
5.6
0.7
0.0
35.4
14.8
11.9
44
5
149
459
1 068
7
5
456
425
1 987
567
703
0
15
62 581
6
148
604
1 052
523
0
16 617
3 795
91 216
1.4
5.9
4.6
5.1
11.3
0.2
0.2
10.4
5.7
12.5
10.6
17.2
0
2.4
44.1
19.2
2
7.8
13.8
0.7
0.0
36.3
13.7
24
75
2
182
548
1 159
27
1
427
453
1 999
614
721
0
9
8
127
557
955
653
0
17 305
25 822
2.6
2.6
5.6
6
12.4
0.7
0
9.7
6
12.4
11.4
17.7
0
1.5
25.1
1.8
7.1
12.2
0.9
0.0
37.9
12.2
82
2
227
517
1 229
25
15
528
487
2 011
701
757
0
14
5
128
622
865
1 068
0
16 847
26 130
2.9
2.6
6.9
5.6
13
0.7
0.7
11.9
6.4
12.4
12.8
18.5
0
2.3
15
1.8
7.8
10.8
1.4
0.0
37.1
12.3
117
5
238
514
1 377
27
15
474
490
2 140
503
706
0
10
0
147
574
825
1 313
17 875
27 350
4.1
6.6
7.3
5.5
14.6
0.7
0.7
10.7
6.3
13
9.1
17.3
0
1.6
0
2
7.1
10.1
1.7
39.4
12.8
701
68
1 619
4 298
15 711
250
71
4 131
8 008
21 870
5 113
8 540
34
153
62 581
81
3 001
33 946
5 461
6 763
2
203 899
24 057
410 358
29 944
2 560
27 143
59 647
7.5
1.4
19.6
8.2
30 039
2 671
90 237
122 947
7.4
1.4
32.1
14.1
29 235
3 185
24 741
57 161
7.2
1.7
22.2
8.1
30 396
3 731
24 496
58 623
7.4
2
21.9
8.2
26 847
4 166
25 494
56 507
6.3
2.2
22.7
7.8
496 391
44 334
374 088
914 813
EU/EEA
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Bosnia and Herzegovina
former Yugoslav Republic of Macedonia, the
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
23
SURVEILLANCE REPORT
Table1a: HIV diagnoses and rates per 100 000 population, by country and year of statistics (20042013) and
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area
Country*
EU/EEA
West Austria
West Belgium
Centre Bulgaria
Centre Croatia
Centre Cyprus
West Denmark
East
Estonia
West Finland
West France
West Germany
West Greece
Centre Hungary
West Iceland
West Ireland
West Italy
East
Latvia
East
Lithuania
West Luxembourg
West Malta
West Netherlands
West Norway
Centre Poland
West Portugal
Centre Romania
Centre Slovakia
Centre Slovenia
West Spain
West Sweden
West United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West Andorra
East
Armenia
East
Azerbaijan
East
Belarus
East
Georgia
West Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West Monaco
Centre Montenegro
East
Russia***
West San Marino
Centre Serbia****
West Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
2004
N
Rate
2005
N
Rate
2006
N
Rate
2007
N
Rate
2008
N
Rate
338
1 004
50
53
25
72
306
743
124
5 774
2 224
441
75
4
358
1 666
323
135
60
16
1 183
251
670
2 201
245
15
24
1 687
429
7 696
28 192
4.2
9.7
0.6
1.2
3.5
0.7
5.7
54.4
2.4
9.3
2.7
4.0
0.7
1.4
8.9
8.7
14.2
4.0
13.2
4.0
7.3
5.5
1.8
21.3
1.1
0.3
1.2
9.7
4.8
13.0
6.5
324
1 070
83
68
43
90
264
621
134
5 985
2 508
565
106
8
325
1 490
299
120
63
15
1 221
219
703
2 026
228
21
38
1 648
388
7 888
28 561
4.0
10.2
1.1
1.6
5.9
0.9
4.9
45.7
2.6
9.5
3.1
5.1
1.1
2.7
7.9
7.6
13.3
3.6
13.7
3.7
7.5
4.8
1.8
19.6
1.1
0.4
1.9
9.3
4.3
13.2
6.6
328
1 018
91
57
35
91
245
668
191
5 698
2 666
573
81
11
353
2 017
299
100
57
22
1 129
276
810
2 057
187
27
33
1 779
385
7 437
28 721
4.0
9.7
1.2
1.3
4.7
0.9
4.5
49.5
3.6
9.0
3.2
5.2
0.8
3.7
8.4
8.4
13.4
3.0
12.2
5.4
6.9
5.9
2.1
19.9
0.9
0.5
1.6
9.9
4.3
12.4
6.5
345
1 072
126
49
46
121
306
633
187
5 680
2 800
521
119
13
391
2 206
350
106
47
16
1 232
248
804
1 963
173
39
37
2 747
528
7 344
30 249
4.2
10.1
1.7
1.1
6.1
1.2
5.6
47.1
3.5
8.9
3.4
4.7
1.2
4.2
9.0
7.1
15.8
3.3
9.9
3.9
7.5
5.3
2.1
19.0
0.8
0.7
1.8
11.3
5.8
12.1
6.7
359
1 092
123
71
37
148
285
545
147
5 764
2 850
659
145
10
404
2 463
358
95
68
28
1 307
299
840
2 050
259
53
48
3 310
441
7 220
31 478
4.3
10.2
1.6
1.7
4.8
1.4
5.2
40.7
2.8
9.0
3.5
5.9
1.5
3.2
9.1
6.6
16.3
3.0
14.1
6.9
8.0
6.3
2.2
19.8
1.3
1.0
2.4
11.8
4.8
11.8
6.8
32
31
49
101
778
16
1
163
318
694
161
360
2
2
3
103
749
198
165
0
10 218
2 016
16 160
1.0
42.9
1.5
1.2
7.9
0.4
0.0
3.8
4.9
4.7
3.2
10.0
6.1
0.3
10.3
1.4
10.2
3.0
0.2
0.0
21.5
7.8
7.0
30
10
75
206
751
13
1
242
355
958
171
533
0
9
4
103
724
189
298
0
11 464
2 198
18 334
1.0
13.0
2.3
2.5
7.7
0.3
0.0
5.6
5.4
6.4
3.4
12.8
0.0
1.4
13.5
1.4
9.8
2.8
0.4
0.0
24.3
8.4
7.9
32
1
66
239
733
17
8
276
336
1 729
244
621
1
5
2
88
760
204
260
0
13 456
2 205
21 283
1.0
1.3
2.1
2.8
7.6
0.4
0.4
6.3
5.0
11.4
4.8
15.0
3.0
0.8
6.7
1.2
10.2
2.9
0.4
0.0
28.8
8.4
9.1
44
3
109
437
990
4
5
344
365
1 973
409
731
1
11
0
91
757
305
399
0
13 469
3 169
23 616
1.4
3.7
3.4
5.1
10.3
0.1
0.2
7.9
5.3
12.8
8.0
17.8
3.0
1.8
0.0
1.2
10.1
4.3
0.6
0.0
29.0
11.9
10.2
49
4
136
433
881
9
4
351
394
2 321
551
793
0
11
4
118
766
331
393
0
15 544
3 061
26 154
1.5
4.8
4.2
5.0
9.2
0.2
0.2
8.1
5.5
14.9
10.6
19.3
0.0
1.8
12.5
1.6
10.1
4.5
0.6
0.0
33.7
11.3
11.2
26 865
1 548
15 939
44 352
7.9
0.8
11.7
6.7
27 234
1 834
17 827
46 895
8.0
1.0
13.0
7.1
27 342
1 822
20 840
50 004
7.8
1.0
15.2
7.4
28 772
2 068
23 025
53 865
7.9
1.1
16.8
7.8
29 924
2 308
25 400
57 632
8.0
1.2
18.4
8.2
*
*** No official data were reported by Russia. Information about new and cumulative HIV diagnoses were published by the Federal Scientific and Methodological
Center for Prevention and Control of AIDS: 33 407 (2004), 35 401 (2005), 39 312 (2006), 45 099 (2007), 54 799 (2008), 58 142 (2009), 58 305 (2010), 62 385
(2011), 70 744 (2012), 79 728 (2013), 800 531 (cumulative as of 31 December 2013). Reference: HIV-infection bulletin number 39. Moscow: The Federal Service for
Surveillance of Consumer Rights Protection and human well-being; 2014
24
SURVEILLANCE REPORT
2009
N
Rate
2010
N
Rate
2011
N
Rate
2012
N
Rate
2013
N
Rate
Cumulative Country*
total**
EU/EEA
308
1 132
171
54
38
156
236
411
172
5 450
2 885
611
141
15
395
3 797
275
180
64
18
1 195
282
958
1 864
253
53
48
3 430
485
6 630
31 707
3.7
10.5
2.3
1.3
4.8
1.5
4.3
30.8
3.2
8.5
3.5
5.5
1.4
4.7
8.7
6.6
12.7
5.7
13.0
4.4
7.2
5.9
2.5
18.0
1.3
1.0
2.4
10.5
5.2
10.8
6.5
321
1 199
163
70
41
180
275
372
184
5 538
2 723
612
182
24
330
3 980
274
153
63
19
1 187
258
955
1 824
274
28
35
3 666
493
6 329
31 752
3.8
11.1
2.2
1.6
5.0
1.7
5.0
27.9
3.4
8.6
3.3
5.5
1.8
7.6
7.3
6.7
12.9
4.9
12.5
4.6
7.2
5.3
2.5
17.6
1.4
0.5
1.7
11.2
5.3
10.2
6.4
314
1 183
201
77
54
153
266
370
172
5 414
2 703
966
162
23
326
3 838
299
166
73
21
1 129
269
1 118
1 613
427
49
55
3 390
461
6 165
31 457
3.7
10.8
2.7
1.8
6.4
1.5
4.8
27.8
3.2
8.3
3.3
8.7
1.7
7.2
7.1
6.5
14.4
5.4
14.3
5.1
6.8
5.5
2.9
15.6
2.1
0.9
2.7
10.3
4.9
9.9
6.4
320
1 229
157
74
58
212
201
315
156
5 660
2 976
1 188
219
19
341
4 098
339
160
83
30
1 036
242
1 095
1 542
489
50
45
3 611
441
6 238
32 624
3.8
11.1
2.1
1.8
6.7
2.0
3.6
23.8
2.9
8.7
3.6
10.7
2.2
5.9
7.4
6.9
16.6
5.3
15.8
7.2
6.2
4.9
2.8
14.6
2.4
0.9
2.2
9.5
4.7
9.8
6.5
260
1 115
200
85
54
235
233
325
157
4 002
3 263
920
240
11
343
3 608
340
177
82
36
949
233
1 090
1 093
507
83
44
3 278
458
5 994
29 415
3.1
10.0
2.7
2.0
6.2
2.2
4.2
24.6
2.9
6.1
4.0
8.3
2.4
3.4
7.5
6.0
16.8
6.0
15.3
8.5
5.7
4.6
2.8
10.4
2.5
1.5
2.1
7.0
4.8
9.4
5.7
7 942
26 850
1 830
1 111
847
2 122
6 572
8 702
3 218
60 047
48 891
13 627
2 574
310
6 976
29 163
5 867
2 237
1 251
223
22 044
5 370
17 662
47 390
6 077
539
633
29 987
10 787
133 606
504 455
62
2
149
455
1 072
7
6
385
387
2 078
687
704
0
14
1
132
656
418
470
0
16 268
4 041
27 994
1.9
2.4
4.6
5.1
11.2
0.2
0.3
8.9
5.3
13.2
13.0
17.2
0.0
2.2
3.2
1.8
8.5
5.6
0.7
0.0
35.4
14.8
11.9
48
6
148
459
1 069
7
5
455
425
1 987
570
703
0
15
62 581
6
148
604
1 004
489
0
16 617
3 809
91 155
1.5
7.1
4.6
5.1
11.3
0.2
0.2
10.4
5.7
12.5
10.7
17.2
0.0
2.4
44.1
19.2
2.0
7.8
13.2
0.7
0.0
36.3
13.7
24.0
72
2
182
548
1 196
28
1
424
453
1 999
598
721
0
9
8
127
557
989
699
0
17 305
25 918
2.5
2.6
5.6
6.0
12.8
0.7
0.0
9.6
6.0
12.4
11.1
17.7
0.0
1.5
25.1
1.8
7.1
12.7
0.9
0.0
37.9
12.3
90
2
228
517
1 223
25
14
526
487
2 011
724
757
0
14
5
128
622
828
1 068
0
16 847
26 116
3.2
2.6
7.0
5.6
12.9
0.7
0.7
11.9
6.4
12.4
13.2
18.5
0.0
2.3
15.0
1.8
7.8
10.3
1.4
0.0
37.1
12.3
124
7
238
514
1 533
27
16
490
490
2 140
504
706
0
10
0
147
574
876
1 313
17 875
27 584
4.4
9.2
7.3
5.5
16.2
0.7
0.8
11.0
6.3
13.0
9.1
17.3
0.0
1.6
0.0
0.0
2.0
7.1
10.7
1.7
39.4
12.9
701
68
1 619
4 298
15 711
250
71
4 131
8 008
21 870
5 113
8 540
34
153
62 581
81
3 001
33 946
5 461
6 763
2
203 899
24 057
410 358
30 015
2 563
27 123
59 701
7.5
1.4
19.6
8.2
30 066
2 640
90 201
122 907
7.4
1.4
32.1
14.1
29 346
3 232
24 797
57 375
7.2
1.7
22.2
8.1
30 527
3 738
24 475
58 740
7.4
2.0
21.8
8.2
27 106
4 175
25 718
56 999
6.4
2.2
22.9
7.8
496 391
44 334
374 088
914 813
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
25
SURVEILLANCE REPORT
Table2: HIV diagnoses in males and rates per 100 000 population, by country and year of diagnosis (20042013) and
Area
Country*
EU/EEA
West Austria
West Belgium
Centre Bulgaria
Centre Croatia
Centre Cyprus
West Denmark
East
Estonia
West Finland
West France
West Germany
West Greece
Centre Hungary
West Iceland
West Ireland
West Italy
East
Latvia
East
Lithuania
West Luxembourg
West Malta
West Netherlands
West Norway
Centre Poland
West Portugal
Centre Romania
Centre Slovakia
Centre Slovenia
West Spain
West Sweden
West United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West Andorra
East
Armenia
East
Azerbaijan
East
Belarus
East
Georgia
West Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West Monaco
Centre Montenegro
East
Russia
West San Marino
Centre Serbia***
West Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
2004
N
Rate
2005
N
Rate
2006
N
Rate
2007
N
Rate
2008
N
Rate
231
588
33
48
13
55
230
497
101
3 395
1 740
392
63
4
194
1 161
207
114
45
12
884
148
477
1 475
132
13
21
1 264
252
4 439
18 228
5.8
11.6
0.9
2.3
3.7
1.1
8.6
78.2
4.0
11.3
4.3
7.2
1.3
2.8
9.7
12.5
19.8
7.2
20.0
6.1
11.0
6.5
2.6
29.5
1.3
0.5
2.1
14.8
5.7
15.2
8.6
235
622
56
58
28
70
193
391
95
3 689
1 988
408
80
5
188
1 067
193
90
30
9
931
122
513
1 401
108
15
35
1 257
229
4 662
18 768
5.9
12.2
1.5
2.8
7.8
1.4
7.2
61.9
3.7
12.1
5.0
7.5
1.7
3.4
9.2
11.3
18.7
5.8
13.2
4.5
11.5
5.3
2.8
28.0
1.0
0.6
3.6
14.5
5.1
15.9
8.9
248
674
71
48
21
71
174
429
134
3 573
2 138
399
49
8
221
1 478
185
78
38
16
907
179
615
1 392
96
20
30
1 382
243
4 487
19 404
6.2
13.1
1.9
2.3
5.8
1.4
6.5
68.3
5.2
11.7
5.3
7.3
1.0
5.3
10.5
12.6
18.1
5.1
16.4
8.0
11.2
7.8
3.3
27.8
0.9
0.8
3.1
15.7
5.4
15.2
9.0
266
662
105
44
31
97
224
374
136
3 665
2 324
466
88
6
242
1 597
224
74
33
8
994
166
570
1 312
88
32
35
2 169
304
4 694
21 030
6.6
12.8
2.8
2.1
8.3
1.9
8.3
59.9
5.3
11.9
5.8
8.5
1.9
3.8
11.1
10.6
22.1
4.9
14.0
4.0
12.3
7.1
3.1
26.2
0.9
1.2
3.5
18.2
6.7
15.8
9.5
275
745
102
68
24
121
204
315
105
3 744
2 357
506
110
7
258
1 798
231
65
48
17
1 107
182
616
1 410
148
48
45
2 615
267
4 591
22 129
6.8
14.3
2.8
3.3
6.3
2.4
7.5
50.6
4.0
12.1
5.9
9.2
2.3
4.4
11.6
10.0
22.9
4.4
20.0
8.4
13.6
7.7
3.3
28.1
1.5
1.8
4.6
19.0
5.9
15.3
9.7
21
0
36
80
477
8
1
119
216
469
125
199
2
2
3
83
477
164
133
0
6 078
1 687
10 380
1.4
0.0
2.3
2.0
10.3
0.4
0.1
5.8
6.8
6.6
5.0
11.5
12.6
0.7
20.9
2.3
13.2
4.9
0.4
0.0
27.7
13.1
9.3
23
5
60
172
432
8
0
171
226
692
122
316
0
9
2
87
478
172
179
0
6 756
1 715
11 625
1.5
12.5
3.9
4.2
9.4
0.4
0.0
8.4
6.9
9.6
4.9
15.6
0.0
2.9
13.7
2.4
13.2
5.0
0.5
0.0
31.1
13.2
10.4
21
0
42
213
453
9
2
199
218
1 278
181
369
1
5
2
73
498
155
193
0
7 890
1 683
13 485
1.3
0.0
2.7
5.1
10.0
0.5
0.2
9.6
6.5
17.4
7.2
18.3
6.2
1.6
13.6
2.0
13.6
4.4
0.5
0.0
36.6
12.8
11.9
33
5
75
380
529
4
2
242
247
1 391
287
422
1
10
0
75
524
241
248
0
8 201
2 087
15 004
2.1
11.8
4.8
9.0
11.7
0.2
0.2
11.7
7.2
18.8
11.3
21.0
6.2
3.3
0.0
2.1
14.2
6.7
0.7
0.0
38.3
15.7
13.3
34
3
104
350
467
7
3
251
251
1 642
309
438
0
8
2
98
553
184
273
0
8 644
1 830
15 451
2.1
6.9
6.7
8.2
10.4
0.4
0.3
12.1
7.2
21.9
12.0
22.2
0.0
2.6
12.2
2.7
14.8
5.0
0.8
0.0
40.6
13.6
13.6
17 253
1 103
10 252
28 608
10.4
1.2
15.8
8.8
17 842
1 269
11 282
30 393
10.7
1.4
17.3
9.4
18 410
1 324
13 155
32 889
10.8
1.4
20.1
10.0
20 045
1 462
14 527
36 034
11.3
1.6
22.1
10.8
21 045
1 705
14 830
37 580
11.5
1.9
22.5
11.0
*
*** Excluding a cumulative 61 cases from Kosovo, including 2 diagnosed in 2013 (without prejudice to positions on status, and in line with UNSCR 1244 and the ICJ
26
SURVEILLANCE REPORT
2009
N
Rate
2010
N
Rate
2011
N
Rate
2012
N
Rate
2013
N
Rate
Cumulative Country*
total**
EU/EEA
240
748
133
48
26
130
179
243
106
3 590
2 404
507
107
6
258
2 862
170
131
41
10
991
183
730
1 273
144
48
40
2 731
281
4 453
22 813
5.9
14.2
3.7
2.3
6.7
2.5
6.6
39.1
4.1
11.5
6.0
9.2
2.3
3.7
11.5
10.2
17.1
8.9
16.7
4.9
12.1
7.6
4.0
25.4
1.5
1.8
4.0
16.9
6.1
14.7
9.5
259
794
132
67
34
159
201
230
130
3 650
2 308
556
142
17
241
3 002
170
125
36
16
997
173
714
1 239
179
25
31
2 998
277
4 306
23 208
6.3
14.9
3.7
3.3
8.5
3.1
7.3
37.0
5.0
11.7
5.8
10.1
3.0
10.6
10.7
10.5
17.5
8.6
14.4
7.8
12.2
7.1
3.9
24.8
1.8
1.0
3.1
18.6
6.0
14.1
9.6
244
784
163
66
39
140
192
226
112
3 587
2 270
803
122
12
239
2 890
196
134
38
17
966
190
916
1 122
304
46
48
2 803
245
4 391
23 305
6.0
14.5
4.5
3.2
9.5
2.7
7.0
36.5
4.2
11.4
5.7
14.7
2.6
7.5
10.5
10.0
20.7
9.5
14.9
8.2
11.7
7.7
4.9
22.5
3.1
1.8
4.7
17.4
5.2
14.2
9.6
257
836
123
71
49
185
146
209
111
3 813
2 520
960
186
13
253
3 227
218
114
43
23
869
166
915
1 092
359
44
42
3 050
231
4 497
24 622
6.3
15.3
3.4
3.5
11.7
3.6
5.3
33.8
4.2
12.1
6.3
17.6
3.9
8.1
11.1
11.2
23.3
8.2
16.4
11.1
10.5
6.6
4.9
21.7
3.7
1.7
4.1
16.4
4.9
14.4
10.0
216
777
161
77
46
211
178
200
102
2 692
2 668
724
189
8
248
2 814
203
125
45
30
830
158
933
773
357
71
39
2 785
223
4 471
22 354
5.2
14.2
4.5
3.8
10.9
4.1
6.4
32.5
3.8
8.5
6.6
13.4
4.0
5.0
10.9
9.7
21.9
9.1
16.8
14.3
10.0
6.2
5.0
15.5
3.7
2.7
3.8
12.1
4.7
14.2
8.9
5 958
16 827
1 394
954
596
1 764
4 776
5 864
2 336
38 341
38 786
11 194
1 982
219
3 667
21 896
4 014
1 812
936
160
17 595
3 618
13 499
34 520
3 434
461
551
24 151
7 346
92 873
361 524
44
2
96
377
551
6
6
276
267
1 393
514
400
0
12
1
122
470
327
344
0
9 096
2 248
16 552
2.8
4.5
6.1
8.7
12.3
0.3
0.6
13.3
7.4
18.4
19.8
20.1
0.0
3.9
6.5
3.4
12.4
8.7
1.0
0.0
42.9
16.5
14.4
30
5
98
365
566
7
5
323
289
1 254
399
341
0
15
36 172
6
132
443
850
384
0
9 524
2 062
53 270
1.9
11.4
6.2
8.2
12.8
0.4
0.5
15.4
7.9
16.3
15.2
17.2
0.0
4.9
55.1
39.1
3.7
11.6
22.2
1.1
0.0
45.1
14.9
29.3
54
2
115
410
594
23
0
303
299
1 208
422
377
0
8
6
110
419
672
485
0
9 470
14 977
3.8
5.0
7.3
9.1
13.5
1.2
0.0
14.3
8.0
15.6
15.8
18.9
0.0
2.6
38.4
3.1
10.8
17.1
1.3
0.0
45.0
14.7
59
2
157
356
664
23
10
382
355
1 169
406
375
0
13
2
117
463
556
819
0
9 394
15 322
4.1
5.0
9.9
7.8
15.1
1.2
1.0
17.9
9.4
14.9
15.0
19.2
0.0
4.2
12.3
3.3
11.8
13.8
2.2
0.0
44.8
14.8
79
4
161
329
714
21
15
356
357
1 204
292
381
0
10
0
135
417
509
1 072
10 082
16 138
5.6
10.3
10.1
7.1
16.2
1.1
1.5
16.7
9.3
15.2
10.7
19.5
0.0
3.2
0.0
3.9
10.5
12.4
2.8
47.8
15.4
489
55
1 132
3 353
9 341
201
50
3 039
5 219
14 734
3 500
4 980
21
129
36 172
63
2 347
21 379
3 923
4 912
1
122 477
16 262
253 779
21 603
1 940
15 822
39 365
11.0
2.1
23.9
11.1
21 943
2 056
52 479
76 478
11.1
2.2
39.7
18.1
21 631
2 524
14 127
38 282
10.9
2.7
26.7
11.1
22 929
3 015
14 000
39 944
11.4
3.2
26.4
11.5
20 520
3 416
14 556
38 492
9.9
3.6
27.1
10.8
351 936
32 763
230 604
615 303
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
27
SURVEILLANCE REPORT
Table3: HIV diagnoses in females and rates per 100 000 population, by country and year of diagnosis (20042013) and
Area
Country*
EU/EEA
West Austria
West Belgium
Centre Bulgaria
Centre Croatia
Centre Cyprus
West Denmark
East
Estonia
West Finland
West France
West Germany
West Greece
Centre Hungary
West Iceland
West Ireland
West Italy
East
Latvia
East
Lithuania
West Luxembourg
West Malta
West Netherlands
West Norway
Centre Poland
West Portugal
Centre Romania
Centre Slovakia
Centre Slovenia
West Spain
West Sweden
West United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West Andorra
East
Armenia
East
Azerbaijan
East
Belarus
East
Georgia
West Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West Monaco
Centre Montenegro
East
Russia
West San Marino
Centre Serbia***
West Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
2004
N
107
412
17
5
12
17
76
246
23
2 379
455
98
12
Rate
2005
N
Rate
2006
N
Rate
2007
N
Rate
2008
N
Rate
164
505
116
21
23
4
299
103
181
726
113
2
3
423
185
3 256
9 983
2.6
7.8
0.4
0.2
3.3
0.3
2.8
33.7
0.9
7.4
1.1
1.8
0.2
0.0
8.1
5.1
9.4
1.2
10.0
2.0
3.6
4.5
0.9
13.7
1.0
0.1
0.3
4.8
4.1
10.8
4.5
88
440
27
10
15
20
71
230
39
2 295
484
128
14
3
137
423
106
30
23
6
290
97
175
625
120
6
3
391
167
3 226
9 689
2.1
8.2
0.7
0.5
4.0
0.4
2.6
31.6
1.5
7.1
1.2
2.3
0.3
2.0
6.6
4.2
8.7
1.7
9.9
3.0
3.5
4.2
0.9
11.7
1.1
0.2
0.3
4.4
3.7
10.6
4.4
79
338
20
9
14
20
71
239
57
2 116
505
104
13
3
132
539
114
22
15
8
222
97
174
665
91
7
3
397
152
2 950
9 176
1.9
6.3
0.5
0.4
3.7
0.4
2.6
33.1
2.1
6.5
1.2
1.8
0.2
2.0
6.3
4.3
9.5
1.2
6.3
3.9
2.7
4.1
0.9
12.5
0.8
0.3
0.3
4.4
3.3
9.6
4.1
78
403
21
5
15
24
82
259
51
1 995
452
88
10
7
149
609
126
32
11
6
238
82
155
651
85
7
2
578
184
2 650
9 055
1.8
7.5
0.5
0.2
3.9
0.5
3.0
36.0
1.9
6.1
1.1
1.6
0.2
4.6
6.9
3.8
10.5
1.8
4.6
2.9
2.9
3.5
0.8
12.2
0.8
0.3
0.2
4.7
4.0
8.6
3.9
82
343
21
3
13
27
81
230
42
1 999
469
103
9
3
146
665
127
30
11
11
200
117
153
640
111
5
3
694
158
2 629
9 125
1.9
6.3
0.5
0.1
3.3
0.5
2.9
32.1
1.6
6.1
1.1
1.8
0.2
1.9
6.5
3.5
10.7
1.7
4.5
5.4
2.4
4.9
0.8
12.0
1.1
0.2
0.3
4.9
3.4
8.5
3.8
11
1
13
21
309
2
0
38
102
225
36
158
0
0
0
20
268
34
68
0
4 140
368
5 814
0.7
2.9
0.8
0.5
5.9
0.1
0.0
1.7
3.1
2.9
1.4
8.4
0.0
0.0
0.0
0.5
7.1
1.0
0.2
0.0
16.2
2.8
5.0
10
1
15
34
368
5
1
66
128
266
49
217
0
0
2
16
242
17
92
0
4 516
444
6 489
0.6
2.7
0.9
0.8
7.1
0.3
0.1
2.9
3.8
3.4
1.9
10.1
0.0
0.0
13.2
0.4
6.4
0.5
0.3
0.0
17.8
3.4
5.5
11
1
25
26
365
2
5
77
118
451
63
249
0
0
0
15
254
48
83
0
5 366
522
7 681
0.7
2.7
1.5
0.6
7.1
0.1
0.5
3.4
3.4
5.7
2.5
11.7
0.0
0.0
0.0
0.4
6.7
1.4
0.2
0.0
21.3
3.9
6.5
13
0
32
57
462
0
1
98
116
582
115
309
0
1
0
16
222
64
100
0
5 038
1 082
8 308
0.8
0.0
1.9
1.3
9.0
0.0
0.1
4.3
3.3
7.3
4.4
14.7
0.0
0.3
0.0
0.4
5.8
1.8
0.3
0.0
20.1
8.1
7.1
20
0
32
83
433
2
1
102
143
679
182
355
0
3
2
20
203
62
122
0
6 683
1 231
10 358
1.3
0.0
1.9
1.9
8.5
0.1
0.1
4.5
4.0
8.4
6.9
16.6
0.0
0.9
12.8
0.5
5.3
1.7
0.3
0.0
26.8
9.1
8.7
9 609
463
5 725
15 797
5.5
0.5
8.1
4.7
9 306
514
6 358
16 178
5.4
0.5
8.9
4.8
8 823
467
7 567
16 857
5.0
0.5
10.6
4.9
8 652
455
8 256
17 363
4.7
0.5
11.5
5.0
8 741
513
10 229
19 483
4.6
0.5
14.2
5.4
*
28
SURVEILLANCE REPORT
2009
N
Rate
2010
N
Rate
2011
N
Rate
2012
N
Rate
2013
N
Rate
Cumulative Country*
total**
EU/EEA
68
381
38
6
12
26
57
168
66
1 840
465
93
15
9
137
935
105
49
16
9
204
99
158
591
109
5
8
699
149
2 177
8 694
1.6
6.9
1.0
0.3
2.9
0.5
2.1
23.5
2.4
5.5
1.1
1.6
0.3
5.7
6.0
3.1
9.0
2.9
6.4
4.4
2.4
4.1
0.8
11.0
1.0
0.2
0.8
4.2
3.2
7.0
3.5
62
403
31
3
7
21
74
146
54
1 877
404
78
9
7
89
974
104
28
16
2
190
85
154
585
95
3
4
668
179
2 023
8 375
1.4
7.3
0.8
0.1
1.7
0.4
2.7
20.5
2.0
5.6
1.0
1.4
0.2
4.4
3.9
3.2
9.0
1.7
6.3
1.0
2.3
3.5
0.8
10.9
0.9
0.1
0.4
4.0
3.8
6.4
3.3
70
399
38
11
15
13
74
140
60
1 825
425
143
12
11
88
948
103
32
14
4
163
79
157
491
123
3
7
587
146
1 772
7 953
1.6
7.1
1.0
0.5
3.5
0.2
2.6
19.7
2.2
5.4
1.0
2.5
0.2
6.9
3.8
3.1
9.1
1.9
5.4
1.9
1.9
3.2
0.8
9.2
1.2
0.1
0.7
3.5
3.1
5.6
3.1
63
392
34
3
9
27
54
106
45
1 826
453
173
14
6
98
871
121
46
15
7
167
76
159
450
130
6
3
561
149
1 740
7 804
1.5
6.9
0.9
0.1
2.0
0.5
1.9
15.0
1.6
5.4
1.1
3.0
0.3
3.8
4.2
2.8
10.9
2.8
5.7
3.3
2.0
3.1
0.8
8.2
1.3
0.2
0.3
3.0
3.1
5.4
3.0
43
338
39
8
8
24
55
125
55
1 296
593
83
17
3
84
794
137
52
8
6
119
75
143
320
150
12
5
488
130
1 522
6 732
1
6
1.0
0.4
1.8
0.4
1.9
17.8
2.0
3.8
1.4
1.5
0.3
1.9
3.6
2.6
12.5
3.2
3.0
2.8
1.4
3.0
0.7
5.8
1.5
0.4
0.5
2.1
2.7
4.7
2.6
1 976
9 740
436
157
251
358
1 795
2 826
882
21 586
9 323
2 387
276
91
2 106
7 263
1 853
425
315
63
4 449
1 752
3 601
12 860
2 643
78
82
5 830
3 434
40 689
139 527
19
0
53
78
518
0
0
109
120
685
182
304
0
2
0
10
180
91
126
0
7 003
1 807
11 287
1.2
0.0
3.2
1.7
10.2
0.0
0.0
4.8
3.3
8.4
6.8
14.5
0.0
0.6
0.0
0.3
4.6
2.5
0.4
0.0
28.3
13.1
9.6
14
0
51
94
502
0
0
133
136
733
168
362
0
0
26 409
0
16
160
202
139
0
6 916
1 733
37 768
0.9
0.0
3.1
2.1
9.9
0.0
0.0
5.8
3.6
8.9
6.2
17.3
0.0
0.0
34.6
0.0
0.4
4.0
5.3
0.4
0.0
28.0
12.4
19.4
21
0
67
138
565
4
0
124
153
791
192
344
0
1
2
17
132
283
166
0
7 697
10 697
1.5
0.0
4.0
3.0
11.3
0.2
0.0
5.4
4.0
9.5
7.0
16.4
0.0
0.3
12.3
0.5
3.3
7.3
0.5
0.0
31.3
10.0
23
0
70
161
565
2
4
146
132
842
295
382
0
1
3
11
150
309
249
0
7 301
10 646
1.6
0.0
4.2
3.5
11.2
0.1
0.4
6.3
3.4
10.0
10.6
18.0
0.0
0.3
17.5
0.3
3.7
7.8
0.7
0.0
29.8
9.8
38
1
77
185
663
6
0
118
124
936
211
325
0
0
12
153
316
241
7 793
11 199
2.7
2.7
4.6
3.9
13.1
0.3
0.0
5.1
3.2
11.0
7.5
15.3
0.0
0.0
0.0
0.3
3.8
7.7
0.6
31.6
10.3
212
13
487
945
6 370
46
16
1 092
2 673
7 048
1 544
3 542
13
24
26 409
18
654
9 863
1 452
1 849
1
81 422
7 794
153 487
8 295
534
11 152
19 981
4.1
0.6
15.4
5.4
8 066
496
37 581
46 143
3.9
0.5
25.2
10.3
7 586
588
10 476
18 650
3.7
0.6
17.9
5.2
7 431
675
10 344
18 450
3.5
0.7
17.5
5.0
6 290
703
10 938
17 931
2.9
0.7
18.4
4.8
139 121
10 683
143 210
293 014
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
29
SURVEILLANCE REPORT
Table4: HIV diagnoses in men infected through sex with men, by country and year of diagnosis (20042013) and
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West Andorra
East
Armenia
East
Azerbaijan
East
Belarus
East
Georgia
West Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West Monaco
Centre Montenegro
East
Russia***
West San Marino
Centre Serbia****
West Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
2004
2005
2006
2007
Year of report
2008
2009
90
209
0
27
8
33
147
0
46
1 230
1 079
221
45
2
63
373
7
4
24
3
583
70
35
260
7
12
15
489
78
2 419
7 579
89
256
4
34
16
53
120
0
32
1 371
1 254
245
56
3
60
363
14
3
9
4
640
56
46
271
15
9
31
545
107
2 638
8 344
130
299
10
37
7
55
100
0
62
1 360
1 385
247
39
2
89
536
15
9
17
7
666
90
51
330
11
14
25
617
102
2 603
8 915
130
299
24
30
20
77
142
0
72
1 454
1 568
297
63
0
91
593
15
4
19
0
769
77
38
291
6
25
30
1 226
124
2 831
10 315
162
367
17
52
9
92
133
0
49
1 488
1 576
323
93
2
105
715
21
9
29
0
851
92
62
402
34
33
34
1 512
119
2 755
11 136
1
0
0
4
1
0
0
6
66
2
0
0
2
0
1
31
170
0
11
0
9
9
313
0
3
2
0
1
3
0
8
92
3
0
5
0
3
0
43
224
0
25
0
20
10
442
0
0
2
3
1
5
2
4
77
10
1
2
0
2
0
45
263
0
29
0
35
0
481
1
3
2
3
4
0
3
11
123
10
1
7 625
225
42
7 892
8 382
338
66
8 786
8 982
332
82
9 396
2010
2011
2012
2013
Cumulative
total**
138
376
28
42
9
107
108
0
43
1 429
1 646
330
87
2
138
1 177
14
9
24
4
765
87
79
381
32
35
29
1 556
122
2 745
11 542
159
398
32
60
22
129
112
0
48
1 503
1 599
367
126
5
134
1 252
18
7
22
6
765
85
164
422
45
21
28
1 813
115
2 727
12 184
155
404
47
49
27
113
113
0
36
1 407
1 481
331
106
0
145
1 267
20
9
27
4
742
97
312
434
78
32
35
1 789
94
2 833
12 187
154
396
59
65
31
152
82
1
47
1 586
1 707
319
148
1
176
1 560
18
11
27
8
679
76
342
450
69
28
33
1 882
116
3 031
13 254
132
415
72
70
35
180
116
6
43
1 068
1 735
288
159
0
152
1 420
27
29
25
16
663
98
260
330
72
58
27
1 678
111
2 943
12 228
2 851
6 405
324
645
321
1 356
2 661
100
1 019
14 905
22 745
6 307
1 478
105
1 918
9 256
285
157
487
53
12 624
1 721
2 011
7 155
393
344
398
13 493
3 586
59 665
174 768
1
6
0
40
270
0
25
0
48
0
551
10
3
3
2
6
1
0
6
125
13
0
2
0
6
0
66
265
0
0
0
65
0
573
8
1
5
2
10
3
3
7
142
20
0
12
0
7
0
84
251
0
2
0
94
1
652
4
3
0
7
14
4
5
26
147
22
0
6
0
11
0
81
246
0
32
0
90
698
9
1
4
5
27
12
1
25
152
27
0
5
0
5
4
66
209
0
0
0
143
695
8
1
4
12
34
21
7
43
155
24
3
4
0
5
0
84
228
0
0
0
152
785
10
3
13
11
38
13
13
66
162
40
14
4
0
6
0
94
184
0
187
262
1 120
67
24
37
52
162
79
36
217
1 872
187
19
49
14
62
0
21
886
5 291
0
405
0
967
29
10 476
10 380
388
98
10 866
11 073
509
127
11 709
11 465
555
174
12 194
11 928
764
190
12 882
11 725
892
265
12 882
12 681
1 052
306
14 039
11 582
1 256
510
13 348
174 178
8 805
2 261
185 244
*
*** No official data were reported by Russia. Information about HIV diagnoses in men infected through sex with men were published by the Federal Scientific and
Methodological Center for Prevention and Control of AIDS: 133 (2004), 178 (2005), 137 (2006), 203 (2007), 278 (2008), 364 (2009), 357 (2010), 380 (2011), 296
(2012), 371 (2013), 3647 (cumulative as of 31 December 2013). Reference: HIV-infection bulletin number 39. Moscow: The Federal Service for Surveillance of
Consumer Rights Protection and human well-being; 2014
30
SURVEILLANCE REPORT
Table5: HIV diagnoses in persons infected through injecting drug use, by country and year of diagnosis (20042013)
and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West Andorra
East
Armenia
East
Azerbaijan
East
Belarus
East
Georgia
West Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West Monaco
Centre Montenegro
East
Russia***
West San Marino
Centre Serbia****
West Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
Year of report
2008
2009
2010
2011
2012
2013
Cumulative
total**
31
14
74
0
0
4
14
85
13
128
101
15
0
5
30
272
78
118
0
0
6
11
61
247
7
1
0
291
25
155
1 786
32
15
56
2
0
5
8
62
8
124
81
24
0
9
23
260
86
107
1
0
6
11
42
221
9
2
0
236
24
148
1 602
38
16
63
4
0
9
10
69
8
117
77
309
0
12
17
184
90
86
0
0
6
10
64
137
116
1
0
211
13
130
1 797
36
14
40
1
0
6
11
72
7
118
82
513
0
3
13
214
94
63
4
0
7
11
43
134
170
1
1
183
17
113
1 971
21
17
33
0
0
6
13
72
3
67
100
248
1
1
18
162
77
62
5
3
5
8
39
78
149
0
2
145
8
112
1 455
1 666
852
428
65
9
94
519
3 883
374
1 609
3 292
1 442
23
52
1 530
2 013
3 043
1 468
139
9
761
604
6 028
17 178
476
12
16
2 846
1 192
5 784
57 407
0
0
36
285
190
0
0
198
41
1 475
294
136
0
0
0
10
28
157
0
0
7 009
1 561
11 420
1
0
46
292
212
0
0
224
42
1 230
466
62
0
0
0
10
26
232
1
0
7 105
612
10 561
0
0
49
272
223
0
0
215
41
1 081
347
59
0
0
0
6
20
556
0
0
6 934
1 850
11 653
0
0
41
319
243
0
0
189
41
903
355
61
0
0
0
9
21
377
5
0
6 588
9 152
1
0
44
215
219
0
0
225
71
774
255
40
0
1
0
5
25
269
6
0
5 933
8 083
0
0
32
203
180
1
0
164
73
719
188
20
0
0
9
13
227
4
5 847
7 680
2
13
504
2 444
6 561
22
2
2 121
1 113
13 094
2 966
2 701
8
4
0
11
963
3 759
2 391
99
0
105 979
11 410
156 167
1 538
136
11 521
13 195
1 426
159
10 762
12 347
1 292
122
11 841
13 255
1 357
271
9 321
10 949
1 576
275
8 203
10 054
1 100
244
7 791
9 135
46 766
8 243
158 565
213 574
2004
2005
2006
2007
72
28
7
2
0
7
13
247
10
195
131
14
2
0
74
192
147
101
3
1
13
15
213
608
1
0
0
361
29
155
2 641
63
14
12
3
1
4
17
192
16
183
140
21
2
0
67
149
115
85
6
0
17
20
158
555
0
0
0
310
20
187
2 357
40
19
34
3
0
5
10
191
10
172
164
12
0
1
59
185
108
62
3
3
15
7
131
474
4
1
0
277
34
192
2 216
54
21
43
2
2
12
21
115
12
153
154
12
3
1
55
184
141
59
6
0
13
13
95
393
4
1
0
259
62
174
2 064
36
18
54
1
1
8
13
36
7
142
126
9
2
0
40
211
100
44
5
2
8
12
53
365
4
3
0
275
23
177
1 775
0
0
33
45
362
2
0
99
70
463
126
182
0
0
0
15
79
105
3
0
5 778
851
8 213
0
0
46
108
296
2
0
127
61
664
103
228
0
0
0
11
74
142
6
0
6 270
1 120
9 258
0
0
24
172
272
1
1
153
49
1 208
168
236
1
1
0
8
56
99
5
0
7 127
1 454
11 035
0
0
32
316
294
0
0
183
40
1 292
254
224
0
0
0
12
50
138
5
0
7 084
1 816
11 739
2 063
252
8 539
10 854
1 920
199
9 496
11 615
1 783
194
11 274
13 251
1 677
179
11 947
13 803
*
*** No official data were reported by Russia. Information about HIV diagnoses in people infected through injecting drug use were published by the Federal Scientific
and Methodological Center for Prevention and Control of AIDS: 11 191 (2004), 10 988 (2005), 11 893 (2006), 12 429 (2007), 16 689 (2008), 16 009 (2009), 16 308
(2010), 16 937 (2011), 18 029 (2012), 19 875 (2013), 299 923 (cumulative as of 31 December 2013). Reference: HIV-infection bulletin number 39. Moscow: The
Federal Service for Surveillance of Consumer Rights Protection and human well-being; 2014
**** Excluding a cumulative 2 cases from Kosovo (without prejudice to positions on status, and in line with UNSCR 1244 and the ICJ Opinion on the Kosovo
Declaration of Independence)
31
SURVEILLANCE REPORT
Table6: HIV diagnoses in persons infected through heterosexual contact, by country and year of diagnosis (20042013)
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West Andorra
East
Armenia
East
Azerbaijan
East
Belarus
East
Georgia
West Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West Monaco
Centre Montenegro
East
Russia***
West San Marino
Centre Serbia****
West Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
Year of report
2008
2009
2010
2011
2012
2013
Cumulative
total**
123
421
68
11
27
43
105
17
91
2 250
710
118
23
8
166
1 838
133
36
27
9
343
170
75
1 167
144
9
6
1 218
209
3 269
12 834
104
436
71
7
15
38
141
71
94
2 186
454
118
18
10
127
1 861
131
28
28
10
339
157
99
1 123
148
4
7
1 226
238
2 994
12 283
101
438
89
22
23
25
132
56
88
2 022
518
146
19
6
126
1 792
144
32
25
13
292
155
90
1 003
149
12
8
1 062
222
2 814
11 624
112
457
58
7
23
40
96
127
71
2 106
484
148
23
0
137
1 744
112
48
25
15
282
142
98
925
164
14
4
1 084
198
2 568
11 312
84
372
70
13
16
44
90
169
67
1 325
593
103
24
0
131
1 605
125
50
19
10
215
123
82
665
192
21
7
933
167
2 134
9 449
2 716
10 495
1 012
335
471
556
2 922
803
1 290
25 383
11 905
2 939
388
100
2 730
13 398
1 486
381
508
120
6 819
2 807
1 264
21 211
2 140
133
104
10 632
4 803
59 493
189 344
40
0
86
100
674
8
3
132
201
682
162
588
0
4
0
28
281
119
274
0
7 880
716
11 978
47
1
83
116
822
3
2
146
177
750
173
574
0
5
0
23
254
127
218
0
8 541
955
13 017
38
2
86
130
787
3
0
201
210
819
186
606
0
3
0
35
223
262
202
0
9 122
852
13 767
63
1
127
188
860
14
0
202
209
1 010
181
613
0
4
4
37
211
356
250
0
10 248
14 578
69
1
160
243
949
4
7
243
202
1 138
307
664
0
7
3
27
218
344
376
0
10 440
15 402
99
1
176
267
1 138
12
2
236
182
1 273
276
325
0
1
0
21
212
477
428
11 472
16 598
569
21
960
1 372
8 605
126
27
1 656
4 097
7 451
1 631
5 082
11
65
23
674
7 133
1 881
3 120
0
91 345
4 730
140 579
13 061
722
11 334
25 117
12 674
704
12 473
25 851
12 081
688
13 281
26 050
11 380
805
14 017
26 202
11 018
921
14 775
26 714
9 031
1 032
15 984
26 047
191 556
10 984
127 383
329 923
2004
2005
2006
2007
157
472
43
21
17
30
130
0
54
2 851
627
152
13
2
181
779
68
24
39
7
478
163
47
1 273
124
2
4
752
270
4 825
13 605
152
466
65
26
25
29
110
0
67
2 800
701
175
20
5
172
665
96
20
37
9
462
134
93
1 140
125
12
2
694
208
4 792
13 302
134
420
46
15
28
25
127
0
93
2 413
697
153
15
7
182
912
87
16
31
10
369
164
76
1 204
99
8
3
750
201
4 329
12 614
138
439
58
15
21
28
130
0
74
2 315
674
131
15
0
167
1 051
127
27
19
12
371
141
71
1 227
113
12
2
1 045
228
4 010
12 661
142
401
52
15
22
45
122
3
59
2 478
712
158
17
6
190
1 151
164
28
25
24
359
185
67
1 223
135
8
4
1 226
207
3 911
13 139
29
1
15
29
393
7
1
49
161
198
34
169
0
1
0
26
425
14
120
0
4 041
221
5 934
29
2
25
63
456
8
0
81
173
247
58
291
0
4
0
25
364
28
158
0
4 586
364
6 962
25
1
37
41
511
4
5
112
186
334
71
366
0
1
1
24
340
52
153
0
5 646
495
8 405
36
1
70
77
668
4
2
125
176
504
107
500
0
5
0
23
295
91
295
0
5 736
701
9 416
13 799
485
5 255
19 539
13 328
621
6 315
20 264
12 724
527
7 768
21 019
12 644
700
8 733
22 077
*
*** No official data were reported by Russia. Information about HIV diagnoses in persons infected through heterosexual transmission were published by the Federal
Scientific and Methodological Center for Prevention and Control of AIDS: 5191 (2004), 5653 (2005), 6329 (2006), 7255 (2007), 9910 (2008), 10 526 (2009), 12
230 (2010), 12 785 (2011), 14 038 (2012), 15 604 (2013), 117 389 (cumulative as of 31 December 2013). Reference: HIV-infection bulletin number 39. Moscow: The
Federal Service for Surveillance of Consumer Rights Protection and human well-being; 2014
32
SURVEILLANCE REPORT
Table7: HIV diagnoses in persons infected through mother-to-child transmission, by country and year of diagnosis
(20042013) and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West Andorra
East
Armenia
East
Azerbaijan
East
Belarus
East
Georgia
West Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West Monaco
Centre Montenegro
East
Russia***
West San Marino
Centre Serbia****
West Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
Year of report
2008
2009
2010
2011
2012
2013
Cumulative
total**
2
4
1
0
0
0
0
3
2
34
11
0
2
0
5
18
2
0
1
0
17
4
12
15
11
0
0
11
11
120
286
1
7
4
0
0
0
3
2
1
41
20
3
0
0
9
12
4
0
0
0
21
1
11
17
16
0
0
15
16
106
310
2
10
2
1
0
0
3
2
1
35
16
4
0
0
3
24
2
1
0
0
9
4
7
8
12
0
1
9
13
105
274
0
8
0
0
1
2
4
4
2
48
20
0
1
0
5
13
7
0
0
0
7
7
4
4
11
0
0
6
8
77
239
1
5
5
0
0
0
5
2
2
26
21
0
1
0
3
9
10
1
0
0
5
1
4
5
16
0
0
10
3
83
218
54
428
19
13
3
6
96
46
24
388
326
64
11
1
75
136
59
3
7
0
277
76
193
393
243
0
7
86
203
2 399
5 636
5
21
0
0
12
16
44
25
17
0
1
0
1
2
4
8
0
217
57
432
2
0
3
5
9
0
0
4
10
22
16
8
0
0
0
2
4
9
7
0
169
96
366
0
0
3
11
27
0
0
13
7
21
19
10
0
0
0
0
7
15
0
0
177
73
383
3
0
2
9
19
0
0
7
8
18
20
16
0
0
0
1
4
28
4
0
136
275
2
0
3
14
16
0
0
9
7
30
33
9
0
0
0
0
2
40
12
0
146
323
6
0
5
10
14
0
0
3
8
36
10
13
0
0
0
4
4
40
11
127
291
28
1
28
65
230
1
2
81
230
243
135
122
1
3
0
1
43
191
144
82
0
3 129
363
5 123
264
32
418
714
269
37
346
652
287
31
375
693
258
31
260
549
218
33
311
562
191
47
271
509
5 457
654
4 648
10 759
2004
2005
2006
2007
0
9
0
0
0
0
5
7
1
37
19
4
0
0
3
30
4
0
0
0
15
1
14
20
10
0
1
3
18
158
359
1
8
1
0
1
0
3
4
1
39
24
2
2
0
3
9
2
0
1
0
15
5
7
10
15
0
0
3
12
135
303
2
6
0
1
0
0
2
4
1
27
20
3
0
7
6
25
11
11
0
0
4
9
135
291
4
19
1
1
0
0
7
2
0
38
27
3
2
0
6
4
8
1
0
0
12
9
16
18
5
0
0
10
8
122
323
1
8
0
1
0
0
4
8
1
29
16
1
0
0
7
7
8
0
0
0
19
4
13
15
6
0
0
10
17
107
282
0
0
1
1
20
0
0
2
9
6
6
0
0
0
3
4
8
0
186
4
250
0
0
2
3
37
0
1
7
16
9
2
9
0
0
0
1
5
5
0
192
11
300
5
0
4
1
25
1
0
6
13
20
2
14
0
0
0
1
1
3
0
200
31
327
3
0
3
3
20
0
0
15
11
30
8
7
0
0
0
1
7
7
3
0
230
84
432
2
0
336
36
237
609
292
33
278
603
259
46
313
618
305
32
418
755
0
2
10
5
0
*
*** No official data were reported by Russia. Information about HIV diagnoses in persons infected through mother to child transmission were published by the
Federal Scientific and Methodological Center for Prevention and Control of AIDS: 445 (2004), 549 (2005), 581 (2006), 523 (2007), 621 (2008), 557 (2009), 494
(2010), 487 (2011), 446 (2012), 366 (2013), 5964 (cumulative as of 31 December 2013). Reference: HIV-infection bulletin number 39. Moscow: The Federal Service
for Surveillance of Consumer Rights Protection and human well-being; 2014
33
SURVEILLANCE REPORT
Table8: HIV diagnoses*, by geographical area, sex, transmission group and year of diagnosis (20042013) and
cumulative totals
Transmission mode
EU/EEA
Injecting drug use
Heterosexual contact
Mother-to-child
Haemophiliac/transfusion recipient
Nosocomial infection
Other/undetermined
Total EU/EEA
Non-EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total non-EU/EEA
Transmission mode
EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total EU/EEA
Non-EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total non-EU/EEA
*
**
34
Female
2004
Male Unknown
Female
2005
Male Unknown
Female
2006
Male Unknown
Female
2007
Male Unknown
345
7 020
161
53
14
1 035
8 628
6 682
1 279
4 995
143
36
9
1 685
14 829
0
4
12
1
0
0
20
37
304
6 892
141
44
12
1 077
8 470
7 388
1 239
4 938
138
42
5
1 790
15 540
2
5
20
1
0
0
31
59
306
6 259
135
34
11
1 082
7 827
7 701
1 122
4 604
113
38
8
1 914
15 500
10
4
13
0
0
0
33
60
315
5 864
169
30
13
1 063
7 454
8 438
1 092
4 610
121
32
15
2 012
16 320
20
4
20
1
0
1 619
3 500
18
8
0
233
5 378
14 006
293
5 740
2 093
34
8
0
392
8 560
23 389
0
0
0
186
0
0
7
193
230
1 613
4 060
42
13
1
224
5 953
14 423
407
6 519
2 380
50
5
3
367
9 731
25 271
0
0
0
192
0
0
5
197
256
1 818
4 898
43
11
24
282
7 076
14 903
451
7 758
2 859
50
9
51
431
11 609
27 109
1
0
0
200
0
0
12
213
273
1 871
4 893
54
7
35
266
7 126
14 580
524
8 045
3 525
61
4
57
453
12 669
28 989
2
3
2
230
0
0
12
249
323
Female
2012
Male Unknown
Female
2013
Male Unknown
Female
Cumulative total**
Male Unknown
Total
282
4 496
105
29
6
1 189
6 107
9 448
1 177
3 763
107
27
4
2 695
17 221
21
0
0
0
0
1
24
46
197
3 618
102
16
9
1 240
5 182
8 849
840
3 041
90
24
10
2 768
15 622
15
0
1
1
0
0
36
53
9 262
89 877
2 699
1 252
756
16 161
120 007
149 781
32 562
72 832
2 455
3 472
850
34 162
296 114
127
813
538
21
110
1
1 210
2 820
149 908
42 637
163 247
5 175
4 834
1 607
51 533
418 941
1 335
8 693
77
7
39
246
10 397
16 504
784
6 742
6 332
88
5
57
495
14 503
31 724
1
0
1
146
0
0
8
156
202
1 241
9 196
63
5
4
378
10 887
16 069
933
6 435
6 973
90
3
9
550
14 993
30 615
0
1
127
0
0
29
157
210
0
29 404
78 446
693
179
196
7 994
116 912
236 919
10 033
114 275
53 850
823
256
284
15 707
195 228
491 342
9
979
433
3 162
105
13
2 945
7 646
10 466
10 042
144 658
132 729
4 678
540
493
26 646
319 786
738 727
29
74
Cases from Russia, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period; cases from Estonia, Poland and Turkey excluded
due to incomplete reporting on transmission mode during the period; cases from Italy and Spain excluded due to increasing national coverage over the period.
Therefore, totals by transmission mode, gender and overall may differ from totals presented in Tables 17.
Cumulative total is the total number of cases reported by country since the start of reporting
SURVEILLANCE REPORT
Female
2008
Male Unknown
Female
2009
Male Unknown
Female
2010
Male Unknown
Female
243
5 893
120
25
11
1 091
7 383
8 825
955
4 779
124
23
9
2 070
16 785
22
2
20
0
1
0
33
78
230
5 272
140
18
9
1 065
6 734
8 709
844
4 405
102
26
12
2 149
16 247
21
3
9
0
0
0
25
58
202
4 973
151
35
10
1 062
6 433
8 944
800
4 048
119
24
12
2 317
16 264
11
0
5
0
0
0
40
56
249
4 623
123
28
8
1 090
6 121
1 729
6 860
70
3
38
305
9 005
16 388
573
8 040
4 098
76
6
36
520
13 349
30 134
0
90
30
221
0
12
16
369
447
1 705
7 316
35
7
16
275
9 354
16 088
649
8 243
4 528
59
5
25
443
13 952
30 199
0
0
0
169
0
0
6
175
233
1 616
7 579
51
4
7
230
9 487
15 920
666
8 187
5 134
82
1
9
569
14 648
30 912
0
0
0
177
0
0
1
178
234
1 707
8 481
69
2
23
249
10 531
16 652
2011
Transmission mode
Male Unknown
EU/EEA
8 817
2 Men who have sex with men
1 020
0 Injecting drug use
3 998
3 Heterosexual contact
107
2 Mother-to-child
19
0 Haemophiliac/transfusion recipient
8
0 Nosocomial infection
2 501
32 Other/undetermined
16 470
39 Total EU/EEA
Non-EU/EEA
694
7 440
5 847
65
137 Mother-to-child
6
32
408
14 492
144 Total non-EU/EEA
30 962
183 Total WHO European Region
35
SURVEILLANCE REPORT
Table8: HIV diagnoses*, by geographical area, sex, transmission group and year of diagnosis (20042013) and
cumulative totals
Table8b: Geographical areas, WHO European Region
Transmission mode
West
Injecting drug use
Mother-to-child
Other/undetermined
Total West
Centre
Injecting drug use
Mother-to-child
Other/undetermined
Total Centre
East
Female
2004
Male Unknown
Female
2005
Male Unknown
Female
2006
Male Unknown
Female
2007
Male Unknown
324
7 163
158
56
10
970
8 681
6 763
1 182
5 093
144
36
6
1 604
14 828
0
4
12
1
0
0
24
41
303
6 969
136
45
11
1 028
8 492
7 472
1 153
4 980
143
41
2
1 727
15 518
2
5
20
1
0
0
24
52
293
6 376
134
36
11
1 037
7 887
7 819
1 024
4 673
111
41
7
1 875
15 550
10
4
13
0
0
0
22
49
286
5 914
168
33
11
1 053
7 465
8 541
944
4 613
122
32
13
2 014
16 279
20
4
21
1
0
0
20
66
4
142
6
5
4
53
214
179
32
176
8
7
3
88
493
0
0
0
0
0
0
0
0
5
171
14
5
1
51
247
267
30
199
7
4
3
67
577
0
0
0
0
0
0
12
12
8
146
7
3
251
50
152
11
0
1
51
516
1
0
0
0
0
0
19
20
13
141
9
2
2
33
200
323
66
193
4
3
2
53
644
2
0
0
0
0
0
21
23
46
210
33
56
82
98
Injecting drug use
1,636
5,805
1,609
6,575
1,823
7,806
1,887
8,127
3,215
1,819
3,812
2,139
4,635
2,638
4,702
3,329
Mother-to-child
15
25
186
33
38
192
37
41
200
46
56
230
24
51
35
57
Other/undetermined
245
385
222
363
281
419
243
398
5,111
8,068
189
5,684
9,176
192
6,806
11,043
204
6,915
12,066
234
14,006
23,389
230
14,423
25,271
256
14,903
27,109
273
14,580
28,989
323
Female
2012
Male Unknown
Female
2013
Male Unknown
Female
Cumulative total**
Male Unknown
Total
Total East
Transmission mode
West
Injecting drug use
Mother-to-child
Other/undetermined
Total West
Centre
Injecting drug use
Mother-to-child
Other/undetermined
Total Centre
East
213
4 492
99
29
5
1 161
5 999
9 218
966
3 697
100
29
4
2 638
16 652
21
0
1
0
0
1
13
36
150
3 544
88
19
9
1 198
5 008
8 469
643
2 947
83
26
9
2 744
14 921
15
0
2
1
0
0
14
32
9 631
92 504
2 730
1 245
148
19 770
126 028
151 304
31 454
74 455
2 483
3 442
151
42 600
305 889
125
822
567
22
110
1
3 677
5 324
151 429
41 907
167 526
5 235
4 797
300
66 047
437 241
46
169
8
1
1
42
267
709
180
278
9
0
0
105
1 281
1
0
0
0
0
0
19
20
36
216
16
0
0
51
319
809
165
306
16
0
1
114
1 411
0
0
0
0
0
0
34
34
229
2 780
173
147
608
844
4 781
6 382
1 055
3 480
179
253
699
1 332
13 380
7
832
340
27
103
0
439
1 748
6 389
2 116
6 600
379
503
1 307
2 615
19 909
305
504
2 128
2 132
Injecting drug use
1 358
6 773
1 252
6 467
28 806
114 328
138
143 434
8 528
6 120
9 054
6 761
73 039
48 747
64
121 850
75
86
146
61
81
127
489
616
3 134
4 239
39
33
74
39
57
196
284
13
493
Mother-to-child
Other/undetermined
232
447
369
460
17
3 541
5 937
39
9 517
Total East
10 238
13 791
146
10 742
14 283
144
106 110
172 073
3 394
281 739
16 504
31 724
202
16 069
30 615
210
236 919
491 342
10 466
738 889
**
36
Cases from Russia, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period; cases from Estonia, Poland and Turkey excluded
due to incomplete reporting on transmission mode during the period; cases from Italy and Spain excluded due to increasing national coverage over the period.
Therefore, totals by transmission mode, gender and overall may differ from totals presented in Tables 17.
SURVEILLANCE REPORT
Female
2008
Male Unknown
Female
2009
Male Unknown
Female
2010
Male Unknown
Female
221
5 924
126
26
10
1 075
7 382
8 824
829
4 739
121
25
8
2 086
16 632
22
2
21
0
1
0
16
62
199
5 233
137
23
9
1 060
6 661
8 713
661
4 376
103
29
12
2 116
16 010
19
3
9
0
0
0
15
46
183
4 991
147
39
9
1 055
6 424
8 852
613
3 998
113
24
12
2 331
15 943
11
0
5
0
0
0
10
26
198
4 625
122
27
8
1 071
6 051
7
169
5
0
1
56
238
447
76
212
6
2
1
72
816
0
0
0
0
0
0
26
26
14
190
11
0
0
35
250
472
83
221
7
1
0
82
866
2
0
0
0
0
0
16
18
9
149
9
0
1
35
203
568
71
238
11
1
0
69
958
0
0
0
0
0
0
31
31
39
173
8
2
0
43
265
2011
Transmission mode
Male Unknown
West
8 667
764
3 898
100
3 Mother-to-child
22
7
2 480
15 938
18 Total West
Centre
579
163
292
12
0 Mother-to-child
1
1
75
1 123
29 Total Centre
East
265
127
173
190
1 744
8 090
90
1 722
8 343
1 626
8 303
1 719
7 533
6 660
3 926
29
7 165
4 336
7 412
4 946
8 306
5 655
59
73
221
27
51
169
46
77
177
62
60

136 Mother-to-child
38
36
12
16
25
23
32
265
432
245
394
202
486
225
354
8 768
12 686
359
9 177
13 323
169
9 293
14 011
177
10 336
13 901
136 Total East
16 388
30 134
447
16 088
30 199
233
15 920
30 912
234
16 652
30 962
37
SURVEILLANCE REPORT
Table9: HIV diagnoses*, by geographical area, sex, age and year of diagnosis (20042013) and cumulative totals
Age category
EU/EEA
<15
1519
2024
2529
3039
4049
50+
Unknown
Total EU/EEA
Non-EU/EEA
<15
1519
2024
2529
3039
4049
50+
Unknown
Female
2004
Male Unknown
Female
2005
Male Unknown
Female
2006
Male Unknown
Female
2007
Male Unknown
199
478
1 151
2 033
3 168
1 195
666
165
9 055
185
270
1 107
2 163
6 082
3 613
1 962
421
15 803
1
2
5
3
19
5
3
10
48
160
369
1 100
1 897
3 120
1 326
747
156
8 875
159
288
1 195
2 333
6 041
3 916
2 189
323
16 444
2
1
3
17
15
9
7
24
78
167
305
903
1 687
2 975
1 285
756
162
8 240
146
226
1 174
2 348
6 004
4 136
2 164
346
16 544
0
0
5
14
29
10
1
30
89
185
300
914
1 585
2 799
1 359
708
18
7 868
137
231
1 393
2 627
6 035
4 322
2 432
87
17 264
2
2
9
29
39
24
8
38
151
27
330
283
260
1 495
413
140
2 498
47
139
324
510
3 351
1 339
332
2 651
0
0
2
1
0
0
0
4
63
400
282
299
1 713
556
149
2 583
67
162
317
616
3 875
1 601
379
2 893
192
0
0
0
0
1
1
3
74
397
339
383
2 136
749
200
2 881
115
166
372
725
4 856
1 983
483
3 102
200
1
0
1
1
2
0
8
108
446
456
535
2 512
868
264
2 037
135
126
499
942
5 498
2 306
611
2 800
230
0
2
1
6
2
0
11
Total non-EU/EEA
5 446
8 693
6 045
9 910
197
7 159
11 802
213
7 226
12 917
252
14 501
24 496
55
14 920
26 354
275
15 399
28 346
302
15 094
30 181
403
2012
Male Unknown
Female
2013
Male Unknown
Female
Cumulative total**
Male Unknown
Total
Age category
EU/EEA
<15
1519
2024
2529
3039
4049
50+
Unknown
Total EU/EEA
Non-EU/EEA
<15
1519
2024
2529
3039
4049
50+
Unknown
Female
111
189
564
1 010
2 238
1 283
963
14
6 372
102
308
1 774
2 821
5 764
4 526
2 990
60
18 345
2
0
5
10
16
7
0
27
67
86
174
485
856
1 868
1 142
830
9
5 450
84
257
1 636
2 703
5 318
3 955
2 768
34
16 755
1
1
4
5
10
7
1
37
66
3 931
5 690
16 248
26 435
42 906
18 101
11 058
2 065
126 434
4 581
6 602
29 000
52 217
111 607
67 015
38 971
5 484
315 477
81
32
145
295
495
221
90
2 035
3 394
8 593
12 324
45 393
78 947
155 008
85 337
50 119
9 584
445 305
160
286
1 454
2 267
3 756
1 857
855
11
260
77
783
2 393
6 807
3 528
1 460
14
152
0
0
0
2
0
1
7
112
247
1 347
2 225
4 013
2 121
1 058
76
173
98
917
2 521
6 986
3 746
1 613
84
127
0
0
2
4
2
0
5
1 359
6 078
14 126
18 501
37 204
13 714
5 468
22 382
1 728
4 263
12 053
25 255
79 148
32 896
10 857
34 173
1 659
17
146
242
351
111
38
3 551
4 746
10 358
26 325
43 998
116 703
46 721
16 363
60 035
Total non-EU/EEA
10 646
15 322
162
11 199
16 138
140
118 832
200 373
6 115
325 249
17 018
33 667
229
16 649
32 893
206
245 266
515 850
9 509
770 554
*
**
38
Cases from Russia, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period; cases from Italy and Spain excluded due to
increasing national coverage over the period. Therefore, totals by gender and overall may differ from totals presented in Tables 13.
SURVEILLANCE REPORT
Female
2008
Male Unknown
Female
2009
Male Unknown
Female
2010
Male Unknown
Female
139
268
813
1 476
2 763
1 423
860
24
7 766
150
272
1 411
2 632
5 939
4 667
2 563
82
17 716
0
3
14
17
49
14
1
52
150
136
258
727
1 287
2 449
1 305
881
17
7 060
111
264
1 444
2 497
5 656
4 535
2 643
70
17 220
0
0
7
22
36
15
4
42
126
147
219
654
1 155
2 254
1 388
906
10
6 733
115
284
1 592
2 447
5 560
4 400
2 757
53
17 208
0
0
5
15
31
19
7
67
144
118
193
643
1 094
2 270
1 253
841
6
6 418
128
404
1 903
2 331
2 937
1 060
347
17
132
98
1 088
2 979
5 965
2 613
720
26
234
2
9
27
70
20
3
9
74
387
1 836
2 314
3 157
1 252
452
8
104
91
1 062
2 856
6 511
2 827
833
20
169
0
73
320
1 572
2 369
3 348
1 387
549
8
101
95
1 104
2 764
6 781
3 165
1 013
13
177
0
0
0
1
0
0
0
119
296
1 590
2 358
3 788
1 773
765
8
2
0
1
0
3
2011
Age category
Male Unknown
EU/EEA
105
2 <15
267
0 1519
1 587
2 2024
2 733
1 2529
5 608
3 3039
4 430
6 4049
2 836
2 50+
46
65 Unknown
17 612
81 Total EU/EEA
Non-EU/EEA
145
137 <15
82
0 1519
930
1 2024
2 502
0 2529
6 839
1 3039
3 289
2 4049
1 178
1 50+
12
4 Unknown
9 127
13 621
374
9 480
14 304
175
9 626
15 036
178
10 697
14 977
146 Total non-EU/EEA
16 893
31 337
524
16 540
31 524
301
16 359
32 244
322
17 115
32 589
39
SURVEILLANCE REPORT
Table9: HIV diagnoses*, by geographical area, sex, age and year of diagnosis (20042013) and cumulative totals
Age category
West
<15
1519
2024
2529
3039
4049
50+
Unknown
Total West
Centre
<15
1519
2024
2529
3039
4049
50+
Unknown
Total Centre
Female
2004
Male Unknown
Female
2005
Male Unknown
Female
2006
Male Unknown
Female
2007
Male Unknown
175
329
1 079
2 018
3 165
1 201
680
34
8 681
160
176
963
2 022
5 900
3 587
1 956
64
14 828
1
1
7
4
16
3
3
6
41
145
278
1 024
1 852
3 091
1 330
744
28
8 492
153
187
1 062
2 141
5 840
3 889
2 184
62
15 518
2
1
2
13
12
7
7
8
52
151
223
854
1 638
2 948
1 277
765
31
7 887
128
168
1 035
2 158
5 716
4 095
2 186
64
15 550
0
1
3
7
21
7
1
9
49
169
223
768
1 468
2 754
1 362
704
17
7 465
130
193
1 145
2 269
5 794
4 267
2 417
64
16 279
0
1
4
11
18
17
3
12
66
24
57
82
89
123
36
24
28
32
34
129
188
372
194
104
50
0
1
0
0
3
2
0
5
24
41
94
118
132
51
37
17
15
44
151
266
416
200
140
37
0
0
1
4
3
3
1
19
20
32
75
122
126
56
30
6
28
27
174
276
468
208
105
38
0
0
2
8
8
5
0
26
24
40
80
98
128
39
41
5
15
35
191
332
460
228
162
39
2
1
7
18
22
8
5
37
463
1 103
11
514
1 269
31
467
1 324
49
455
1 462
100
East
<15
27
40
54
58
192
70
105
200
100
127
230
1519
422
199
450
219
447
197
483
129
2024
273
339
264
299
313
337
522
556
2529
186
463
226
542
310
639
554
968
3039
1 375
3 161
1 610
3 660
2 037
4 676
2 429
5 279
4049
371
1 171
501
1 428
701
1 816
826
2 133
50+
102
234
115
244
161
356
227
464
Unknown
2 601
2 958
2 694
3 117
3 006
3 346
2 033
2 784
Total East
5 357
8 565
5 914
9 567
192
7 045
11 472
204
7 174
12 440
237
14 501
24 496
55
14 920
26 354
275
15 399
28 346
302
15 094
30 181
403
Age category
West
<15
1519
2024
2529
3039
4049
50+
Unknown
Total West
Centre
<15
1519
2024
2529
3039
4049
50+
Unknown
Total Centre
Female
2012
Male Unknown
Female
2013
Male Unknown
Female
Cumulative total**
Male Unknown
Total
98
161
451
936
2 143
1 249
946
15
5 999
91
264
1 521
2 407
5 084
4 279
2 958
48
16 652
2
0
2
7
13
4
1
7
36
69
146
403
751
1 754
1 083
792
10
5 008
74
222
1 383
2 246
4 543
3 718
2 703
32
14 921
1
1
1
4
11
8
1
5
32
3 182
4 372
15 937
27 281
43 987
18 275
11 256
1 738
126 028
3 680
4 645
26 496
50 440
109 738
67 192
39 676
4 022
305 889
121
43
229
421
652
254
109
3 495
5 324
6 983
9 060
42 662
78 142
154 377
85 721
51 041
9 255
437 241
20
28
103
120
214
119
69
2
25
59
377
625
1 069
555
285
20
0
0
3
3
5
3
0
27
24
23
103
134
226
110
80
3
26
55
414
701
1 287
604
314
15
0
0
3
3
3
1
0
37
1 171
825
1 998
1 928
2 390
971
666
282
1 354
957
4 624
6 417
10 214
4 710
2 606
909
2
4
53
88
117
58
15
1 975
2 527
1 786
6 675
8 433
12 721
5 739
3 287
3 166
703
3 416
47
10 231
31 791
2 312
44 334
675
3 015
41
East
<15
153
246
152
105
157
127
937
1 275
1 617
3 829
1519
286
62
252
78
6 571
5 263
11 836
2024
1 464
659
1 326
756
12 439
9 933
22 381
2529
2 221
2 182
2 196
2 277
15 727
20 615
28
36 370
3039
3 637
6 418
3 901
6 474
33 733
70 803
77
104 613
4049
1 772
3 220
2 070
3 379
12 569
28 009
20
40 598
803
1 207
1 016
1 364
4 604
7 546
12 154
72
71
22 427
34 726
116
57 198
50+
Unknown
Total East
10 344
14 000
152
10 938
14 556
127
109 007
178 170
1 873
288 979
17 018
33 667
229
16 649
32 893
206
245 266
515 850
9 509
770 554
*
**
40
Cases from Russia, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period; cases from Italy and Spain excluded due to
increasing national coverage over the period. Therefore, totals by gender and overall may differ from totals presented in Tables 13.
SURVEILLANCE REPORT
Female
2008
Male Unknown
Female
2009
Male Unknown
Female
2010
Male Unknown
Female
2011
Age category
Male Unknown
West
92
3 <15
226
0 1519
1 342
1 2024
2 291
0 2529
4 940
4 3039
4 244
5 4049
2 773
3 50+
30
2 Unknown
15 938
18 Total West
Centre
20
0 <15
53
0 1519
323
2 2024
522
1 2529
909
0 3039
427
3 4049
250
0 50+
20
67 Unknown
132
212
678
1 380
2 707
1 406
844
23
7 382
137
222
1 192
2 286
5 591
4 593
2 542
69
16 632
0
2
6
6
29
9
1
9
62
127
204
597
1 185
2 370
1 288
871
19
6 661
105
212
1 258
2 158
5 182
4 451
2 602
42
16 010
0
0
3
14
17
7
1
4
46
138
185
547
1 085
2 210
1 362
884
13
6 424
101
251
1 335
2 103
5 086
4 307
2 725
35
15 943
0
0
1
6
9
9
1
0
26
111
169
517
990
2 179
1 229
849
7
6 051
17
34
90
113
159
47
49
4
17
46
197
359
583
299
173
31
0
1
8
11
20
6
0
52
19
35
99
108
163
53
54
3
18
50
221
379
706
331
204
31
0
0
4
10
19
9
3
41
15
23
87
101
148
65
53
4
19
38
292
415
713
334
222
23
0
0
4
9
23
10
6
67
15
20
108
115
184
94
49
3
513
1 705
98
534
1 940
86
496
2 056
119
588
2 524
118
128
234
64
92
169
67
96
177
111
138
East
136 <15
0 1519
73 Total Centre
426
102
406
93
331
90
300
70
1 948
1 110
1 867
1 027
1 592
1 069
1 608
852
0 2024
2 314
2 966
27
2 308
2 816
2 338
2 693
2 347
2 422
0 2529
2 834
5 730
70
3 073
6 279
3 244
6 542
3 695
6 598
0 3039
1 030
2 388
19
1 216
2 580
1 348
2 924
1 703
3 048
314
568
408
670
518
823
708
991
0 4049
0 50+
14
17
8 998
13 000
364
9 345
13 574
169
9 439
14 245
177
10 476
14 127
136 Total East
0 Unknown
16 893
31 337
524
16 540
31 524
301
16 359
32 244
322
17 115
32 589
41
SURVEILLANCE REPORT
Table10: HIV diagnoses in persons infected through heterosexual contact, by country and transmission subcategory,
cases diagnosed in 2013, in EU/EEA and other countries of the WHO European Region
Area
Country*
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Yugoslav Republic of
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
Case from country

with generalised HIV
epidemic
Partner from a
country with a
generalised HIV
epidemic
N
%
Partner IDU
21
193
18
0
2
1
48
0
8
262
337
17
5
0
72
269
0
0
11
4
62
56
0
158
0
1
2
159
97
1 055
2 858
25.0
51.9
25.7
0.0
12.5
2.3
53.3
0.0
11.9
19.8
56.8
16.5
20.8
0.0
55.0
16.8
0.0
0.0
57.9
40.0
28.8
45.5
0.0
23.8
0.0
4.8
28.6
17.0
58.1
49.4
30.2
17
25
0
0
0
1
20
0
33
587
35
4
0
0
19
0
0
0
0
0
0
6
0
25
0
1
3
0
0
0
776
0
0
0
0
0
0
0.0
0.0
0.0
0.0
0.0
0.0
0
0
0
0
0
0
0.0
0.0
3
92
0
0
0
0
0
0
0
0
55
0
5
0
0
0
155
1.3
50.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
25.9
0.0
1.2
0.0
0.0
0.0
0.9
30
0
0
0
0
0
0
0
0
0
41
0
0
0
0
0
71
12.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
19.3
0.0
0.0
0.0
0.0
0.0
0.4
2 976
34
3
3 013
33
3.3
0.0
11.6
812
5
30
847
9
0.5
0.2
3.3
49
12
105
166
Bisexual partner
Other/ undetermined
Total
20.2
6.7
0.0
0.0
0.0
2.3
22.2
0.0
49.3
44.3
5.9
3.9
0.0
0.0
14.5
0.0
0.0
0.0
0.0
0.0
0.0
4.9
0.0
3.8
0.0
4.8
42.9
0.0
0.0
0.0
8.2
4
2
0
0
0
0
2
5
3
10
13
4
0
0
2
0
10
0
0
0
0
0
0
4
12
0
0
0
0
0
71
4.8
0.5
0.0
0.0
0.0
0.0
2.2
3.0
4.5
0.8
2.2
3.9
0.0
0.0
1.5
0.0
8.0
0.0
0.0
0.0
0.0
0.0
0.0
0.6
6.3
0.0
0.0
0.0
0.0
0.0
0.8
0
0
0
0
0
0
2
1
0
10
10
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
0
0
26
0.0
0.0
0.0
0.0
0.0
0.0
2.2
0.6
0.0
0.8
1.7
1.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
14.3
0.0
0.0
0.0
0.3
42
152
52
13
14
42
18
163
23
456
198
77
19
0
38
1 336
115
50
8
6
153
61
82
477
180
19
1
774
70
1 079
5 718
50.0
40.9
74.3
100.0
87.5
95.5
20.0
96.4
34.3
34.4
33.4
74.8
79.2
0.0
29.0
83.2
92.0
100.0
42.1
60.0
71.2
49.6
100.0
71.7
93.8
90.5
14.3
83.0
41.9
50.6
60.5
84
372
70
13
16
44
90
169
67
1 325
593
103
24
0
131
1 605
125
50
19
10
215
123
82
665
192
21
7
933
167
2 134
9 449
0.0
0.0
0.0
0.0
0.0
0.0
0
0
10
38
0
0
0.0
0.0
5.7
14.2
0.0
0.0
0
0
1
0
0
0
0.0
0.0
0.6
0.0
0.0
0.0
99
1
165
229
1 138
12
100.0
100.0
93.8
85.8
100.0
100.0
99
1
176
267
1 138
12
0.0
0.0
100.0
42
4
0
0
0
0
0
0
0
0
1
0
0
0
0
0
95
17.8
2.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.5
0.0
0.0
0.0
0.0
0.0
0.6
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0.0
1.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
161
83
1 273
276
325
0
1
0
0
21
115
477
423
0
11 472
0
16 273
68.2
45.6
100.0
100.0
100.0
0.0
100.0
0.0
0.0
100.0
54.2
100.0
98.8
0.0
100.0
0.0
98.0
236
182
1 273
276
325
0
1
0
0
21
212
477
428
0
11 472
0
16 598
0.5
1.2
0.7
0.6
27
1
2
30
0.3
0.1
0.0
0.1
5 167
980
15 844
21 991
57.2
95.0
99.1
84.4
9 031
1 032
15 984
26 047
* Country-specific comments are in Annex5
43
SURVEILLANCE REPORT
Table11: HIV diagnoses, by country of report and country or subcontinent of origin, cases diagnosed in 2013, in EU/EEA
and other countries of the WHO European Region
Area
Country*
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
*
44
Country of report
N
Western Europe
N
Central & Eastern Europe

N
%
Sub-Saharan Africa
N
%
168
400
173
84
41
170
112
295
76
1 406
2 021
578
216
5
140
2 737
111
169
16
7
661
80
897
765
503
78
39
2 214
85
2 289
16 536
64.6
35.9
86.5
98.8
75.9
72.3
48.1
90.8
48.4
35.1
61.9
71.6
90.0
45.5
42.2
75.9
32.6
95.5
30.2
19.4
69.7
34.3
82.4
70.0
99.2
94.0
88.6
67.5
24.0
38.2
56.7
15
101
1
0
2
9
26
1
5
71
115
2
1
1
16
34
0
0
21
10
46
15
0
14
1
0
0
131
11
501
1 150
5.8
9.1
0.5
0.0
3.7
3.8
11.2
0.3
3.2
1.8
3.5
0.2
0.4
9.1
4.8
0.9
0.0
0.0
39.6
27.8
4.8
6.4
0.0
1.3
0.2
0.0
0.0
4.0
3.1
8.4
3.9
43
43
5
0
8
48
19
9
30
67
306
97
9
0
31
233
0
5
0
3
42
18
0
17
3
3
4
90
22
340
1 495
16.5
3.9
2.5
0.0
14.8
20.4
8.2
2.8
19.1
1.7
9.4
12.0
3.8
0.0
9.3
6.5
0.0
2.8
0.0
8.3
4.4
7.7
0.0
1.6
0.6
3.6
9.1
2.7
6.2
5.7
5.1
20
228
19
0
2
1
41
0
24
832
301
21
8
2
75
312
0
1
12
8
77
57
0
194
0
1
1
182
140
1 225
3 784
7.7
20.4
9.5
0.0
3.7
0.4
17.6
0.0
15.3
20.8
9.2
2.6
3.3
18.2
22.6
8.6
0.0
0.6
22.6
22.2
8.1
24.5
0.0
17.7
0.0
1.2
2.3
5.6
39.5
20.4
13.0
116
2
238
494
1 376
27
15
465
176
0
479
700
0
9
0
0
147
202
604
1 126
0
0
0
6 176
99.1
40.0
100.0
96.1
99.9
100.0
100.0
98.1
35.9
0.0
95.2
99.2
0.0
90.0
0.0
0.0
100.0
35.2
73.2
85.8
0.0
0.0
0.0
22.6
0
1
0
0
0
0
0
0
13
0
3
0
0
0
0
0
0
66
0
10
0
0
0
93
0.0
20.0
0.0
0.0
0.0
0.0
0.0
0.0
2.7
0.0
0.6
0.0
0.0
0.0
0.0
0.0
0.0
11.5
0.0
0.8
0.0
0.0
0.0
0.3
0
0
0
19
0
0
0
9
131
0
20
6
0
1
0
0
0
19
0
74
0
0
0
279
0.0
0.0
0.0
3.7
0.0
0.0
0.0
1.9
26.7
0.0
4.0
0.8
0.0
10.0
0.0
0.0
0.0
3.3
0.0
5.6
0.0
0.0
0.0
1.0
0
0
0
0
0
0
0
0
94
0
0
0
0
0
0
0
0
75
0
37
0
0
0
206
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
19.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
13.1
0.0
2.8
0.0
0.0
0.0
0.8
14 140
3 641
4 931
22 712
52.7
87.4
19.4
40.2
1 215
24
4
1 243
4.5
0.6
0.0
2.2
1 551
155
68
1 774
5.8
3.7
0.3
3.1
3 920
69
1
3 990
14.6
1.7
0.0
7.1
SURVEILLANCE REPORT
Latin America & Caribbean

N
Rate
South & South-east Asia

N
%
Other
N
Unknown
N
Total Country
7
29
0
0
0
0
8
1
1
146
59
3
1
1
35
187
0
0
2
2
64
9
0
61
0
1
0
526
15
259
1 417
2.7
2.6
0.0
0.0
0.0
0.0
3.4
0.3
0.6
3.6
1.8
0.4
0.4
9.1
10.5
5.2
0.0
0.0
3.8
5.6
6.7
3.9
0.0
5.6
0.0
1.2
0.0
16.0
4.2
4.3
4.9
5
14
0
0
0
7
22
0
10
42
93
26
2
0
8
31
0
1
2
0
34
32
0
3
0
0
0
0
41
254
627
1.9
1.3
0.0
0.0
0.0
3.0
9.4
0.0
6.4
1.0
2.9
3.2
0.8
0.0
2.4
0.9
0.0
0.6
3.8
0.0
3.6
13.7
0.0
0.3
0.0
0.0
0.0
0.0
11.6
4.2
2.2
2
27
2
0
1
0
5
0
0
100
57
29
3
0
5
68
0
1
0
1
25
7
0
1
0
0
0
63
15
147
559
0.8
2.4
1.0
0.0
1.9
0.0
2.1
0.0
0.0
2.5
1.7
3.6
1.3
0.0
1.5
1.9
0.0
0.6
0.0
2.8
2.6
3.0
0.0
0.1
0.0
0.0
0.0
1.9
4.2
2.5
1.9
0
273
0
1
0
0
0
19
11
1 338
311
51
0
2
22
6
229
0
0
5
0
15
192
38
0
0
0
72
25
979
3 589
0.0
24.5
0.0
1.2
0.0
0.0
0.0
5.8
7.0
33.4
9.5
6.3
0.0
18.2
6.6
0.2
67.4
0.0
0.0
13.9
0.0
6.4
17.6
3.5
0.0
0.0
0.0
2.2
7.1
16.3
12.3
260
1 115
200
85
54
235
233
325
157
4 002
3 263
807
240
11
332
3 608
340
177
53
36
949
233
1 089
1 093
507
83
44
3 278
354
5 994
29 157
0
0
0
0
1
0
0
0
8
0
0
0
0
0
0
0
0
24
0
5
0
0
0
38
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
1.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.2
0.0
0.4
0.0
0.0
0.0
0.1
0
0
0
1
0
0
0
0
6
0
0
0
0
0
0
0
0
17
0
7
0
0
0
31
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
1.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.0
0.0
0.5
0.0
0.0
0.0
0.1
1
0
0
0
0
0
0
0
62
0
1
0
0
0
0
0
0
6
0
32
0
0
0
102
0.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
12.7
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
1.0
0.0
2.4
0.0
0.0
0.0
0.4
0
2
0
0
0
0
0
0
0
2 140
0
0
0
0
0
0
0
165
221
22
0
17 875
0
20 425
0.0
40.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
100.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
28.7
26.8
1.7
0.0
100.0
0.0
74.7
117
5
238
514
1 377
27
15
474
490
2 140
503
706
0
10
0
0
147
574
825
1 313
0
17 875
0
27 350
1 446
7
2
1 455
5.4
0.2
0.0
2.6
640
16
2
658
2.4
0.4
0.0
1.2
620
39
2
661
2.3
0.9
0.0
1.2
3 315
215
20 484
24 014
12.3
5.2
80.3
42.5
26 847
4 166
25 494
56 507
EU/EEA
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
45
SURVEILLANCE REPORT
Table12: HIV diagnoses, by geographical area, transmission mode and country or subcontinent of origin, cases
reported in 2013

Transmission mode
EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total EU/EEA
Non-EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total non-EU/EEA
Country of report
N
Western Europe
N

N
%
Sub-Saharan Africa
N
8 784
1 018
4 223
85
14
7
2 405
16 536
71.8
70.0
44.7
39.0
29.8
36.8
41.9
56.7
812
42
202
1
3
0
90
1 150
6.6
2.9
2.1
0.5
6.4
0.0
1.6
3.9
469
202
534
9
11
5
265
1 495
3.8
13.9
5.7
4.1
23.4
26.3
4.6
5.1
193
17
3 160
84
9
3
318
3 784
1.6
1.2
33.4
38.5
19.1
15.8
5.5
13.0
677
983
3 344
107
6
15
1 044
6 176
22 712
82.8
88.2
86.8
83.6
46.2
100.0
74.9
84.2
62.2
53
5
27
0
1
0
7
93
1 243
6.5
0.4
0.7
0
7.7
0
0.5
1.3
3.4
27
72
103
3
1
0
73
279
1 774
3.3
6.5
2.7
2.3
7.7
0
5.2
3.8
4.9
4
1
153
4
3
0
41
206
3 990
0.5
0.1
4.0
3.1
23.1
0
2.9
2.8
10.9

Transmission mode
West
Injecting drug use
Mother-to-child
Other/undetermined
Total West
Centre
Injecting drug use
Mother-to-child
Other/undetermined
Total Centre
East
Injecting drug use
Mother-to-child
Other/undetermined
Total East
46
Country of report
N
Western Europe
N

N
%
Sub-Saharan Africa
N
8 145
681
3 690
58
14
7
1 545
14 140
70.3
61.9
40.9
30.4
26.9
38.9
31.7
52.7
854
44
220
1
4
0
92
1 215
7.4
4.0
2.4
0.5
7.7
0.0
1.9
4.5
448
248
554
10
12
4
275
1 551
3.9
22.5
6.1
5.2
23.1
22.2
5.6
5.8
194
17
3 281
88
12
3
325
3 920
1.7
1.5
36.3
46.1
23.1
16.7
6.7
14.6
1 125
233
924
45
3
2
1 309
3 641
89.6
95.5
89.5
95.7
60.0
66.7
82.9
87.4
11
1
7
0
0
0
5
24
0.9
0.4
0.7
0.0
0.0
0.0
0.3
0.6
43
6
46
1
0
1
58
155
3.4
2.5
4.5
2.1
0.0
33.3
3.7
3.7
2
1
32
0
0
0
34
69
0.2
0.4
3.1
0.0
0.0
0.0
2.2
1.7
191
1 087
2 953
89
3
13
595
4 931
22 712
37.5
13.9
18.5
32.8
100.0
100.0
65.7
19.4
40.2
0
2
2
0
0
0
0
4
1 243
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.2
5
20
37
1
0
0
5
68
1 774
1.0
0.3
0.2
0.4
0.0
0.0
0.6
0.3
3.1
1
0
0
0
0
0
0
1
3 990
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
7.1
SURVEILLANCE REPORT

N
%

N
%
Other
N
Unknown
N
Total Transmission mode
845
6
434
4
2
1
125
1 417
6.9
0.4
4.6
1.8
4.3
5.3
2.2
4.9
263
32
249
4
4
1
74
627
2.2
2.2
2.6
1.8
8.5
5.3
1.3
2.2
257
33
188
6
2
0
73
559
2.1
2.3
2.0
2.8
4.3
0.0
1.3
1.9
605
105
459
25
2
2
2 391
3 589
4.9
7.2
4.9
11.5
4.3
10.5
41.6
12.3
12 228
1 455
9 449
218
47
19
5 741
29 157
21
0
11
0
0
0
6
38
1 455
2.6
0
0.3
0
0
0
0.4
0.5
4.0
8
1
15
0
0
0
7
31
658
1.0
0.1
0.4
0
0
0
0.5
0.4
1.8
9
5
19
1
2
0
66
102
661
1.1
0.4
0.5
0.8
15.4
0
4.7
1.4
1.8
19
47
181
13
0
0
387
20 425
24 014
2.3
4.2
4.7
10.2
0.0
0.0
23.0
74.7
42.5
818
1 114
3 853
128
13
15
1 631
27 350
56 507

N
%

N
%
Other
N
Unknown
N
EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total EU/EEA
Non-EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total non-EU/EEA
Total Transmission mode
862
6
444
4
2
1
127
1 446
7.4
0.5
4.9
2.1
3.8
5.6
2.6
5.4
270
31
258
4
4
1
72
640
2.3
2.8
2.9
2.1
7.7
5.6
1.5
2.4
261
38
198
7
2
114
620
2.3
3.5
2.2
3.7
3.8
2.3
2.3
548
35
386
19
2
2
2 323
3 315
4.7
3.2
4.3
9.9
3.8
11.1
47.7
12.3
11 582
1 100
9 031
191
52
18
4 873
26 847
3
0
0
0
0
0
4
7
0.2
0.0
0.0
0.0
0.0
0.0
0.3
0.2
1
1
5
0
0
0
9
16
0.1
0.4
0.5
0.0
0.0
0.0
0.6
0.4
5
0
7
0
2
0
25
39
0.4
0.0
0.7
0.0
40.0
0.0
1.6
0.9
66
2
11
1
0
0
135
215
5.3
0.8
1.1
2.1
0.0
0.0
8.5
5.2
1 256
244
1 032
47
5
3
1 579
4 166
1
0
1
0
0
0
0
2
1 455
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.6
0
1
1
0
0
0
0
2
658
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.2
0
0
2
0
0
0
0
2
661
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.2
312
6 683
12 988
181
0
0
320
20 484
24 014
61.2
85.8
81.3
66.8
0.0
0.0
33.7
80.3
42.5
510
7 793
15 984
271
3
13
920
25 494
56 507
West
Injecting drug use
Mother-to-child
Other/undetermined
Total West
Centre
Injecting drug use
Mother-to-child
Other/undetermined
Total Centre
East
Injecting drug use
Mother-to-child
Other/undetermined
Total East
47
SURVEILLANCE REPORT
Table13: HIV diagnoses, by probable region of infection, in 2013, in EU/EEA and other countries of the WHO European
Region
Area
Country*
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
*
48
Country of report
N
Western Europe
N

N
%
Sub-Saharan Africa
N
%
44
351
0
0
33
2
111
238
0
1 262
0
0
0
2
129
0
255
123
0
0
624
70
1 089
598
452
0
0
0
90
0
5 473
16.9
31.5
0.0
0.0
61.1
0.9
47.6
73.2
0.0
31.5
0.0
0.0
0.0
18.2
38.9
0.0
75.0
69.5
0.0
0.0
65.8
30.0
100.0
54.7
89.2
0.0
0.0
0.0
25.4
0.0
18.8
7
38
0
0
10
3
25
6
8
0
0
0
0
0
20
0
3
8
0
6
19
21
0
9
0
0
0
0
22
0
205
2.7
3.4
0.0
0.0
18.5
1.3
10.7
1.8
5.1
0.0
0.0
0.0
0.0
0.0
6.0
0.0
0.9
4.5
0.0
16.7
2.0
9.0
0.0
0.8
0.0
0.0
0.0
0.0
6.2
0.0
0.7
2
18
0
0
3
3
16
1
27
0
0
0
0
1
11
0
4
7
0
1
9
14
0
2
13
0
0
0
19
0
151
0.8
1.6
0.0
0.0
5.6
1.3
6.9
0.3
17.2
0.0
0.0
0.0
0.0
9.1
3.3
0.0
1.2
4.0
0.0
2.8
0.9
6.0
0.0
0.2
2.6
0.0
0.0
0.0
5.4
0.0
0.5
6
130
0
0
2
2
41
0
18
0
0
0
0
0
54
0
0
0
0
6
23
63
0
53
0
0
0
0
132
0
530
2.3
11.7
0.0
0.0
3.7
0.9
17.6
0.0
11.5
0.0
0.0
0.0
0.0
0.0
16.3
0.0
0.0
0.0
0.0
16.7
2.4
27.0
0.0
4.8
0.0
0.0
0.0
0.0
37.3
0.0
1.8
0
0
95
301
1 376
0
0
209
281
0
501
661
0
0
0
0
0
172
0
0
0
0
0
3 596
0.0
0.0
39.9
58.6
99.9
0.0
0.0
44.1
57.3
0.0
99.6
93.6
0.0
0.0
0.0
0.0
0.0
30.0
0.0
0.0
0.0
0.0
0.0
13.2
0
0
1
0
0
0
0
18
9
0
0
0
0
0
0
0
0
41
0
0
0
0
0
69
0.0
0.0
0.4
0.0
0.0
0.0
0.0
3.8
1.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
7.1
0.0
0.0
0.0
0.0
0.0
0.3
0
0
126
107
0
0
0
115
56
0
2
45
0
0
0
0
0
9
0
0
0
0
0
460
0.0
0.0
52.9
20.8
0.0
0.0
0.0
24.3
11.4
0.0
0.4
6.4
0.0
0.0
0.0
0.0
0.0
1.6
0.0
0.0
0.0
0.0
0.0
1.7
0
0
0
0
0
0
0
0
69
0
0
0
0
0
0
0
0
59
0
0
0
0
0
128
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
14.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
10.3
0.0
0.0
0.0
0.0
0.0
0.5
3 734
1 576
3 759
9 069
13.9
37.8
14.8
16.1
225
13
36
274
0.8
0.3
0.1
0.5
185
19
407
611
0.7
0.5
1.6
1.1
654
4
0
658
2.4
0.1
0
1.2
SURVEILLANCE REPORT

N
Rate

N
%
Other
N
Unknown
N
Total Country
0
11
0
0
0
1
6
1
2
0
0
0
0
0
15
0
0
0
0
1
18
6
0
9
0
0
0
0
5
0
75
0.0
1.0
0.0
0.0
0.0
0.4
2.6
0.3
1.3
0.0
0.0
0.0
0.0
0.0
4.5
0.0
0.0
0.0
0.0
2.8
1.9
2.6
0.0
0.8
0.0
0.0
0.0
0.0
1.4
0.0
0.3
5
17
0
0
0
1
21
1
22
0
0
0
0
0
5
0
1
1
0
0
11
38
0
2
0
0
0
0
53
0
178
1.9
1.5
0.0
0.0
0.0
0.4
9.0
0.3
14.0
0.0
0.0
0.0
0.0
0.0
1.5
0.0
0.3
0.6
0.0
0.0
1.2
16.3
0.0
0.2
0.0
0.0
0.0
0.0
15.0
0.0
0.6
0
10
0
0
0
1
7
0
0
0
0
0
0
0
4
0
0
0
0
1
7
12
0
0
0
0
0
0
20
0
62
0.0
0.9
0.0
0.0
0.0
0.4
3.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.2
0.0
0.0
0.0
0.0
2.8
0.7
5.2
0.0
0.0
0.0
0.0
0.0
0.0
5.6
0.0
0.2
196
540
200
85
6
222
6
78
80
2 740
3 263
807
240
8
94
3 608
77
38
53
21
238
9
0
420
42
83
44
3 278
13
5 994
22 483
75.4
48.4
100.0
100.0
11.1
94.5
2.6
24.0
51.0
68.5
100.0
100.0
100.0
72.7
28.3
100.0
22.6
21.5
100.0
58.3
25.1
3.9
0.0
38.4
8.3
100.0
100.0
100.0
3.7
100.0
77.1
260
1 115
200
85
54
235
233
325
157
4 002
3 263
807
240
11
332
3 608
340
177
53
36
949
233
1 089
1 093
507
83
44
3 278
354
5 994
29 157
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
8
0
0
0
0
0
10
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.4
0.0
0.0
0.0
0.0
0.0
0.0
0
0
0
1
0
0
0
1
7
0
0
0
0
0
0
0
0
22
0
0
0
0
0
31
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.2
1.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.8
0.0
0.0
0.0
0.0
0.0
0.1
0
0
1
1
0
0
0
0
9
0
0
0
0
0
0
0
0
2
0
0
0
0
0
13
0.0
0.0
0.4
0.2
0.0
0.0
0.0
0.0
1.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0
117
5
15
104
1
27
15
131
57
2 140
0
0
0
10
0
0
147
261
825
1 313
0
17 875
0
23 043
100.0
100.0
6.3
20.2
0.1
100.0
100.0
27.6
11.6
100.0
0.0
0.0
0.0
100.0
0.0
0.0
100.0
45.5
100.0
100.0
0.0
100.0
0.0
84.2
117
5
238
514
1 377
27
15
474
490
2 140
503
706
0
10
0
0
147
574
825
1 313
0
17 875
0
27 350
83
1
1
85
0.3
0
0
0.2
203
1
5
209
0.8
0
0
0.4
72
1
2
75
0.3
0
0
0.1
21 691
2 551
21 284
45 526
80.8
61.2
83.5
80.6
26 847
4 166
25 494
56 507
EU/EEA
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
49
SURVEILLANCE REPORT
Table14: Percentage of new HIV diagnoses (2013) reported with information about CD4 cell count, by CD4 cell count
level (<200 and <350 cells per mm3 blood) and by transmission mode in cases with CD4 <350, in EU/EEA and other
countries of the WHO European Region
CD4 < 350 per mm3 blood in 2013 (%)
2013
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine***
East
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
Number of
cases with CD4
cell count
Completeness
(%) CD4
CD4 <200 (%)
CD4 <350 (%)
Hetero
IDU
MSM
MTCT**
50.0
25.0
14.3
-
237
659
134
52
206
205
122
109
2 257
563
295
2 778
208
40
853
755
430
66
43
2 747
4 767
17 526
91.5
59.6
68.7
96.3
87.7
89.5
37.9
71.2
56.9
70.0
89.7
77.3
63.0
78.4
90.8
69.5
87.8
79.5
97.7
84.2
80.0
60.7
61
129
32
7
29
58
31
39
585
194
73
1 046
63
11
209
276
19
8
11
752
1 117
4 750
25.7
19.6
23.9
13.5
14.1
28.3
25.4
35.8
25.9
34.5
24.7
37.7
30.3
27.5
24.5
36.6
4.4
12.1
25.6
27.4
23.4
27.1
106
285
63
10
54
99
63
62
1 046
308
146
1 600
112
22
365
438
145
14
25
1 284
1 982
8 229
44.7
43.2
47.0
19.2
26.2
48.3
51.6
56.9
46.3
54.7
49.5
57.6
53.8
55.0
42.8
58.0
33.7
21.2
58.1
46.7
41.6
47.0
55.7
45.8
57.5
20.0
48.6
59.7
54.8
63.6
54.4
64.0
58.3
64.2
51.1
69.2
62.8
63.6
38.8
5.3
100.0
55.0
56.2
57.1
61.5
57.1
47.8
60.0
33.3
43.9
43.1
74.6
56.3
60.7
58.6
50.0
50.0
58.8
25.4
55.0
50.0
52.3
32.5
39.8
40.7
17.1
19.1
42.3
50.0
44.7
33.6
39.4
37.8
48.2
56.5
47.8
33.2
46.1
27.4
24.4
51.9
40.7
30.7
36.7
100.0
33.3
100.0
43.6
26.2
76
189
85
26
68.5
81.1
17.0
96.3
36
69
24
10
47.4
36.5
28.2
38.5
54
100
42
16
71.1
52.9
49.4
61.5
74.3
51.0
40.6
66.7
68.0
76.2
-
33.3
36.4
61.5
25.0
50.0
-
13
86.7
7.7
7.7
9.1
408
280
79
7
128
334
277
118
15 837
17 857
86.6
60.7
16.5
70.0
88.9
59.1
39.2
9.1
89.3
40.0
164
66
18
5
47
96
88
31
4 246
4 901
40.2
23.6
22.8
71.4
36.7
28.7
31.8
26.3
26.8
27.4
269
129
44
6
74
164
152
59
7 991
9 101
65.9
46.1
55.7
85.7
57.8
49.1
54.9
50.0
50.5
51.0
63.1
55.4
55.8
100.0
77.8
52.6
51.7
55.0
55.8
78.6
40.0
60.0
28.6
40.0
65.2
66.3
46.7
40.3
42.9
75.0
52.3
43.0
52.2
44.6
50.0
33.3
33.3
25.0
25.0
20.7
100.0
27.3
16 879
1 299
17 205
35 383
63.4
32.0
40.4
48.3
4 712
236
4 703
9 651
27.9
18.2
27.3
27.3
8 036
521
8 773
17 330
47.6
40.1
51.0
49.0
57.8
50.1
53.9
57.0
57.2
29.0
68.1
56.2
37.2
32.6
47.6
37.1
29.9
15.0
24.4
26.6
*
** Includes all ages
*** Ukraine reported HIV data through the aggregate reporting format and could therefore not present CD4 cell data by transmission mode
Hetero: heterosexual contact; IDU: injecting drug use; MSM: men who have sex with men; MTCT: mother-to-child transmission.
51
SURVEILLANCE REPORT
Table15: AIDS cases and rates per 100 000 population, by country and year of diagnosis (20042013) and cumulative
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia***
West
San Marino
Centre Serbia****
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
Year of
start of
reporting
2004
2005
2006
2007
2008
Rate
Rate
Rate
Rate
Rate
1982
1983
1987
1986
1986
1986
1980
1992
1983
1980
1981
1981
1986
1985
1983
1982
1990
1988
1983
1986
1999
1983
1986
1983
1985
1985
1986
1981
1982
1981
106
128
22
13
2
13
61
29
20
1 416
745
88
23
3
44
1 641
89
21
15
3
290
36
176
927
366
2
10
2 083
66
1 017
9 455
1.3
1.2
0.3
0.3
0.3
0.1
1.1
2.1
0.4
2.3
0.9
0.8
0.2
1.0
1.1
8.5
3.9
0.6
3.3
0.8
1.8
0.8
0.5
9.0
1.7
0.0
0.5
4.9
0.7
1.7
2.1
117
156
19
21
11
13
44
29
26
1 369
724
102
33
1
42
1 530
119
10
11
3
358
32
153
913
348
3
10
1 868
46
976
9 087
1.4
1.5
0.2
0.5
1.5
0.1
0.8
2.1
0.5
2.2
0.9
0.9
0.3
0.3
1.0
7.9
5.3
0.3
2.4
0.7
2.2
0.7
0.4
8.8
1.6
0.1
0.5
4.3
0.5
1.6
2.0
118
105
16
20
8
18
51
32
26
1 177
715
89
22
3
42
1 455
90
27
9
7
289
32
167
803
289
4
5
1 747
55
885
8 306
1.4
1.0
0.2
0.5
1.1
0.2
0.9
2.4
0.5
1.9
0.9
0.8
0.2
1.0
1.0
6.0
4.0
0.8
1.9
1.7
1.8
0.7
0.4
7.8
1.4
0.1
0.2
4.0
0.6
1.5
1.8
129
105
21
11
12
23
32
57
33
1 012
645
90
23
0
35
1 404
81
28
11
2
303
9
141
693
288
6
9
1 632
62
841
7 738
1.6
1.0
0.3
0.3
1.6
0.2
0.6
4.2
0.6
1.6
0.8
0.8
0.2
0.0
0.8
4.5
3.7
0.9
2.3
0.5
1.9
0.2
0.4
6.7
1.4
0.1
0.4
3.6
0.7
1.4
1.6
110
119
29
25
12
29
40
61
27
1 057
575
105
23
2
36
1 338
103
54
8
9
274
18
180
697
281
1
11
1 536
825
7 585
1.3
1.1
0.4
0.6
1.5
0.3
0.7
4.6
0.5
1.7
0.7
0.9
0.2
0.6
0.8
3.6
4.7
1.7
1.7
2.2
1.7
0.4
0.5
6.7
1.4
0.0
0.5
3.4
1.3
1.6
1993
2004
1988
1995
1991
1986
11
1
23
22
90
5
0.4
1.4
0.7
0.3
0.9
0.1
7
39
20
163
6
0.2
0.0
1.2
0.2
1.7
0.2
8
46
21
332
4
0.3
0.0
1.4
0.2
3.4
0.1
18
1
59
200
311
4
0.6
1.2
1.8
2.3
3.2
0.1
28
2
83
76
387
5
0.9
2.4
2.6
0.9
4.0
0.1
1989
0.2
10
0.5
10
0.5
10
0.5
0.4
1989
1981
1993
1999
1989
1985
1990
112
72
74
14
58
0
1
0
58
219
0
55
0
2 743
22
3 585
2.6
1.1
0.5
0.3
1.6
0.0
0.2
0.0
0.8
3.0
0.0
0.1
0.0
5.8
0.1
1.6
140
122
100
23
60
1
1
1
54
191
0
32
0
4 217
11
5 198
3.2
1.8
0.7
0.5
1.4
3.0
0.2
3.4
0.7
2.6
0.0
0.0
0.0
8.9
0.0
2.3
162
142
132
29
93
0
3
1
52
159
1
30
0
4 723
13
5 961
3.7
2.1
0.9
0.6
2.2
0.0
0.5
3.3
0.7
2.1
0.0
0.0
0.0
10.1
0.0
2.6
183
98
175
24
218
0
3
0
42
174
31
30
0
4 573
35
6 189
4.2
1.4
1.1
0.5
5.3
0.0
0.5
0.0
0.6
2.3
0.4
0.0
0.0
9.8
0.1
2.7
232
106
174
36
92
0
5
40
159
43
55
0
4 380
184
6 096
5.3
1.5
1.1
0.7
2.2
0.0
0.8
0.0
0.5
2.1
0.6
0.1
0.0
9.5
0.7
2.6
8 981
762
3 297
13 040
2.5
0.4
2.5
1.9
8 633
721
4 931
14 285
2.4
0.4
3.8
2.1
7 910
656
5 701
14 267
2.1
0.3
4.2
2.0
7 311
641
5 975
13 927
1.9
0.3
4.3
2.0
7 043
733
5 905
13 681
1.8
0.4
4.3
1.9
1986
1985
1980
1998
1985
2002
1988
1992
*
*** No official data were reported by Russia. Information about AIDS cases were published by the Federal Scientific and Methodological Center for Prevention and
Control of AIDS: 34 473 (cumulative as of 31 December 2013). Reference: HIV-infection bulletin number 39. Moscow: The Federal Service for Surveillance of
52
SURVEILLANCE REPORT
2009
2010
2011
2012
2013
Cumulative Country*
total**
Rate
Rate
Rate
Rate
Rate
102
121
30
22
8
23
36
38
23
950
614
100
23
0
35
1 205
101
37
3
1
269
18
130
569
257
4
18
1 411
650
6 798
1.2
1.1
0.4
0.5
1.0
0.2
0.7
2.8
0.4
1.5
0.8
0.9
0.2
0.0
0.8
2.1
4.7
1.2
0.6
0.2
1.6
0.4
0.3
5.5
1.3
0.1
0.9
3.1
1.1
1.4
94
102
32
21
10
26
44
26
32
967
478
103
28
1
38
1 143
132
33
8
6
286
22
173
653
247
2
7
1 193
659
6 566
1.1
0.9
0.4
0.5
1.2
0.2
0.8
2.0
0.6
1.5
0.6
0.9
0.3
0.3
0.8
1.9
6.2
1.1
1.6
1.4
1.7
0.5
0.5
6.3
1.2
0.0
0.3
2.6
1.1
1.3
66
86
40
26
5
24
59
38
25
835
473
97
32
2
47
1 049
112
21
11
5
227
19
184
576
299
4
15
1 047
417
5 841
0.8
0.8
0.5
0.6
0.6
0.2
1.1
2.9
0.5
1.3
0.6
0.9
0.3
0.6
1.0
1.8
5.4
0.7
2.1
1.2
1.4
0.4
0.5
5.6
1.5
0.1
0.7
2.3
0.7
1.2
32
90
65
28
7
29
41
36
19
782
448
120
48
1
35
1 061
142
38
7
6
248
25
157
525
293
7
11
916
424
5 641
0.4
0.8
0.9
0.7
0.8
0.3
0.7
2.7
0.4
1.2
0.5
1.1
0.5
0.3
0.8
1.8
6.9
1.3
1.3
1.4
1.5
0.5
0.4
5.0
1.5
0.1
0.5
2.0
0.7
1.1
70
78
71
17
3
26
38
24
20
404
241
118
42
1
26
1 016
133
44
9
1
199
28
160
322
338
6
11
604
319
4 369
0.8
0.7
1.0
0.4
0.3
0.2
0.7
1.8
0.4
0.6
0.3
1.1
0.4
0.3
0.6
1.7
6.6
1.5
1.7
0.2
1.2
0.6
0.4
3.1
1.7
0.1
0.5
1.6
0.5
0.9
3 866
4 435
465
418
248
400
2 927
414
616
69 004
29 800
3 522
745
67
1 189
66 336
1 353
378
278
103
4 107
1 069
3 082
19 075
13 274
74
212
83 776
2 168
28 224
341 625
33
1.0
0.0
2.6
1.2
5.2
0.1
24
94
210
549
6
0.8
0.0
2.9
2.3
5.8
0.2
40
1
87
195
593
7
1.4
1.3
2.7
2.1
6.3
0.2
40
133
235
616
4
1.4
0.0
4.1
2.5
6.5
0.1
56
2
143
189
442
7
2.0
2.6
4.4
2.0
4.7
0.2
311
8
834
1 319
4 070
127
84
109
502
2
2
0.1
0.3
0.4
10
0.5
10
0.5
133
284
100
173
75
262
0
8
55
149
11
67
0
4 437
129
6 482
6.5
1.4
1.1
1.4
6.4
0.0
1.3
0.0
0.8
1.9
0.1
0.1
0.0
9.7
0.5
2.8
339
74
264
130
306
0
7
51
161
75
60
0
5 861
220
8 437
7.7
1.0
1.7
2.4
7.5
0.0
1.1
0.0
0.7
2.1
1.0
0.1
0.0
12.8
3.6
395
108
226
90
439
0
2
1
54
123
94
80
0
9 189
11 732
8.9
1.4
1.4
1.7
10.7
0.0
0.3
3.1
0.7
1.6
1.2
0.1
0.0
20.2
5.6
359
78
234
88
183
0
7
2
51
84
90
95
0
10 073
12 382
8.1
1.0
1.4
1.6
4.5
0.0
1.1
6.0
0.7
1.1
1.1
0.1
0.0
22.2
5.8
303
39
260
67
234
0
7
0
44
71
91
93
9 362
11 420
6.8
0.5
1.6
1.2
5.7
0.0
1.1
0.0
0.6
0.9
1.1
0.1
20.6
5.3
2 664
2 869
1 970
597
2 051
49
78
0
23
1 692
9 534
437
1 109
1
65 733
651
90 083
6 356
682
6 242
13 280
1.6
0.4
4.5
1.8
6 064
700
8 239
15 003
1.5
0.4
5.9
2.0
5 274
820
11 479
17 573
1.3
0.4
10.3
2.5
4 944
852
12 227
18 023
1.2
0.4
10.9
2.5
3 606
891
11 292
15 789
0.9
0.5
10.0
2.2
333 045
22 368
82 472
437 885
EU/EEA
Austria
Belgium
Bulgaria
Cyprus
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
former Yugoslav Republic of
Macedonia, the
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
53
SURVEILLANCE REPORT
Table15a: AIDS cases and rates per 100 000 population, by country and year of statistics (20042013) and cumulative
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia***
West
San Marino
Centre Serbia****
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
2004
N
Rate
2005
N
Rate
2006
N
Rate
2007
N
Rate
2008
N
Rate
2009
N
106
128
22
14
2
13
61
29
20
1 416
745
88
23
3
44
1 641
89
21
15
2
290
36
176
927
366
2
10
2 083
65
1 017
9 454
1.3
1.2
0.3
0.3
0.3
0.1
1.1
2.1
0.4
2.3
0.9
0.8
0.2
1.0
1.1
8.5
3.9
0.6
3.3
0.5
1.8
0.8
0.5
9.0
1.7
0.0
0.5
4.9
0.7
1.7
2.1
117
156
19
21
11
13
44
29
26
1 369
724
102
33
1
42
1 530
119
10
11
4
358
32
153
913
348
3
10
1 868
45
976
9 087
1.4
1.5
0.2
0.5
1.5
0.1
0.8
2.1
0.5
2.2
0.9
0.9
0.3
0.3
1.0
7.9
5.3
0.3
2.4
1.0
2.2
0.7
0.4
8.8
1.6
0.1
0.5
4.3
0.5
1.6
2.0
118
105
16
21
8
18
51
32
26
1 177
715
89
22
3
42
1 455
90
27
9
7
289
32
167
803
289
4
5
1 747
47
885
8 299
1.4
1.0
0.2
0.5
1.1
0.2
0.9
2.4
0.5
1.9
0.9
0.8
0.2
1.0
1.0
6.0
4.0
0.8
1.9
1.7
1.8
0.7
0.4
7.8
1.4
0.1
0.2
4.0
0.5
1.5
1.8
129
105
21
12
12
23
32
57
33
1 012
645
90
23
0
35
1 404
81
28
11
2
303
9
141
693
288
6
9
1 632
73
841
7 750
1.6
1.0
0.3
0.3
1.6
0.2
0.6
4.2
0.6
1.6
0.8
0.8
0.2
0.0
0.8
4.5
3.7
0.9
2.3
0.5
1.9
0.2
0.4
6.7
1.4
0.1
0.4
3.6
0.8
1.4
1.6
110
119
29
24
12
29
40
61
27
1 057
575
105
23
2
36
1 338
103
54
8
9
274
18
180
697
281
1
11
1 536
825
7 584
1.3
1.1
0.4
0.6
1.5
0.3
0.7
4.6
0.5
1.7
0.7
0.9
0.2
0.6
0.8
3.6
4.7
1.7
1.7
2.2
1.7
0.4
0.5
6.7
1.4
0.0
0.5
3.4
1.3
1.6
102
121
30
20
8
23
36
38
23
950
614
100
23
0
35
1 205
101
37
3
1
269
18
130
569
257
4
18
1 411
650
6 796
1.2
1.1
0.4
0.5
1.0
0.2
0.7
2.8
0.4
1.5
0.8
0.9
0.2
0.0
0.8
2.1
4.7
1.2
0.6
0.2
1.6
0.4
0.3
5.5
1.3
0.1
0.9
3.1
1.1
1.4
11
3
21
22
90
16
0.4
4.1
0.7
0.3
0.9
0.4
6
0
41
20
163
8
0.2
0.0
1.3
0.2
1.7
0.2
8
0
46
21
331
8
0.3
0.0
1.4
0.2
3.4
0.2
17
1
59
200
308
4
0.5
1.2
1.8
2.3
3.2
0.1
24
1
83
76
351
5
0.8
1.2
2.6
0.9
3.7
0.1
32
0
84
109
532
2
1.0
0.0
2.6
1.2
5.6
0.1
0.2
0.4
0.4
11
0.5
10
0.5
0.1
112
72
74
14
53
1
0
58
219
47
0
2 743
22
3 583
2.6
1.1
0.5
0.3
1.5
0.0
0.2
0.0
0.8
3.0
0.1
0.0
5.8
0.1
1.6
140
122
100
23
64
1
1
1
54
191
37
0
4 217
11
5 198
3.2
1.8
0.7
0.5
1.5
3.0
0.2
3.4
0.7
2.6
0.1
0.0
8.9
0.0
2.3
162
142
132
27
94
0
2
1
52
159
35
0
4 723
13
5 965
3.7
2.1
0.9
0.5
2.3
0.0
0.3
3.3
0.7
2.1
0.0
0.0
10.1
0.0
2.6
183
98
175
22
214
0
4
0
42
174
32
29
0
4 573
35
6 181
4.2
1.4
1.1
0.4
5.2
0.0
0.6
0.0
0.6
2.3
0.5
0.0
0.0
9.8
0.1
2.7
232
106
174
36
82
0
7
0
40
159
43
55
0
4 380
184
6 096
5.3
1.5
1.1
0.7
2.0
0.0
1.1
0.0
0.5
2.1
0.6
0.1
0.0
9.5
0.7
2.6
284
100
173
77
276
0
6
0
55
149
11
67
0
4 437
129
6 482
6.5
1.4
1.1
1.5
6.7
0.0
1.0
0.0
0.8
1.9
0.1
0.1
0.0
9.7
0.5
2.8
8 981
766
3 290
13 037
2.5
0.4
2.5
1.9
8 633
726
4 931
14 285
2.4
0.4
3.8
2.1
7 902
664
5 698
14 264
2.1
0.4
4.4
2.1
7 322
642
5 967
13 931
1.9
0.3
4.3
2.0
7 043
733
5 905
13 681
1.8
0.4
4.3
1.9
6 356
682
6 242
13 280
1.6
0.4
4.5
1.8
*
*** No official data were reported by Russia. Information about AIDS cases were published by the Federal Scientific and Methodological Center for Prevention and
Control of AIDS: 34 473 (cumulative as of 31 December 2013). Reference: HIV-infection bulletin number 39. Moscow: The Federal Service for Surveillance of
54
Rate
SURVEILLANCE REPORT
2010
N
Rate
2011
N
Rate
2012
N
Rate
2013
N
Rate
Cumulative Country*
total**
94
102
32
18
10
26
44
25
32
967
478
103
28
1
38
1 143
132
33
8
6
286
22
173
653
247
2
7
1 193
659
6 562
1.1
0.9
0.4
0.4
1.2
0.2
0.8
1.9
0.6
1.5
0.6
0.9
0.3
0.3
0.8
1.9
6.2
1.1
1.6
1.4
1.7
0.5
0.5
6.3
1.2
0.0
0.3
2.6
1.1
1.3
66
86
40
26
5
24
59
39
25
835
473
97
32
2
47
1 049
112
21
11
5
227
19
184
576
299
4
15
1 047
417
5 842
0.8
0.8
0.5
0.6
0.6
0.2
1.1
2.9
0.5
1.3
0.6
0.9
0.3
0.6
1.0
1.8
5.4
0.7
2.1
1.2
1.4
0.4
0.5
5.6
1.5
0.1
0.7
2.3
0.7
1.2
32
90
65
27
7
29
41
36
19
782
448
120
48
1
35
1 061
142
38
7
6
248
25
157
525
293
7
11
916
424
5 640
0.4
0.8
0.9
0.6
0.8
0.3
0.7
2.7
0.4
1.2
0.5
1.1
0.5
0.3
0.8
1.8
6.9
1.3
1.3
1.4
1.5
0.5
0.4
5.0
1.5
0.1
0.5
2.0
0.7
1.1
70
78
71
16
3
26
38
24
20
404
241
118
42
1
26
1 016
133
44
9
1
199
28
160
322
338
6
11
604
319
4 368
0.8
0.7
1.0
0.4
0.3
0.2
0.7
1.8
0.4
0.6
0.3
1.1
0.4
0.3
0.6
1.7
6.6
1.5
1.7
0.2
1.2
0.6
0.4
3.1
1.7
0.1
0.5
1.6
0.5
0.9
3 866
4 435
465
418
248
400
2 927
414
616
69 004
29 800
3 522
745
67
1 189
66 336
1 353
378
278
103
4 107
1 069
3 082
19 075
13 274
74
212
83 776
2 168
28 224
341 625
25
0
94
210
475
6
0.8
0.0
2.9
2.3
5.0
0.2
38
1
87
195
590
7
1.3
1.3
2.7
2.1
6.3
0.2
46
0
133
235
598
4
1.6
0.0
4.1
2.5
6.3
0.1
61
2
143
189
547
7
2.2
2.6
4.4
2.0
5.8
0.2
311
8
834
1 319
4 070
127
0.4
0.3
0.4
11
0.5
133
339
74
256
120
290
0
7
0
51
161
75
60
0
5 861
220
8 437
7.7
1.0
1.6
2.2
7.1
0.0
1.1
0.0
0.7
2.1
1.0
0.1
0.0
12.8
0.8
3.5
395
108
234
95
420
0
2
1
54
123
93
80
0
9 189
11 718
8.9
1.4
1.5
1.8
10.3
0.0
0.3
3.1
0.7
1.6
1.2
0.1
0.0
20.2
5.6
359
78
234
95
222
0
7
2
51
84
87
95
0
10 073
12 412
8.1
1.0
1.4
1.7
5.4
0.0
1.1
6.0
0.7
1.1
1.1
0.1
0.0
22.2
5.8
303
39
260
67
234
0
7
0
44
71
94
93
9 362
11 534
6.8
0.5
1.6
1.2
5.7
0.0
1.1
0.0
0.6
0.9
1.1
0.1
20.6
5.4
2 664
2 869
1 970
597
2 051
49
78
23
1 692
9 534
437
1 109
1
65 733
651
90 083
6 064
700
8 239
15 003
1.5
0.4
5.8
2.0
5 274
816
11 470
17 560
1.3
0.4
10.3
2.5
4 944
856
12 252
18 052
1.2
0.5
10.9
2.5
3 606
896
11 400
15 902
0.9
0.5
10.1
2.2
333 045
22 368
82 472
437 885
EU/EEA
Austria
Belgium
Bulgaria
Cyprus
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Macedonia, the
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
55
SURVEILLANCE REPORT
Table16: AIDS cases in males and rates per 100 000 population, by country and year of diagnosis (20042013) and
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia***
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
2004
N
Rate
2005
N
Rate
2006
N
Rate
2007
N
Rate
2008
N
2009
N
Rate
68
84
16
12
1
11
41
18
14
951
600
73
19
2
29
1 216
63
17
10
3
225
26
132
740
214
1
9
1 600
46
597
6 838
1.7
1.7
0.4
0.6
0.3
0.2
1.5
2.8
0.5
3.2
1.5
1.3
0.4
1.4
1.4
13.1
6.0
1.1
4.5
1.5
2.8
1.1
0.7
14.8
2.1
0.0
0.9
7.6
1.0
2.1
3.1
88
83
16
19
6
8
30
15
25
922
593
78
29
1
28
1 144
74
7
6
1
271
18
119
722
202
2
8
1 442
35
618
6 610
2.2
1.6
0.4
0.9
1.7
0.2
1.1
2.4
1.0
3.0
1.5
1.4
0.6
0.7
1.4
12.1
7.2
0.4
2.6
0.5
3.4
0.8
0.6
14.4
2.0
0.1
0.8
6.7
0.8
2.1
2.9
95
65
12
14
7
13
31
22
20
813
591
64
15
2
34
1 081
63
22
6
5
229
24
130
595
161
4
5
1 351
33
528
6 035
2.4
1.3
0.3
0.7
1.9
0.3
1.2
3.5
0.8
2.7
1.5
1.2
0.3
1.3
1.6
9.2
6.2
1.4
2.6
2.5
2.8
1.0
0.7
11.9
1.6
0.2
0.5
6.2
0.7
1.8
2.6
101
65
18
10
8
18
22
46
22
691
516
69
17
0
18
1 076
59
26
8
2
233
6
108
527
170
4
7
1 275
40
555
5 717
2.5
1.3
0.5
0.5
2.2
0.4
0.8
7.4
0.9
2.2
1.3
1.3
0.4
0.0
0.8
7.2
5.8
1.7
3.4
1.0
2.9
0.3
0.6
10.5
1.7
0.2
0.7
5.8
0.9
1.9
2.5
89
76
20
24
10
22
33
44
24
716
480
93
21
2
27
988
77
45
5
9
221
11
139
520
154
0
9
1 168
510
5 537
2.2
1.5
0.5
1.2
2.6
0.4
1.2
7.1
0.9
2.3
1.2
1.7
0.4
1.2
1.2
5.5
7.6
3.0
2.1
4.4
2.7
0.5
0.8
10.4
1.6
0.0
0.9
5.2
1.7
2.4
70
76
22
20
8
17
25
26
15
673
500
80
17
0
27
909
67
28
2
1
228
13
99
416
161
3
16
1 080
442
5 041
1.7
1.4
0.6
1.0
2.1
0.3
0.9
4.2
0.6
2.2
1.2
1.5
0.4
0.0
1.2
3.2
6.7
1.9
0.8
0.5
2.8
0.5
0.5
8.3
1.6
0.1
1.6
4.8
1.5
2.1
10
1
19
22
61
4
0.6
2.7
1.2
0.5
1.3
0.2
6
0
30
16
114
4
0.4
0.0
1.9
0.4
2.5
0.2
5
0
37
19
221
3
0.3
0.0
2.4
0.5
4.9
0.2
16
1
46
169
210
4
1.0
2.4
3.0
4.0
4.6
0.2
21
2
62
68
254
4
1.3
4.6
4.0
1.6
5.6
0.2
25
0
57
90
309
2
1.6
0.0
3.6
2.1
6.9
0.1
0.3
0.8
0.9
0.9
0.5
0.2
88
48
57
12
46
0
1
0
47
153
46
0
1 823
21
2 462
4.3
1.5
0.8
0.5
2.7
0.0
0.3
0.0
1.3
4.2
0.1
0.0
8.3
0.2
2.2
105
88
78
20
49
1
1
1
46
138
27
0
2 986
10
3 728
5.1
2.7
1.1
0.8
2.4
6.2
0.3
6.9
1.3
3.8
0.1
0.0
13.8
0.1
3.2
129
106
88
23
53
0
3
1
40
113
1
26
0
3 392
9
4 278
6.2
3.2
1.2
0.9
2.6
0.0
1.0
6.8
1.1
3.1
0.0
0.1
0.0
15.8
0.1
3.7
138
76
110
24
137
0
3
0
27
125
30
25
0
3 208
27
4 285
6.7
2.2
1.5
0.9
6.8
0.0
1.0
0.0
0.8
3.4
0.8
0.1
0.0
15.1
0.2
3.7
179
68
124
24
59
0
3
0
30
112
35
48
0
3 060
141
4 299
8.6
1.9
1.7
0.9
3.0
0.0
1.0
0.0
0.8
3.0
1.0
0.1
0.0
14.4
1.0
3.7
208
65
111
61
166
0
6
0
47
107
10
60
0
3 019
92
4 437
10.0
1.8
1.5
2.3
8.3
0.0
1.9
0.0
1.3
2.8
0.3
0.2
0.0
14.3
0.7
3.8
6 527
526
2 247
9 300
3.7
0.6
3.3
2.8
6 333
501
3 504
10 338
3.5
0.5
5.2
3.0
5 787
447
4 079
10 313
3.2
0.5
6.0
3.0
5 428
444
4 230
10 102
2.9
0.5
6.2
2.9
5 154
510
4 172
9 836
2.7
0.6
6.1
2.8
4 729
505
4 244
9 478
2.4
0.5
6.2
2.6
*
*** Excluding a cumulative 32 cases from Kosovo (without prejudice to positions on status, and in line with UNSCR 1244 and the ICJ Opinion on the Kosovo
56
Rate
SURVEILLANCE REPORT
2010
N
Rate
2011
N
Rate
2012
N
Rate
2013
N
Rate
Cumulative Country*
total**
73
59
21
20
7
20
34
21
23
665
395
84
26
1
27
843
86
27
4
4
226
20
132
460
135
2
7
925
433
4 780
1.8
1.1
0.6
1.0
1.8
0.4
1.2
3.4
0.9
2.1
1.0
1.5
0.6
0.6
1.2
2.9
8.9
1.9
1.6
1.9
2.8
0.8
0.7
9.2
1.4
0.1
0.7
4.1
1.4
2.0
47
54
38
25
2
16
40
31
18
610
400
81
27
1
34
798
80
15
7
3
178
17
142
429
200
4
12
815
286
4 410
1.1
1.0
1.1
1.2
0.5
0.3
1.5
5.0
0.7
1.9
1.0
1.5
0.6
0.6
1.5
2.8
8.4
1.1
2.7
1.5
2.2
0.7
0.8
8.6
2.1
0.2
1.2
3.6
0.9
1.8
24
54
47
26
6
23
35
25
16
541
356
99
45
1
27
776
102
28
5
5
194
23
120
376
212
7
10
701
293
4 177
0.6
1.0
1.3
1.3
1.4
0.4
1.3
4.0
0.6
1.7
0.9
1.8
1.0
0.6
1.2
2.7
10.9
2.0
1.9
2.4
2.3
0.9
0.6
7.5
2.2
0.3
1.0
3.1
0.9
1.7
51
56
53
14
2
21
29
18
17
293
190
101
38
1
19
763
90
31
8
1
164
19
130
230
242
6
10
468
232
3 297
1.2
1.0
1.5
0.7
0.5
0.4
1.0
2.9
0.6
0.9
0.5
1.9
0.8
0.6
0.8
2.6
9.7
2.3
3.0
0.5
2.0
0.7
0.7
4.6
2.5
0.2
1.0
2.5
0.7
1.4
2 982
3 021
348
367
193
326
2 488
306
504
54 412
25 529
2 968
655
58
915
51 154
950
306
218
89
3 220
835
2 429
15 224
7 686
63
185
66 761
1 773
22 150
268 115
17
0
73
195
336
6
1.1
0.0
4.6
4.4
7.6
0.3
31
1
65
171
369
4
2.2
2.5
4.1
3.8
8.4
0.2
27
0
95
209
394
4
1.9
0.0
6.0
4.6
9.0
0.2
40
1
99
162
292
6
2.8
2.6
6.2
3.5
6.6
0.3
234
6
621
1 158
2 622
102
0.6
0.5
0.8
0.9
97
245
42
194
111
179
0
7
0
44
120
65
46
0
3 988
163
5 837
11.7
1.1
2.5
4.2
9.0
0.0
2.3
0.0
1.2
3.1
1.7
0.1
0.0
19.0
1.2
4.9
277
72
150
69
269
0
2
1
47
85
77
65
0
6 141
7 901
13.1
1.9
1.9
2.6
13.5
0.0
0.7
6.4
1.3
2.2
2.0
0.2
0.0
29.2
7.7
248
57
180
65
93
0
7
2
45
57
67
83
0
6 498
8 139
11.7
1.5
2.3
2.4
4.8
0.0
2.3
12.3
1.3
1.5
1.7
0.2
0.0
31.0
7.9
219
30
191
49
128
0
7
0
38
50
63
74
6 013
7 471
10.3
0.8
2.4
1.8
6.6
0.0
2.3
0.0
1.1
1.3
1.5
0.2
28.7
7.2
1 977
2 082
1 407
477
1 252
38
65
21
1 279
7 097
349
927
0
38 305
494
60 610
4 438
496
5 683
10 617
2.2
0.5
8.2
2.9
3 977
620
7 714
12 311
2.0
0.7
14.6
3.6
3 642
670
8 004
12 316
1.8
0.7
15.1
3.5
2 723
690
7 355
10 768
1.4
0.7
13.8
3.1
263 545
14 956
50 224
328 725
EU/EEA
Austria
Belgium
Bulgaria
Cyprus
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Macedonia, the
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
57
SURVEILLANCE REPORT
Table17: AIDS cases in females and rates per 100 000 population, by country and year of diagnosis (20042013) and
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia***
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
2004
N
Rate
2005
N
Rate
2006
N
Rate
2007
N
Rate
2008
N
Rate
2009
N
32
45
8
2
38
44
6
1
1
2
20
11
6
465
145
15
4
1
15
425
26
4
5
0
65
10
44
187
152
1
1
483
20
420
2 617
0.9
0.8
0.1
0.0
0.3
0.0
0.7
1.5
0.2
1.4
0.3
0.3
0.1
0.7
0.7
4.3
2.1
0.2
2.2
0.0
0.8
0.4
0.2
3.5
1.4
0.0
0.1
2.2
0.4
1.4
1.1
29
73
3
2
5
5
14
14
1
446
131
24
4
0
14
386
45
3
5
2
87
14
34
191
146
1
2
426
11
358
2 476
0.7
1.4
0.1
0.1
1.3
0.1
0.5
1.9
0.0
1.4
0.3
0.4
0.1
0.0
0.7
3.8
3.7
0.2
2.1
1.0
1.1
0.6
0.2
3.6
1.3
0.0
0.2
1.9
0.2
1.2
1.1
23
40
4
6
1
5
20
10
6
362
124
25
7
1
8
374
27
5
3
2
60
8
37
208
128
0
0
396
22
357
2 269
0.5
0.7
0.1
0.3
0.3
0.1
0.7
1.4
0.2
1.1
0.3
0.4
0.1
0.7
0.4
3.0
2.2
0.3
1.3
1.0
0.7
0.3
0.2
3.9
1.2
0.0
0.0
1.8
0.5
1.2
1.0
28
40
3
1
4
5
10
11
11
316
129
21
6
0
15
328
22
2
3
0
70
3
33
166
118
2
2
357
22
286
2 014
0.7
0.7
0.1
0.0
1.0
0.1
0.4
1.5
0.4
1.0
0.3
0.4
0.1
0.0
0.7
2.1
1.8
0.1
1.2
0.0
0.8
0.1
0.2
3.1
1.1
0.1
0.2
1.6
0.5
0.9
0.8
21
43
9
1
2
7
7
17
3
338
95
12
2
0
9
350
26
9
3
0
53
7
41
177
127
1
2
368
315
2 045
0.5
0.8
0.2
0.0
0.5
0.1
0.3
2.4
0.1
1.0
0.2
0.2
0.0
0.0
0.4
1.8
2.2
0.5
1.2
0.0
0.6
0.3
0.2
3.3
1.2
0.0
0.2
1.6
1.0
0.8
6
11
12
8
275
114
20
6
0
8
296
34
9
1
0
41
5
31
153
96
1
2
331
208
1 755
0.7
0.8
0.2
0.1
0.0
0.1
0.4
1.7
0.3
0.8
0.3
0.4
0.1
0.0
0.4
1.0
2.9
0.5
0.4
0.0
0.5
0.2
0.2
2.9
0.9
0.0
0.2
1.4
0.7
0.7
1
0
4
0
29
1
0.1
0.0
0.2
0.0
0.6
0.1
1
0
9
4
49
2
0.1
0.0
0.5
0.1
0.9
0.1
3
0
9
2
111
1
0.2
0.0
0.5
0.0
2.2
0.1
2
0
13
31
101
0
0.1
0.0
0.8
0.7
2.0
0.0
7
0
21
8
133
1
0.4
0.0
1.3
0.2
2.6
0.1
8
0
27
19
193
0
0.5
0.0
1.6
0.4
3.8
0.0
0.2
0.2
0.1
0.1
0.4
0.0
24
24
17
2
12
0
0
0
11
66
9
0
920
1
1 123
1.1
0.7
0.2
0.1
0.6
0.0
0.0
0.0
0.3
1.8
0.0
0.0
3.6
0.0
0.9
35
34
21
3
11
0
0
0
8
53
5
0
1 231
1
1 469
1.5
1.0
0.3
0.1
0.5
0.0
0.0
0.0
0.2
1.4
0.0
0.0
4.9
0.0
1.2
33
36
44
6
40
0
0
0
12
46
4
0
1 331
4
1 683
1.4
1.1
0.6
0.2
1.9
0.0
0.0
0.0
0.3
1.2
0.0
0.0
5.3
0.0
1.4
45
22
65
0
81
0
0
0
15
49
1
5
0
1 365
8
1 804
2.0
0.6
0.8
0.0
3.8
0.0
0.0
0.0
0.4
1.3
0.0
0.0
0.0
4.1
0.1
1.5
53
38
50
9
33
0
2
0
8
47
8
7
0
1 320
43
1 792
2.3
1.1
0.6
0.3
1.5
0.0
0.6
0.0
0.2
1.2
0.2
0.0
0.0
5.3
0.3
1.5
76
35
62
14
96
0
2
0
10
42
1
7
0
1 418
37
2 047
3.3
1.0
0.8
0.5
4.6
0.0
0.6
0.0
0.3
1.1
0.0
0.0
0.0
5.7
0.3
1.7
2 454
236
1 050
3 740
1.3
0.3
1.4
1.1
2 299
220
1 426
3 945
1.2
0.2
1.9
1.1
2 121
209
1 622
3 952
1.1
0.2
2.2
1.1
1 876
197
1 745
3 818
1.0
0.2
2.4
1.0
1 886
221
1 730
3 837
1.0
0.2
2.3
1.0
1 625
179
1 998
3 802
0.8
0.2
2.7
1.0
*
58
Rate
SURVEILLANCE REPORT
2010
N
Rate
2011
N
Rate
2012
N
Rate
2013
N
Rate
Cumulative Country*
total**
21
43
11
1
3
6
10
5
9
300
83
19
2
0
11
300
46
6
4
2
60
2
41
193
112
0
0
268
226
1 784
0.5
0.8
0.3
0.0
0.7
0.1
0.4
0.7
0.3
0.9
0.2
0.3
0.0
0.0
0.5
1.0
4.0
0.4
1.6
1.0
0.7
0.1
0.2
3.6
1.1
0.0
0.0
1.1
0.7
0.7
19
32
2
1
3
8
19
7
7
224
73
16
5
1
13
251
32
6
4
2
49
2
42
147
99
0
3
232
131
1 430
0.4
0.6
0.1
0.0
0.7
0.1
0.7
1.0
0.3
0.7
0.2
0.3
0.1
0.6
0.6
0.8
2.8
0.4
1.6
1.0
0.6
0.1
0.2
2.7
1.0
0.0
0.3
1.0
0.4
0.6
8
36
18
2
1
6
6
11
3
239
92
21
3
0
8
285
40
10
2
1
54
2
37
149
81
0
1
215
131
1 462
0.2
0.6
0.5
0.1
0.2
0.1
0.2
1.6
0.1
0.7
0.2
0.4
0.1
0.0
0.3
0.9
3.6
0.6
0.8
0.5
0.6
0.1
0.2
2.7
0.8
0.0
0.1
0.9
0.4
0.6
19
22
18
3
1
5
9
6
3
109
51
17
4
0
7
253
43
13
1
0
35
9
30
92
96
0
1
136
87
1 070
0.4
0.4
0.5
0.1
0.2
0.1
0.3
0.9
0.1
0.3
0.1
0.3
0.1
0.0
0.3
0.8
3.9
0.8
0.4
0.0
0.4
0.4
0.2
1.7
0.9
0.0
0.1
0.7
0.3
0.4
884
1 412
117
51
55
74
439
108
112
14 569
4 271
554
90
9
272
15 182
403
72
60
14
887
234
653
3 850
5 588
11
27
17 015
395
6 074
73 482
7
0
21
15
213
0
0.4
0.0
1.3
0.3
4.2
0.0
9
0
22
24
224
3
0.6
0.0
1.3
0.5
4.5
0.2
13
0
38
26
222
0
0.9
0.0
2.3
0.6
4.4
0.0
16
1
44
27
150
1
1.1
2.7
2.6
0.6
3.0
0.1
77
2
213
161
1 448
23
0.0
0.0
0.2
0.1
30
94
32
70
19
127
0
0
0
7
41
10
14
0
1 823
57
2 550
4.1
0.9
0.8
0.7
6.1
0.0
0.0
0.0
0.2
1.0
0.3
0.0
0.0
7.6
0.4
2.1
118
36
76
21
170
0
0
0
7
38
17
15
0
3 048
3 828
5.1
0.9
0.9
0.8
8.1
0.0
0.0
0.0
0.2
1.0
0.4
0.0
0.0
12.4
3.6
111
21
54
23
90
0
0
0
6
27
23
12
0
3 575
4 243
4.8
0.5
0.6
0.8
4.2
0.0
0.0
0.0
0.2
0.7
0.6
0.0
0.0
14.6
4.0
84
9
69
18
106
0
0
0
6
21
28
19
3 349
3 949
3.6
0.2
0.8
0.6
5.0
0.0
0.0
0.0
0.2
0.5
0.7
0.1
13.7
3.6
687
787
559
117
799
11
13
0
2
413
2 437
88
182
1
9 972
157
18 179
1 624
204
2 506
4 334
0.8
0.2
3.3
1.1
1 296
197
3 765
5 258
0.6
0.2
6.4
1.5
1 300
182
4 223
5 705
0.6
0.2
7.2
1.6
881
201
3 937
5 019
0.4
0.2
6.7
1.4
69 472
7 404
14 785
91 661
EU/EEA
Austria
Belgium
Bulgaria
Cyprus
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Macedonia, the
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Total non-EU/EEA
Geographic area
West
Centre
East
59
SURVEILLANCE REPORT
Table18: AIDS cases in men infected through sex with men, by country and year of diagnosis (20042013) and
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia***
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
Year of diagnosis
2008
2009
2010
2011
2012
2013
Cumulative
total**
28
34
4
17
4
10
12
0
6
261
275
49
13
0
10
294
7
1
1
0
134
7
26
56
20
1
10
312
188
1 780
25
31
5
19
4
10
15
0
7
247
239
63
23
0
13
251
10
0
2
0
129
9
29
75
15
1
7
333
200
1 762
21
29
2
18
0
10
13
0
6
231
208
50
24
0
17
265
7
2
5
1
109
9
45
83
18
3
7
309
146
1 638
9
22
8
22
1
11
13
1
2
178
195
48
37
0
14
261
4
2
3
0
119
10
25
73
11
3
7
288
152
1 519
22
20
12
11
2
12
11
0
4
118
102
39
30
0
6
282
10
5
6
1
103
15
44
41
17
2
5
195
105
1 220
1 271
1 412
67
220
103
192
1 724
26
286
27 728
17 580
1 935
514
43
368
11 323
100
68
122
41
1 819
486
588
2 397
201
41
115
12 560
1 085
14 766
99 181
7
0
0
1
0
0
2
0
1
4
2
5
2
1
2
1
6
2
2
0
2
1
3
4
4
1
5
3
3
3
31
4
15
14
17
28
2004
2005
2006
2007
24
27
1
2
0
5
19
2
6
311
372
44
15
2
5
310
5
7
6
0
119
10
23
73
3
1
4
345
16
235
1 992
28
40
7
3
2
6
18
1
10
336
339
49
19
0
6
314
4
0
2
1
150
11
23
78
8
1
5
291
8
248
2 008
33
25
4
11
2
3
17
1
8
292
338
37
10
2
8
309
3
1
2
3
127
11
14
72
8
3
3
302
9
243
1 901
39
25
4
6
4
8
13
0
13
243
309
42
12
0
7
315
3
2
2
0
137
2
19
61
6
2
6
298
17
251
1 846
28
22
4
12
4
7
16
1
10
256
266
56
16
1
8
299
3
7
0
1
130
6
27
86
11
0
7
320
227
1 831
1
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
0
1
1
2
0
0
8
1
3
1
0
0
32
5
8
0
0
1
0
1
0
8
57
2
0
3
86
5
24
0
0
0
1
0
1
16
48
4
0
8
112
3
18
0
0
0
0
2
0
14
43
4
0
8
94
3
10
0
1
2
0
2
0
12
62
5
0
9
112
7
10
1
0
0
0
2
0
15
48
11
0
10
119
3
14
0
0
2
0
4
0
25
41
2
0
10
110
10
12
0
0
2
0
5
0
21
60
3
0
10
138
11
16
1
0
2
0
2
1
22
34
0
31
138
11
8
0
0
0
0
1
2
28
28
0
45
138
16
7
1
0
0
0
3
0
20
22
12
50
153
83
583
3
1
10
21
31
11
357
3 214
0
93
0
189
1
4 738
1 989
66
23
2 078
2 003
98
19
2 120
1 899
80
16
1 995
1 847
88
23
1 958
1 791
126
33
1 950
1 722
144
24
1 890
1 711
150
39
1 900
1 554
159
63
1 776
1 425
163
69
1 657
1 100
180
93
1 373
100 779
2 613
527
103 919
*
*** Excluding a cumulative 2 cases from Kosovo (without prejudice to positions on status, and in line with UNSCR 1244 and the ICJ Opinion on the Kosovo
60
SURVEILLANCE REPORT
Table19: AIDS cases in persons infected through injecting drug use, by country and year of diagnosis (20042013) and
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia***
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
Year of diagnosis
2008
2009
2004
2005
2006
2007
18
8
1
2
0
3
4
18
5
172
79
2
0
0
7
540
64
5
1
1
12
4
84
374
2
0
1
970
9
35
2 421
22
9
1
1
0
0
4
16
7
129
60
5
2
0
9
445
71
7
3
0
26
4
79
393
2
0
0
846
4
33
2 178
21
7
0
1
0
4
3
23
1
104
81
5
0
0
9
399
51
17
0
2
10
4
90
297
3
0
1
747
3
25
1 908
26
3
1
1
0
3
3
45
8
87
62
3
1
0
10
383
45
21
2
0
13
0
77
224
5
0
0
668
6
30
1 727
27
8
4
0
0
5
6
41
1
85
50
3
0
0
11
317
60
35
0
0
7
2
74
203
1
0
0
535
27
1 502
0
1
18
19
52
1
0
0
25
12
97
1
0
0
28
13
217
1
0
0
25
131
200
1
0
1
30
50
209
0
2010
2011
2012
2013
Cumulative
total**
16
5
7
0
0
2
3
26
2
56
47
5
0
0
8
275
49
20
0
0
9
1
55
155
6
0
0
449
19
1 215
11
3
10
1
0
4
4
14
3
60
32
3
0
0
6
228
70
20
0
0
6
3
70
174
9
0
0
331
27
1 089
11
4
17
1
0
1
4
20
0
55
36
8
0
0
10
191
57
9
1
0
7
0
62
136
37
0
0
287
14
968
6
1
39
1
0
2
4
15
4
41
36
22
0
0
2
177
70
21
0
0
4
1
58
121
79
0
0
219
11
934
14
2
29
0
0
2
5
9
2
27
16
37
0
0
1
172
62
19
0
0
3
1
45
74
102
0
0
136
10
768
937
282
109
25
3
31
253
235
55
13 757
4 245
192
6
5
373
34 636
762
179
39
3
164
155
1 465
8 351
250
1
9
49 562
242
1 488
117 814
0
0
33
69
252
0
0
0
42
160
238
0
0
0
33
148
270
0
0
0
42
159
250
0
0
0
22
122
143
0
0
2
325
909
1 973
18
76
8
11
43
0
0
0
18
32
1
0
2 018
12
2 310
79
8
17
42
0
0
0
11
41
1
0
3 041
3
3 379
105
28
102
19
45
0
0
0
9
29
1
0
3 360
9
3 968
103
18
95
20
101
0
0
0
14
20
15
2
0
3 086
20
3 852
134
24
118
27
55
0
0
0
5
19
27
1
0
2 868
116
3 684
170
14
104
53
103
0
0
0
13
13
7
4
0
2 732
70
3 637
186
6
185
102
95
0
0
0
8
11
43
2
0
3 660
131
4 869
191
14
132
58
101
0
0
0
12
17
35
2
0
4 979
5 992
160
15
151
55
17
0
1
0
7
5
32
1
0
4 933
5 828
141
14
156
38
22
0
0
0
8
4
23
1
4 273
4 967
1 457
430
1 043
417
695
19
2
6
652
3 274
183
59
0
38 097
380
49 950
2 282
113
2 336
4 731
2 048
99
3 410
5 557
1 775
112
3 989
5 876
1 566
106
3 907
5 579
1 326
90
3 770
5 186
1 077
87
3 688
4 852
908
104
4 946
5 958
795
132
6 033
6 960
669
188
5 905
6 762
518
187
5 030
5 735
118 470
2 639
46 655
167 764
*
*** There are no cumulative cases from Kosovo (without prejudice to positions on status, and in line with UNSCR 1244 and the ICJ Opinion on the Kosovo Declaration
of Independence)
61
SURVEILLANCE REPORT
Table20: AIDS cases in persons infected through heterosexual contact, by country and year of diagnosis (20042013)
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia***
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
Year of diagnosis
2008
2009
2004
2005
2006
2007
49
84
20
7
2
5
36
5
9
757
188
34
4
1
27
655
13
6
8
1
115
20
39
462
120
1
3
595
37
691
3 994
45
95
11
14
7
7
22
10
8
723
198
44
8
1
25
660
31
3
5
2
142
16
34
420
130
2
2
578
23
642
3 908
47
63
12
8
6
9
29
8
15
605
192
41
11
1
22
626
21
3
7
2
109
16
33
420
113
1
0
533
36
562
3 551
42
66
16
4
6
11
16
10
11
543
174
35
5
0
14
614
22
4
7
2
111
7
29
397
120
3
2
488
30
507
3 296
38
75
15
10
7
14
16
17
11
589
147
42
5
0
13
604
25
6
8
5
103
10
34
389
123
1
2
532
515
3 356
10
0
5
2
29
4
7
0
9
8
51
4
8
0
17
6
103
3
13
0
32
55
100
3
20
0
46
14
160
5
2010
2011
2012
2013
Cumulative
total**
45
73
19
4
4
11
18
10
12
507
152
34
8
0
15
525
32
15
1
1
105
10
24
339
124
1
0
489
385
2 963
37
64
14
1
5
12
23
7
12
520
114
31
4
1
12
558
36
11
6
6
119
10
52
387
113
1
0
392
374
2 922
22
49
20
6
5
12
40
9
15
432
143
33
7
2
17
500
34
9
5
3
84
9
44
348
140
1
3
338
244
2 574
11
65
15
4
4
12
22
16
10
467
124
38
6
1
19
506
55
13
4
5
95
12
36
318
125
3
2
311
244
2 543
27
43
20
6
1
10
21
9
12
204
68
22
10
0
16
477
37
15
2
0
61
11
30
195
125
4
3
202
183
1 814
943
2 303
257
146
123
144
765
116
213
19 339
3 846
912
140
15
326
16 074
346
101
100
35
1 610
370
586
7 597
2 349
27
42
15 059
665
9 856
84 405
25
0
45
34
240
2
20
0
41
38
289
1
37
0
50
44
305
4
38
0
83
68
358
0
49
1
103
57
289
3
267
2
445
341
1 945
68
74
27
52
0
2
11
0
0
14
122
40
0
628
2
953
41
82
0
5
15
0
1
0
13
94
16
0
941
1 293
53
84
19
8
43
0
1
0
13
84
15
0
1 089
2
1 554
61
66
33
108
0
1
0
7
84
10
20
0
1 265
6
1 868
76
68
38
6
31
0
3
0
11
71
13
32
0
1 342
51
1 991
102
66
55
17
101
0
4
0
12
75
1
28
0
1 509
40
2 357
132
52
70
24
146
0
2
0
11
82
26
26
0
2 264
68
3 295
181
74
81
26
321
0
0
0
12
65
44
36
0
3 944
0
5 227
184
53
76
27
118
0
4
0
7
46
21
35
0
4 873
5 997
139
17
87
24
139
0
1
0
6
39
44
39
4 875
5 918
1 024
1 570
459
143
1 060
6
37
5
346
2 565
159
531
0
25 169
183
36 399
3 943
274
730
4 947
3 825
262
1 114
5 201
3 494
239
1 372
5 105
3 214
244
1 706
5 164
3 236
286
1 825
5 347
2 852
267
2 201
5 320
2 800
265
3 152
6 217
2 423
330
5 048
7 801
2 351
297
5 892
8 540
1 601
313
5 818
7 732
84 176
5 137
31 491
120 804
*
62
SURVEILLANCE REPORT
Table21: AIDS cases in persons infected through mother-to-child transmission, by country and year of diagnosis
(20042013) and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia***
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
Year of diagnosis
2008
2009
2010
2011
2012
2013
Cumulative
total**
2
1
0
0
0
0
0
0
0
10
0
0
1
0
1
5
1
0
0
0
2
0
7
3
12
0
0
8
19
72
0
0
2
0
0
0
1
0
0
5
1
1
0
0
1
3
0
0
0
0
5
0
1
1
11
0
0
3
9
44
1
0
1
1
0
0
0
0
0
8
2
0
0
0
0
3
2
0
0
0
2
0
3
1
10
0
0
3
3
40
0
0
0
0
0
0
0
0
0
11
2
0
1
0
0
4
1
0
0
0
1
0
1
1
8
0
0
3
1
34
0
0
3
0
0
0
1
0
0
5
1
0
0
0
1
6
2
1
0
0
2
1
0
3
7
0
0
1
1
35
47
122
7
4
2
0
25
2
6
772
116
24
4
0
36
735
18
1
3
1
44
7
67
117
438
0
2
970
22
686
4 278
0
0
0
0
14
0
1
0
2
2
8
0
0
0
1
1
13
0
1
0
1
1
12
0
0
0
0
3
4
0
3
0
4
3
3
0
6
0
13
12
97
0
13
2
5
0
7
0
0
0
1
1
0
0
0
110
3
153
10
2
4
2
6
0
0
0
2
0
0
0
0
73
6
119
4
2
5
0
1
0
0
0
1
1
2
2
0
86
3
120
11
2
2
0
3
0
0
0
1
2
0
0
0
129
8
174
8
2
5
3
3
0
0
0
0
0
0
0
0
118
154
1
0
2
4
1
0
0
0
0
1
1
1
0
88
107
3
1
6
1
9
0
0
0
1
1
11
0
59
106
61
75
30
11
41
0
1
0
26
108
14
12
0
1 217
22
1 752
54
15
120
189
54
24
114
192
34
16
168
218
25
16
153
194
24
12
105
141
24
15
102
141
3 916
575
1 539
6 030
2004
2005
2006
2007
0
1
0
0
0
0
0
1
0
10
2
2
0
0
1
4
1
0
0
0
2
0
7
3
8
0
0
6
1
35
84
1
0
0
0
1
0
0
0
0
10
3
0
1
0
0
4
1
0
0
0
1
0
3
5
8
0
0
9
1
30
78
0
1
0
0
0
0
2
0
0
6
1
1
0
0
0
9
2
0
0
0
2
0
4
3
8
0
0
7
1
25
72
1
4
0
0
0
0
0
0
1
8
2
0
0
0
1
2
0
0
0
0
5
0
1
3
3
0
0
10
2
26
69
0
4
0
0
0
0
0
0
0
9
0
0
0
0
3
2
5
0
0
0
1
0
5
4
8
0
0
8
21
70
0
0
0
0
8
0
0
0
2
0
13
0
0
0
1
0
10
0
0
0
1
2
7
0
2
2
0
0
1
0
0
0
1
0
0
0
0
94
0
108
6
4
0
0
1
0
0
0
1
0
0
1
0
139
0
167
1
4
1
1
4
0
0
0
1
0
0
0
0
122
2
147
69
16
107
192
68
15
162
245
62
13
144
219
68
6
148
222
*
*** There are no cumulative cases from Kosovo (without prejudice to positions on status, and in line with UNSCR 1244 and the ICJ Opinion on the Kosovo Declaration
of Independence)
63
SURVEILLANCE REPORT
Table22: AIDS cases*, by geographical area, sex, transmission mode and year of diagnosis (20042013) and
cumulative totals
Transmission mode
EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total EU/EEA
Non-EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total non-EU/EEA
Transmission mode
EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total EU/EEA
Non-EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total non-EU/EEA
*
**
64
Female
2004
Male Unknown
Female
2005
Male Unknown
Female
2006
Male Unknown
Female
2007
Male Unknown
506
1 773
50
26
4
238
2 597
1 976
1 906
2 184
33
40
14
639
6 792
0
0
0
0
0
0
0
0
423
1 738
43
19
6
236
2 465
1 999
1 751
2 147
34
43
8
593
6 575
1
0
0
0
0
0
0
1
379
1 587
31
19
4
227
2 247
1 890
1 526
1 928
40
28
5
585
6 002
2
0
0
0
0
0
0
2
349
1 390
31
10
2
210
1 992
1 823
1 372
1 875
36
14
3
554
5 677
6
0
1
0
0
0
0
7
40
130
6
3
0
23
202
2 799
83
240
193
8
3
1
90
618
7 410
0
0
0
0
0
0
0
0
0
45
145
12
2
1
32
237
2 702
104
290
207
16
6
0
109
732
7 307
0
0
0
0
0
0
1
1
2
108
218
8
1
1
12
348
2 595
86
491
245
15
3
0
37
877
6 879
0
0
0
0
0
0
0
0
2
118
266
18
1
12
16
431
2 423
103
628
331
22
3
14
49
1 150
6 827
0
0
0
0
0
0
0
0
7
2012
Male Unknown
Female
2013
Male Unknown
Female
Cumulative total**
Male Unknown
Total
Female
187
1 114
19
6
2
134
1 462
1 517
747
1 429
15
8
0
461
4 177
2
0
0
0
0
0
0
2
168
749
21
2
1
129
1 070
1 218
600
1 065
14
4
0
396
3 297
2
0
0
0
0
0
0
2
0
24 281
36 364
2 096
2 742
2 374
5 230
73 087
98 073
93 290
47 373
2 160
6 542
3 195
15 709
266 342
23
1
3
0
0
0
1
28
98 096
117 572
83 740
4 256
9 284
5 569
20 940
339 457
69
540
11
1
1
46
668
2 130
93
826
584
8
9
1
120
1 641
5 818
0
0
0
0
0
0
0
0
2
59
461
20
1
3
56
600
1 670
103
635
582
27
2
1
108
1 458
4 755
0
0
0
0
0
0
0
0
2
0
2 144
5 084
244
112
25
441
8 050
81 137
4 541
9 325
5 962
268
336
29
1 348
21 809
288 151
2
3
2
1
0
0
7
15
43
4 543
11 472
11 048
513
448
54
1 796
29 874
369 331
Cases from Russia, Sweden, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period. Therefore, totals by transmission mode,
gender and overall may differ from totals presented in Tables 1521.
SURVEILLANCE REPORT
Female
2008
Male Unknown
Female
2009
Male Unknown
Female
2010
Male Unknown
Female
322
1 459
32
13
3
216
2 045
1 828
1 180
1 897
38
23
5
566
5 537
3
0
0
0
0
0
0
3
240
1 259
37
12
3
204
1 755
1 779
975
1 704
35
15
3
530
5 041
1
0
0
0
0
0
1
2
229
1 320
33
4
5
193
1 784
1 760
860
1 602
11
15
3
529
4 780
2
0
0
0
0
0
0
2
174
1 072
21
5
1
157
1 430
91
289
19
0
2
28
429
2 474
109
606
309
21
1
1
51
1 098
6 635
0
3
0
0
0
0
0
3
6
117
419
16
6
2
32
592
2 347
100
718
389
15
3
3
97
1 325
6 366
0
0
0
0
0
0
0
0
2
124
478
18
2
1
47
670
2 454
128
954
485
19
1
4
94
1 685
6 465
0
0
0
0
0
0
0
0
2
118
622
13
0
1
26
780
2 210
2011
Transmission mode
Male Unknown
EU/EEA
1 637
794
1 502
19
0 Mother-to-child
2
1
455
4 410
1 Total EU/EEA
Non-EU/EEA
105
895
660
23
0 Mother-to-child
9
2
66
1 760
3 Total non-EU/EEA
6 170
65
SURVEILLANCE REPORT
Table22: AIDS cases*, by geographical area, sex, transmission mode and year of diagnosis (20042013) and
cumulative totals
Transmission mode
West
Injecting drug use
Mother-to-child
Other/undetermined
Total West
Centre
Injecting drug use
Mother-to-child
Other/undetermined
Total Centre
East
Female
2004
Male Unknown
Female
2005
Male Unknown
Female
2006
Male Unknown
Female
2007
Male Unknown
473
1 770
38
18
1
134
2 434
1 973
1 800
2 136
30
26
4
512
6 481
0
0
0
0
0
0
0
0
384
1 703
36
9
2
154
2 288
1 994
1 660
2 099
31
34
1
479
6 298
1
0
0
0
0
0
0
1
356
1 558
27
11
3
144
2 099
1 888
1 416
1 900
34
22
5
489
5 754
2
0
0
0
0
0
0
2
318
1 367
29
9
2
129
1 854
1 824
1 242
1 816
37
12
3
454
5 388
6
0
1
0
0
0
0
7
25
83
11
11
3
103
236
66
88
191
5
16
10
150
526
0
0
0
0
0
0
0
0
20
89
9
10
4
88
220
98
79
173
6
12
7
126
501
0
0
0
0
0
0
0
0
17
95
4
8
1
84
209
80
95
144
9
9
110
447
0
0
0
0
0
0
0
0
28
84
4
1
1
79
197
88
78
160
2
4
0
112
444
0
0
0
0
0
0
0
0
0
20
11
14
Injecting drug use
48
258
64
302
114
506
121
680
50
50
91
82
152
129
205
230
Mother-to-child
10
13
12
16
19
11
14
Other/undetermined
24
67
26
97
11
23
18
37
129
403
194
508
287
678
372
995
2 799
7 410
2 702
7 307
2 595
6 879
2 423
6 827
2012
Male Unknown
Female
2013
Male Unknown
Female
Cumulative total**
Male Unknown
Total
Total East
Transmission mode
West
Injecting drug use
Mother-to-child
Other/undetermined
Total West
Centre
Injecting drug use
Mother-to-child
Other/undetermined
Total Centre
East
Female
137
1 039
13
6
1
104
1 300
1 423
532
1 312
11
8
0
356
3 642
2
0
0
0
0
0
0
2
119
671
15
2
1
73
881
1 098
399
930
9
4
0
283
2 723
2
0
0
0
0
0
0
2
0
24 789
36 464
1 958
1 978
51
3 837
69 077
99 671
93 438
47 044
1 936
5 547
54
14 082
261 772
23
1
3
0
0
0
1
28
99 694
118 228
83 511
3 894
7 525
105
17 920
330 877
40
98
8
0
1
35
182
163
148
199
4
9
0
147
670
0
0
0
0
0
0
0
0
35
102
8
0
0
56
201
180
152
211
7
1
0
139
690
0
0
0
0
0
0
0
0
0
566
1 896
245
868
2 324
1 505
7 404
2 606
2 072
3 240
329
1 318
3 143
2 246
14 954
2
0
2
1
0
0
3
8
2 608
2 638
5 138
575
2 186
5 467
3 754
22 366
24
43
337
337
Injecting drug use
79
893
73
684
1 070
7 105
8 178
517
502
437
506
3 088
3 051
6 139
Mother-to-child
18
25
137
163
300
13
21
24
27
51
Other/undetermined
41
78
56
82
329
729
1 062
Total East
*
**
66
648
1 506
588
1 342
4 656
11 425
16 088
2 130
5 818
1 670
4 755
81 137
288 151
43
369 331
SURVEILLANCE REPORT
Female
2008
Male Unknown
Female
2009
Male Unknown
Female
2010
Male Unknown
Female
285
1 419
25
13
3
141
1 886
1 788
1 041
1 817
29
20
4
455
5 154
3
0
0
0
0
0
0
3
218
1 216
25
16
3
147
1 625
1 721
859
1 636
29
15
3
466
4 729
1
0
0
0
0
0
1
2
192
1 275
23
6
4
124
1 624
1 709
716
1 525
11
14
3
460
4 438
2
0
0
0
0
0
0
2
143
1 030
16
5
1
101
1 296
22
107
7
0
0
85
221
126
68
179
8
4
1
124
510
0
0
0
0
0
0
0
0
16
96
14
0
0
53
179
144
71
171
10
2
0
106
504
0
0
0
0
0
0
0
0
22
98
12
0
1
71
204
150
82
167
4
1
0
91
495
0
0
0
0
0
0
0
0
24
105
6
0
0
62
197
2011
Transmission mode
Male Unknown
West
1 553
652
1 393
9
0 Mother-to-child
3
1
366
3 977
1 Total West
Centre
157
108
224
10
0 Mother-to-child
7
0
114
620
3 Total Centre
East
32
23
14
29
106
677
123
763
139
1 016
125
929
222
210
366
286
425
395
559
545
19
22
14
11
16
15
12
23
0 Mother-to-child
18
38
36
55
45
72
20
41
367
971
543
1 133
626
1 532
717
1 573
0 Total East
2 474
6 635
2 347
6 366
2 454
6 465
2 210
6 170
67
SURVEILLANCE REPORT
Table23: AIDS cases*, by geographical area, sex, age and year of diagnosis (20042013) and cumulative totals
Age category
EU/EEA
<15
1519
2024
2529
3039
4049
50+
Unknown
Total EU/EEA
Non-EU/EEA
<15
1519
2024
2529
3039
4049
50+
Unknown
Total non-EU/EEA
Age category
EU/EEA
<15
1519
2024
2529
3039
4049
50+
Unknown
Total EU/EEA
Non-EU/EEA
<15
1519
2024
2529
3039
4049
50+
Unknown
Total non-EU/EEA
*
**
68
Female
2004
Male Unknown
Female
2005
Male Unknown
Female
2006
Male Unknown
Female
2007
Male Unknown
69
100
139
329
1 078
605
277
0
2 597
67
70
127
493
2 492
2 238
1 304
1
6 792
0
0
0
0
0
0
0
0
0
43
85
114
328
957
644
293
1
2 465
42
80
152
451
2 353
2 248
1 243
6
6 575
0
0
0
1
0
0
0
0
1
35
79
104
280
840
618
287
4
2 247
41
70
123
432
2 039
2 103
1 187
7
6 002
0
0
0
0
2
0
0
0
2
29
57
85
249
720
559
292
1
1 992
27
69
153
420
1 815
2 011
1 179
3
5 677
0
0
1
1
3
2
0
0
7
6
0
21
34
80
45
16
0
10
3
19
96
213
191
79
7
0
0
0
0
0
0
0
0
13
5
20
47
92
44
16
0
21
2
23
97
288
193
107
1
0
0
0
0
0
0
0
0
10
3
23
70
152
61
27
2
15
4
19
123
408
208
97
3
0
0
0
0
0
0
0
0
37
8
36
78
155
88
29
0
42
11
37
146
523
276
115
0
0
0
0
0
0
0
0
0
202
618
237
732
348
877
431
1 150
2 799
7 410
2 702
7 307
2 595
6 879
2 423
6 827
2012
Male Unknown
Female
2013
Male Unknown
Female
Cumulative total**
Male Unknown
Total
Female
16
14
79
132
465
440
316
0
1 462
12
19
143
297
1 180
1 421
1 104
1
4 177
0
0
0
2
0
0
0
0
2
12
12
57
88
317
314
269
1
1 070
14
13
103
239
885
1 083
958
2
3 297
0
0
0
1
1
0
0
0
2
5 496
995
5 024
14 309
28 829
11 584
6 798
52
73 087
7 077
1 481
9 917
39 238
112 045
60 394
35 950
240
266 342
0
0
1
8
15
3
0
1
28
12 573
2 476
14 942
53 555
140 889
71 981
42 748
293
339 457
20
0
27
96
287
166
72
0
27
3
26
128
685
546
226
0
0
0
0
0
0
0
0
0
31
7
23
82
234
138
84
1
36
6
29
120
583
466
215
3
0
0
0
0
0
0
0
0
305
93
623
1 531
3 419
1 368
699
12
375
148
742
2 791
9 455
5 490
2 748
60
1
0
2
2
3
1
1
5
681
241
1 367
4 324
12 877
6 859
3 448
77
668
1 641
600
1 458
8 050
21 809
15
29 874
2 130
5 818
1 670
4 755
81 137
288 151
43
369 331
SURVEILLANCE REPORT
Female
2008
Male Unknown
Female
2009
Male Unknown
Female
2010
Male Unknown
Female
24
55
100
226
691
644
305
0
2 045
38
42
128
410
1 728
1 990
1 200
1
5 537
0
0
0
0
2
1
0
0
3
32
30
88
183
603
542
277
0
1 755
30
17
110
317
1 512
1 841
1 213
1
5 041
0
0
0
1
1
0
0
0
2
30
11
114
176
545
556
352
0
1 784
12
10
134
311
1 376
1 684
1 252
1
4 780
0
0
0
0
2
0
0
0
2
18
20
83
142
431
465
270
1
1 430
21
6
33
85
188
65
29
2
26
12
47
126
485
290
111
1
0
0
0
1
2
0
0
0
18
16
53
107
236
117
44
1
21
13
42
166
601
342
137
3
0
0
0
0
0
0
0
0
21
9
43
109
304
121
63
0
23
16
65
189
771
439
182
0
0
0
0
0
0
0
0
0
19
2
51
124
342
164
77
1
2011
Age category
Male Unknown
EU/EEA
17
0 <15
11
0 1519
104
0 2024
321
0 2529
1 261
1 3039
1 553
0 4049
1 140
0 50+
3
0 Unknown
4 410
1 Total EU/EEA
Non-EU/EEA
30
0 <15
3
0 1519
53
0 2024
185
0 2529
798
0 3039
480
1 4049
207
0 50+
4
2 Unknown
429
1 098
592
1 325
670
1 685
780
1 760
3 Total non-EU/EEA
2 474
6 635
2 347
6 366
2 454
6 465
2 210
6 170
69
SURVEILLANCE REPORT
Table23: AIDS cases*, by geographical area, sex, age and year of diagnosis (20042013) and cumulative totals
Age category
West
<15
1519
2024
2529
3039
4049
50+
Unknown
Total West
Centre
<15
1519
2024
2529
3039
4049
50+
Unknown
Total Centre
Female
2004
Male Unknown
Female
2005
Male Unknown
Female
2006
Male Unknown
Female
2007
Male Unknown
35
35
120
305
1 061
606
272
0
2 434
34
13
105
451
2 375
2 216
1 286
1
6 481
0
0
0
0
0
0
0
0
0
30
28
89
299
928
630
283
1
2 288
29
20
133
397
2 261
2 208
1 244
6
6 298
0
0
0
1
0
0
0
0
1
26
19
92
253
818
612
275
4
2 099
33
19
95
387
1 955
2 076
1 183
6
5 754
0
0
0
0
2
0
0
0
2
27
23
65
220
682
555
281
1
1 854
26
21
119
350
1 703
1 978
1 188
3
5 388
0
0
1
1
3
2
0
0
7
34
59
21
23
59
23
17
0
35
56
13
52
175
116
72
7
0
0
0
0
0
0
0
0
15
58
18
34
44
35
16
0
16
62
20
60
144
122
76
1
0
0
0
0
0
0
0
0
9
62
12
25
47
28
24
2
11
54
23
48
145
91
71
4
0
0
0
0
0
0
0
0
4
36
15
32
55
30
25
0
3
49
30
51
154
93
64
0
0
0
0
0
0
0
0
0
220
501
209
447
197
444
236
526
East
<15
11
18
10
12
35
40
1519
10
2024
19
28
27
22
23
24
41
41
2529
35
86
42
91
72
120
75
165
3039
38
155
77
236
127
347
138
481
4049
21
97
23
111
39
144
62
216
50+
25
10
30
15
30
15
42
Unknown
129
403
194
508
287
678
372
995
2 799
7 410
2 702
7 307
2 595
6 879
2 423
6 827
2012
Male Unknown
Female
2013
Male Unknown
Female
Cumulative total**
Male Unknown
Total
Total East
Age category
West
<15
1519
2024
2529
3039
4049
50+
Unknown
Total West
Centre
<15
1519
2024
2529
3039
4049
50+
Unknown
Total Centre
Female
10
10
46
109
414
414
297
0
1 300
9
12
87
210
961
1 290
1 072
1
3 642
0
0
0
2
0
0
0
0
2
6
7
36
64
244
276
247
1
881
7
3
63
153
647
962
885
3
2 723
0
0
0
1
1
0
0
0
2
2 045
617
4 740
14 333
29 056
11 461
6 771
54
69 077
2 350
1 110
9 687
39 142
112 460
60 503
36 277
243
261 772
0
0
1
8
15
3
0
1
28
4 395
1 727
14 428
53 483
141 531
71 967
43 048
298
330 877
8
4
30
21
56
40
23
0
4
7
59
87
236
177
100
0
0
0
0
0
0
0
0
0
9
5
20
18
72
37
39
1
8
11
52
103
256
147
111
2
0
0
0
0
0
0
0
0
3 565
419
535
634
1 233
611
399
8
4 857
446
585
1 375
3 727
2 376
1 538
50
1
0
0
0
0
1
1
5
8 423
865
1 120
2 009
4 960
2 988
1 938
63
7 404
14 954
22 366
182
670
201
690
East
<15
18
26
28
35
191
245
436
1519
52
73
125
2024
30
23
24
17
372
387
761
2529
98
128
88
103
873
1 512
2 387
3039
282
668
235
565
1 959
5 313
7 275
4049
152
500
139
440
880
3 005
3 885
50+
68
158
67
177
327
883
1 210
648
1 506
588
1 342
4 656
11 425
16 088
2 130
5 818
1 670
4 755
81 137
288 151
43
369 331
Unknown
Total East
*
**
70
SURVEILLANCE REPORT
Female
2008
Male Unknown
Female
2009
Male Unknown
Female
2010
Male Unknown
Female
2011
Age category
Male Unknown
West
7
0 <15
7
0 1519
78
0 2024
247
0 2529
1 067
1 3039
1 475
0 4049
1 094
0 50+
2
0 Unknown
3 977
1 Total West
Centre
10
0 <15
4
0 1519
39
0 2024
81
0 2529
231
0 3039
142
1 4049
111
0 50+
2
2 Unknown
17
24
70
197
662
622
292
2
1 886
28
15
96
346
1 581
1 901
1 186
1
5 154
0
0
0
0
2
1
0
0
3
17
22
63
153
564
536
270
0
1 625
24
8
80
268
1 389
1 768
1 191
1
4 729
0
0
0
1
1
0
0
0
2
20
10
70
159
501
520
344
0
1 624
10
9
103
258
1 236
1 611
1 210
1
4 438
0
0
0
0
2
0
0
0
2
11
15
46
126
393
442
262
1
1 296
7
30
32
31
63
32
26
0
9
28
37
50
160
145
80
1
0
0
0
0
0
0
0
0
16
14
28
25
52
24
20
0
10
9
36
57
161
135
96
0
0
0
0
0
0
0
0
0
12
4
43
21
59
37
28
0
4
5
37
61
166
115
107
0
0
0
0
0
0
0
0
0
8
5
41
21
54
37
31
0
221
510
179
504
204
495
197
620
21
27
17
17
19
21
18
30
East
0 <15
3 Total Centre
11
10
13
12
0 1519
31
42
50
36
44
59
47
40
0 2024
83
140
112
158
105
181
119
178
0 2529
154
472
223
563
289
745
326
761
0 3039
55
234
99
280
120
397
150
416
0 4049
16
45
31
63
43
117
54
142
0 50+
367
971
543
1 133
626
1 532
717
1 573
0 Total East
2 474
6 635
2 347
6 366
2 454
6 465
2 210
6 170
0 Unknown
71
SURVEILLANCE REPORT
Table24: The most common AIDS-indicative diseases diagnosed in 2013, by geographical area ordered by frequency
Diseases
EU/EEA
Mycobacterium tuberculosis, pulmonary in an adult or an adolescent (aged 13
years or over)
Kaposis sarcoma
Toxoplasmosis of brain in a patient over one month of age
Cytomegalovirus disease (other than liver, spleen or nodes) in a patient over
one month of age
Encephalopathy, HIV-related
Progressive multifocal leukoencephalopathy
Non-EU/EEA
years or over)
Pneumonia, recurrent in an adult or an adolescent (aged 13 years or over)
Kaposis sarcoma
Candidiasis of bronchi, trachea or lungs
Herpes simplex: chronic ulcer(s) (>1 months duration); or bronchitis,
pneumonitis, or oesophagitis in a patient over one month of age
Men
N
Women
N
Total
N
907
410
368
21.2
9.6
8.6
255
164
88
18.1
11.6
6.2
1162
574
456
%
20.4
10.1
8.0
Children
N
4
1
4
%
13.3
3.3
13.3
321
7.5
123
8.7
444
7.8
3.3
305
172
171
7.1
4.0
4.0
33
102
95
2.3
7.2
6.7
338
274
266
5.9
4.8
4.7
0
0
0
0.0
0.0
0.0
181
4.2
68
4.8
249
4.4
10.0
144
84
3.4
2.0
60
34
4.3
2.4
204
118
3.6
2.1
6
0
20.0
0.0
455
23.7
129
16.2
584
21.5
15
14.7
277
245
150
100
68
61
35
27
14.4
12.7
7.8
5.2
3.5
3.2
1.8
1.4
117
122
43
46
28
28
7
14
14.7
15.3
5.4
5.8
3.5
3.5
0.9
1.8
394
367
193
146
96
89
42
41
14.5
13.5
7.1
5.4
3.5
3.3
1.5
1.5
19
13
0
7
2
2
0
12
18.6
12.7
0.0
6.9
2.0
2.0
0.0
11.8
21
1.1
17
2.1
38
1.4
2.0
Men
N
Women
N

Diseases
West
Kaposis sarcoma
years or over)
Cytomegalovirus disease (other than liver, spleen or nodes) in a patient over
one month of age
Progressive multifocal leukoencephalopathy
Centre
years or over)
Kaposis sarcoma
Lymphoma(s), not specified
East
years or over)
Herpes simplex: chronic ulcer(s) (>1 months duration); or bronchitis,
pneumonitis, or oesophagitis in a patient over one month of age
72
855
367
289
255
23.6
10.1
8
7
Total
N
Children
N
239
159
33
63
20.1
13.4
2.8
5.3
1094
526
322
318
22.7
10.9
6.7
6.6
4
0
0
1
26.7
0
0
6.7
210
5.8
94
7.9
304
6.3
158
145
4.4
4
83
90
7
7.6
241
235
5
4.9
0
0
0
0
170
4.7
63
5.3
233
4.8
13.3
129
74
3.6
2
50
28
4.2
2.4
179
102
3.7
2.1
5
0
33.3
0
142
18.1
37
16
179
17.7
15
95
12.1
19
8.2
114
11.2
87
64
26
22
33
26
20
18
11.1
8.2
3.3
2.8
4.2
3.3
2.6
2.3
14
13
10
12
0
6
4
5
6.1
5.6
4.3
5.2
0
2.6
1.7
2.2
101
77
36
34
33
32
24
23
10
7.6
3.6
3.4
3.3
3.2
2.4
2.3
0
2
0
1
0
0
1
0
0
10
0
5
0
0
5
0
471
26.3
139
17.7
610
23.7
15
15.5
248
224
152
65
61
58
37
23
13.9
12.5
8.5
3.6
3.4
3.2
2.1
1.3
105
114
48
48
26
29
18
13
13.3
14.5
6.1
6.1
3.3
3.7
2.3
1.7
353
338
200
113
87
87
55
36
13.7
13.1
7.8
4.4
3.4
3.4
2.1
1.4
19
12
0
7
2
2
12
0
19.6
12.4
0
7.2
2.1
2.1
12.4
0
18
15
1.9
33
1.3
2.1
SURVEILLANCE REPORT
Table25: Deaths among AIDS cases, by country and year of death (20042013) and cumulative totals in EU/EEA and
other countries of the WHO European Region
Area
EU/EEA
West
West
Centre
Centre
Centre
Centre
West
East
West
West
West
West
Centre
West
West
West
East
East
West
West
West
West
Centre
West
Centre
Centre
Centre
West
West
West
Country*
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Centre former
Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia***
West
San Marino
Centre Serbia****
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
Total non-EU/EEA
Geographical area
West
Centre
East
Year of diagnosis
2008
2009
2004
2005
2006
2007
47
46
10
2
2
4
31
15
425
211
26
13
1
8
917
23
10
0
1
36
14
66
349
224
3
2
1 196
17
302
4 001
60
47
12
3
7
11
27
12
400
153
49
6
0
8
852
34
5
0
1
41
15
65
294
234
0
2
1 157
19
357
3 871
39
33
8
6
4
6
19
18
331
161
38
6
1
8
816
40
9
0
7
33
6
43
235
202
4
0
1 015
8
314
3 410
56
33
6
2
3
11
20
11
243
160
42
10
0
6
819
47
15
0
1
36
1
61
217
172
3
2
993
6
314
3 290
34
25
9
7
0
14
3
8
230
115
31
4
0
3
762
58
20
0
0
36
3
71
203
158
0
5
824
308
2 931
0
0
11
22
59
3
1
0
7
20
78
3
3
0
15
21
138
5
6
0
22
43
141
1
2
1
31
43
146
0
2010
2011
2012
2013
Cumulative
total**
37
27
2
7
3
10
9
0
176
116
29
9
0
5
710
69
17
0
0
37
3
46
193
132
2
1
487
279
2 406
43
19
14
10
3
7
3
2
205
104
48
10
0
5
643
57
12
0
0
25
0
53
197
146
1
2
332
305
2 246
29
31
17
6
4
9
6
7
169
117
53
12
1
4
80
9
0
1
31
1
68
173
221
1
1
249
154
1 454
9
27
16
7
5
11
2
5
139
83
49
9
1
1
88
10
0
2
25
1
57
139
121
3
1
213
153
1 177
36
32
14
8
3
12
4
2
85
65
38
7
0
0
107
18
0
0
16
2
45
145
64
0
5
144
145
997
2 008
2 032
143
176
110
202
2 028
106
36 176
14 373
1 796
343
39
414
41 748
641
156
0
60
401
625
1 255
8 229
6 139
39
93
47 275
1 323
16 023
183 953
5
0
39
27
151
1
6
0
17
45
146
0
10
0
22
39
158
0
8
0
36
40
188
0
11
0
23
26
126
2
59
1
252
368
1 405
57
64
49
56
64
8
31
0
1
0
27
88
0
7
0
1 775
22
2 224
56
60
77
24
41
0
0
0
25
69
0
4
0
2 188
9
2 666
36
74
86
16
45
1
1
0
24
56
0
2
0
2 420
9
2 957
67
80
90
18
68
0
1
0
15
50
11
0
0
2 507
19
3 141
74
60
137
15
65
0
0
0
22
34
30
0
0
2 710
124
3 495
63
42
130
21
54
0
2
0
25
39
7
0
0
2 591
40
3 237
80
44
168
26
72
0
4
0
26
23
29
0
0
3 096
66
3 849
95
60
150
19
127
0
2
0
31
13
47
0
0
3 736
4 513
83
32
148
19
11
0
1
0
17
3
25
0
0
3 870
4 481
82
25
146
6
22
0
1
0
17
2
24
10
3 514
4 040
761
1 729
1 328
189
643
18
36
8
1 061
5 858
173
84
1
31 999
323
46 417
3 771
365
2 089
6 225
3 609
377
2 551
6 537
3 195
319
2 853
6 367
3 077
295
3 059
6 431
2 672
293
3 461
6 426
2 189
245
3 209
5 643
1 996
283
3 816
6 095
1 092
386
4 489
5 967
879
256
4 523
5 658
739
202
4 096
5 037
182 164
9 861
38 345
230 370
*
*** No official data were reported by Russia. Information about AIDS related deaths were published by the Federal Scientific and Methodological Center for
Prevention and Control of AIDS: 28 261 (cumulative as of 31 December 2013). Reference: HIV-infection bulletin number 39. Moscow: The Federal Service for
Surveillance of Consumer Rights Protection and human well-being; 2014
73
SURVEILLANCE REPORT
Table26: Deaths among AIDS cases*, by geographic area, transmission mode and year of death (20042013) and
cumulative totals

Transmission mode
EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total EU/EEA
Non-EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total non-EU/EEA
2004
Male
Female
2005
Male
Female
2006
Male
Female
2007
Male
Female
2008
Male
Female
2009
Male
Female
552
1 013
523
4
36
38
219
2 385
221
336
8
21
29
67
682
559
970
531
17
29
37
200
2 343
215
322
11
17
26
66
657
474
832
473
11
25
40
166
2 021
178
287
7
10
24
59
565
447
819
431
12
15
27
159
1 910
181
274
3
10
26
61
555
382
667
369
14
25
25
158
1 640
176
254
3
7
19
70
529
347
466
296
7
9
25
127
1 277
104
227
4
10
14
60
419
37
153
69
1
1
0
60
321
2 706
30
57
2
1
0
16
106
788
36
165
79
5
3
1
79
368
2 711
26
56
3
0
1
15
101
758
25
233
110
3
3
0
14
388
2 409
57
75
0
0
1
7
140
705
20
288
128
3
5
3
22
469
2 379
61
75
3
2
0
5
146
701
24
291
148
5
1
0
16
485
2 125
50
113
4
0
0
8
175
704
20
264
123
2
0
1
19
429
1 706
49
118
4
0
1
6
178
597

Transmission mode
West
Injecting drug use
Mother-to-child
Other/undetermined
Total West
Centre
Injecting drug use
Mother-to-child
Other/undetermined
Total Centre
East
2004
Male
Female
2005
Male
Female
2006
Male
Female
2007
Male
Female
2008
Male
Female
2009
Male
Female
549
993
501
4
21
0
172
2 240
220
337
5
9
0
26
597
562
934
501
12
14
0
156
2 179
208
304
12
6
1
28
559
474
793
455
6
20
0
128
1 876
172
279
4
4
2
34
495
434
755
441
7
9
0
125
1 771
177
261
3
6
1
33
481
368
598
348
12
16
1
108
1 451
166
244
3
6
1
39
459
328
412
274
4
5
2
94
1 119
97
219
3
6
1
34
360
28
41
63
1
16
38
50
237
8
36
3
13
29
39
128
28
42
66
7
18
37
55
253
9
41
0
11
25
38
124
23
33
66
7
8
40
44
221
6
34
3
6
22
27
98
30
40
51
5
10
27
40
203
8
24
0
6
25
29
92
29
38
54
3
10
24
48
206
8
27
1
1
18
32
87
35
29
42
4
4
23
37
174
6
25
2
4
13
22
72
12
Injecting drug use
132
23
159
24
239
57
312
57
322
52
289
50
101
28
20
43
33
62
49
67
64
115
96
103
Mother-to-child
Other/undetermined
57
18
68
15
16
18
15
10
Total East
*
**
74
229
63
279
75
312
112
405
128
468
158
413
165
2 706
788
2 711
758
2 409
705
2 379
701
2 125
704
1 706
597
Cases from Italy, Russia, Sweden, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period. Therefore, totals by transmission
mode, gender and overall may differ from totals presented in Table 25.
SURVEILLANCE REPORT
2010
Male
Female
2011
Male
Female
364
334
341
2
19
20
149
1 229
81
215
12
5
14
47
374
327
288
296
8
17
20
124
1 080
76
201
5
8
25
59
374
272
258
246
3
10
9
106
904
74
148
5
3
14
28
272
223
241
197
1
3
0
88
753
73
124
2
5
0
40
244
49 219
39 478
14 016
849
4 427
1 762
6 338
116 089
0
9 736
9 808
722
1 680
1 171
1 752
24 869
1
0
0
0
0
0
0
1
49 212
49 177
23 804
1 571
6 107
2 933
8 078
140 882
25
312
143
3
1
0
19
503
1 732
47
128
3
0
0
7
185
559
22
306
199
7
1
0
23
558
1 638
33
174
3
0
0
9
219
593
10
292
145
1
0
0
13
461
1 365
27
118
2
1
0
2
150
422
17
224
131
7
0
0
22
401
1 154
31
79
7
0
0
9
126
370
2 669
4 875
2 240
99
248
5
599
10 735
126 824
0
1 344
1 733
88
70
4
165
3 404
28 273
0
1
0
1
0
0
4
6
7
2 668
6 214
3 955
188
318
9
767
14 119
155 001
2010
Male
Female
Male
Cumulative total**
Female Unknown
Total
2010
Male
Female
2010
Male
Female
2012
Male
Female
2010
Male
Female
2013
Male
Female
Male
Cumulative total**
Female Unknown
Total
338
296
299
2
7
0
109
1 051
68
200
8
2
0
24
302
297
227
222
3
12
0
82
843
56
168
3
4
0
18
249
247
177
216
1
4
0
52
697
46
120
3
1
0
11
181
195
162
164
1
3
0
54
579
49
91
1
5
0
14
160
50 660
40 375
14 156
729
3 855
18
5 729
115 522
0
10 348
10 020
679
1 260
20
1 267
23 594
1
0
0
0
0
0
0
1
50 655
50 712
24 170
1 408
5 115
38
6 995
139 093
47
22
54
0
13
20
44
200
8
31
6
3
14
22
84
45
43
83
7
5
20
47
250
13
55
2
4
25
37
136
29
47
40
2
6
9
52
185
17
22
2
2
14
14
71
34
36
39
0
0
0
38
147
12
22
3
0
0
19
56
1 116
1 019
1 013
182
816
1 744
842
6 732
0
263
629
103
489
1 151
515
3 150
0
0
0
1
0
0
1
2
1 114
1 274
1 636
286
1 305
2 895
1 354
9 864
EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total EU/EEA
Non-EU/EEA
Injecting drug use
Mother-to-child
Other/undetermined
Total non-EU/EEA
Transmission mode
West
Injecting drug use
Mother-to-child
Other/undetermined
Total West
Centre
Injecting drug use
Mother-to-child
Other/undetermined
Total Centre
East
11
112
328
52
324
40
326
38
267
43
2 959
469
3 405 Injecting drug use
131
112
190
152
135
124
125
90
1 087
892
1 953 Heterosexual contact
37
28
15
18
13
15
18
16
366
135
481
173
545
208
483
170
428
154
4 570
1 529
1 732
559
1 638
593
1 365
422
1 154
370
126 824
28 273
111
Transmission mode
65 Mother-to-child
6 044 Total East
155 001 Total WHO European Region
75
SURVEILLANCE REPORT
Table27: Number of HIV tests performed, excluding unlinked anonymous testing and testing of blood donations, by
country and year (20042013) and number of tests per 1 000 population in 2013, in EU/EEA and other countries of the
WHO European Region
Area
Country*
EU/EEA
West
Austria
West
Belgium
Centre Bulgaria
Centre Croatia
Centre Cyprus
West
Denmark
East
Estonia
West
Finland
West
France
West
Germany
West
Greece**
Centre Hungary
West
Iceland
West
Ireland
West
Italy
East
Latvia
East
Lithuania
West
Luxembourg
West
Malta
West
Netherlands
West
Norway
Centre Poland
West
Portugal
Centre Romania
Centre Slovakia
Centre Slovenia
West
Spain
West
Sweden
West
United Kingdom
Non-EU/EEA
Centre Albania
West
Andorra
East
Armenia
East
Azerbaijan
East
Belarus
Yugoslav Republic
Centre former
of Macedonia, the
East
Georgia
West
Israel
East
Kazakhstan
East
Kyrgyzstan
East
Moldova
West
Monaco
Centre Montenegro
East
Russia
West
San Marino
Centre Serbia
West
Switzerland
East
Tajikistan
Centre Turkey
East
Turkmenistan
East
Ukraine
East
Uzbekistan
*
**
76
Number of HIV tests

2008
2009
2004
2005
2006
2007
698 099
593 054
110 000
27 926
38 796
322 267
130 915
59 474
144 613
5 060 329
2 277 000
9 629
109 992
9 001
84 054
59 822
14 794
6 194
187 606
126 738
220 734
94 173
22 014
-
667 825
591 193
110 000
26 085
38 708
330 233
143 671
61 249
142 427
5 433 719
9 169
70 512
9 397
85 538
58 424
13 975
6 197
193 075
136 040
917 117
188 279
103 718
24 522
-
659 693
578 717
105 000
26 124
37 763
317 823
154 332
65 861
147 601
5 169 523
9 840
80 168
9 106
85 117
52 988
14 339
10 309
188 550
159 180
191 223
93 426
25 624
-
777 935
595 394
160 000
32 698
41 913
344 874
141 880
68 478
153 478
5 146 481
17 374
65 980
9 351
63 000
79 279
60 333
13 379
11 957
176 728
220 226
88 520
31 120
-
751 749
619 418
110 000
38 996
42 294
342 223
124 935
74 357
186 822
5 043 124
33 558
83 408
9 522
72 444
162 381
13 366
181 118
282 248
66 926
31 183
-
2 862
1 460
14 415
202 271
449 479
15 755
3 700
1 884
39 469
237 027
440 675
10 834
3 098
3 077
50 221
237 183
441 299
20 904
1 686
3 546
55 342
293 086
437 983
16 858
4 983
7 526
11 172
10 574
2 458
60 701
322 525
430 175
-
24 311
203 537
529 164
144 927
160 978
3 376
17 909 234
4 893
27 021
50 721
1 207 258
121 398
1 521 282
446 317
26 026
234 835
621 261
162 075
185 922
3 594
17 744 347
4 723
35 083
72 114
1 881 750
153 090
1 555 511
515 972
16 989
242 484
862 058
179 407
216 566
3 988
18 535 043
5 061
37 829
91 310
1 908 257
136 145
1 661 600
545 240
16 989
269 071
1 491 190
186 643
347 709
3 838
3 976
42 573
92 474
1 998 163
211 789
1 937 440
619 130
18 792
271 641
1 643 938
268 134
355 711
4 229
3 825
44 555
129 330
5 045 319
2 280 442
796 371
Tests/1000
2013 population
2010
2011
2012
770 901
635 150
140 000
40 938
48 158
347 135
112 533
78 735
190 380
5 014 971
35 171
91 181
7 794
184 980
59 331
100 799
13 308
213 138
284 053
132 990
37 105
-
831 675
651 095
160 000
32 848
48 385
353 507
168 923
78 054
185 114
4 996 825
31 070
89 137
7 318
180 055
58 826
178 554
8 533
229 783
291 915
109 261
36 977
-
826 256
679 655
180 000
32 928
49 074
334 569
137 877
85 025
5 203 501
31 918
84 464
184 521
58 799
102 234
57 685
317 286
306 679
110 025
38 110
-
703 486
190 000
40 071
54 120
349 205
134 709
73 367
5 242 020
34 622
93 060
175 488
60 491
101 042
64 778
358 953
293 204
110 506
33 602
-
695 433
210 000
29 998
50 235
341 583
137 151
82 279
5 207 559
32 241
95 861
150 597
58 302
102 161
68 020
14522
302 898
114 574
33 457
-
62.3
28.8
7.1
58.9
32.5
24.5
62.3
79.4
2.9
9.7
32.8
28.8
34.4
126.7
34.5
15.1
21.2
16.3
-
2 143
2 810
60 103
340 048
459 032
-
2 168
2 678
60 731
353 772
517 625
20 793
-
3 260
2 590
68 449
365 090
621 780
-
3 140
2 062
71 957
514 434
683 125
-
3 063
2 310
83 431
482 282
770 136
-
1.1
30.3
25.5
51.5
81.4
-
17 811
18 105
24 562
11.9
17 562
25 370
278 887
286 995
1 758 026 1 786 289
325 855
297 959
204 702
207 018
5 812
6 492
- 25 209 546
4 181
5 090
47 734
51 727
214 207
280 281
2 347 084 2 319 946
987 464 1 506 724
21 799
274 294
1 897 476
381 295
207 830
6 914
3 961
56 086
438 532
2 392 970
-
15 562
233 516
2 026 174
470 355
212 964
6 781
3 845
64 031
447 636
2 343 099
-
18 091
2 127 136
370 160
146 105
6 970
4 004
65 829
514 701
2 064 019
-
4.1
129.4
66.7
35.9
11.2
119.3
9.2
62.7
45.5
-

HIV tests reported for Greece refer to only to those performed in reference centres and do not include all tests carried out in public hospitals or private
laboratories.
SURVEILLANCE REPORT
Figures
77
Map 1: HIV diagnoses per 100 000 population, 2013: All cases
<2
2 to < 10
10 to < 20
20
Missing or excluded data
Andorra
Liechtenstein
Luxembourg
Malta
Monaco
San Marino
78
SURVEILLANCE REPORT
SURVEILLANCE REPORT
Map 2: HIV diagnoses per 100 000 male population, 2013: Males
<2
2 to < 10
10 to < 20
20
Andorra
Liechtenstein
Luxembourg
Malta
Monaco
San Marino
Map 3: HIV diagnoses per 100 000 female population, 2013: Females
<2
2 to < 10
10 to < 20
20
Andorra
Liechtenstein
Luxembourg
Malta
Monaco
San Marino
79
Map 4: HIV diagnoses per 100 000 population, 2013: Heterosexual transmission
<1
1 to < 3
3 to < 5
5
Andorra
Liechtenstein
Luxembourg
Malta
Monaco
San Marino
Map 5: HIV diagnoses per 100 000 population, 2013: Injecting drug use
<1
1 to < 3
3 to < 5
5
Andorra
Liechtenstein
Luxembourg
Malta
Monaco
San Marino
80
SURVEILLANCE REPORT
SURVEILLANCE REPORT
Map 6: HIV diagnoses per 100 000 population, 2013: Sex between men
<1
1 to < 3
3 to < 5
5
Andorra
Liechtenstein
Luxembourg
Malta
Monaco
San Marino
Map 7: AIDS cases reported per 100 000 population, 2013

<1
1 to < 3
3 to < 5
5
Andorra
Liechtenstein
Luxembourg
Malta
Monaco
San Marino
81
SURVEILLANCE REPORT
Figure1: AIDS cases diagnosed, by transmission mode and geographical area, 20042013
West
4000
Sex between men
Injecting drug use
Number of cases
3000
Other/undetermined
2000
1000
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Cases from Sweden excluded due to inconsistent reporting during the period
Centre
400
Sex between men
Injecting drug use
Number of cases
300
Other/undetermined
200
100
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
East
1500
Sex between men
Number of cases
Injecting drug use

1000
Other/undetermined
500
0
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Cases from Russia, Turkmenistan and Uzbekistan excluded due to inconsistent reporting during the period
82
SURVEILLANCE REPORT
Annexes
83
SURVEILLANCE REPORT
Annex1: Framework for data collection,

validation and presentation
Since 2008, the European Centre for Disease Prevention
and Control (ECDC) and the World Health Organization
Regional Office for Europe (WHO Regional Office) have
carried out the enhanced surveillance of HIV/AIDS in
Europe. Both strive to ensure a high quality of standardised HIV/AIDS surveillance data from the 53 countries of
the WHO European Region, including the 28 countries of
the European Union (EU) and the three countries of the
European Economic Area (EEA) (in this report referred to
together as EU/EEA).
1 Reporting
In EU/EEA countries, the Member States Coordinating
Competent Bodies have nominated national operational contact points for HIV/AIDS surveillance to work
on reporting surveillance data to the joint ECDC/WHO
database for HIV/AIDS surveillance. For non-EU/EEA
countries, nominations for national HIV/AIDS surveillance focal points were received directly by the WHO
Regional Office via the respective ministries of health.
Data are submitted through a web-based platform to
a joint database of The European Surveillance System
(TESSy). Three types of data are collected: HIV (casebased and aggregate), AIDS (case-based and aggregate)
and number of HIV tests performed (aggregate). Data are
uploaded directly by the reporting country into the database. When uploading data, a built-in set of validation
rules ensures the verification of the data within the database. This verification of the data during the uploading
process improves the quality of the data and allows each
country to test their datasets prior to submission.
Liechtenstein, Russia, Turkmenistan and Uzbekistan did
not report any HIV or AIDS data for 2013. HIV data for
Russia were therefore obtained through publicly available sources and used to supplement the other countries
reported data to give a more complete presentation of
the epidemiology of HIV and AIDS in Europe.
Surveillance systems data sources

To describe the national source of data and specify the
national surveillance system from which the reported
data originate, the variable data source is included as a
compulsory part of reporting (Annexes 4 and 4a). Some
cross-country comparisons are hampered by differences
in surveillance systems as the quality and coverage of
national surveillance are not consistent. Particularly in
the early part of the period covered in this report (20042013), some countries did not have national HIV/AIDS
data and others established or substantially modified
the national reporting systems over the course of the
reporting period. These issues are detailed in Annex 5.
2 Data collection and validation

Data collection 2014
The 2013 data submission for HIV and AIDS surveillance
took place between 15 March and 15 September 2014.
Data presented in this report were extracted from the
joint database on 13 October 2014, although minor corrections were made during subsequent country reviews
of the draft report.
Individual country datasets

Data were uploaded, validated and approved in the
joint database for HIV/AIDS surveillance by the reporting countries. Once the data were submitted, individual
datasets were validated. Seventeen countries uploaded
datasets containing only 2013 data for HIV, whereas
the remainder uploaded data concerning longer periods. Two countries (Kazakhstan and Ukraine) reported
aggregated HIV data compared with four countries in
2012. Eighteen countries uploaded datasets containing
only 2013 data for AIDS. Ukraine reported aggregated
AIDS data for the years 2004 to 2013. All other countries
reported case-based AIDS data.
Reporting of aggregated HIV and AIDS data has an
impact on the data presentation and analysis and the
epidemiological overview of HIV/AIDS in Europe because
fewer variables are available from the aggregated datasets, hence reducing the amount of data that can be
presented in certain tables and figures.
3 Data re-coding and

adjustments
Dates used for data presentation
In this report the HIV and AIDS data are presented by
date of diagnosis. If countries could not provide this
date, the date of notification or date of statistics was
used instead.
Region of origin
When available, countries were encouraged to provide
data on the specific country of origin or nationality of
the case. This information was used first and, if absent,
the variable region of origin was used to group cases
into region of origin presented in Table 11 (stratified by
reporting country) and Table 12 (all countries stratified
by mode of transmission).
Origin of reported cases

Cases originating from countries with generalised
epidemics are at times separated from other cases,
namely in the category of heterosexual transmission.
85
This approach is taken to inform epidemiological understanding and to guide public health resource allocation
and prevention efforts. In order to compare the impact of
the epidemic on all transmission modes, cases reported
as originating from regions or countries of sub-Saharan
Africa were used as a proxy for cases originating from
countries with a generalised epidemic (in Tables 11, 12
and in selected Figures). As most of the cases originating from sub-Saharan Africa were reported from West
European countries within the EU/EEA, this information
is presented in detail in Chapter 1.
Reporting delay
Reporting delays refer to the time delay between HIV/
AIDS diagnosis (or death) and the report of this event at
national level, identified by date of notification. Due to
delays in reporting, HIV trends analysed at a European
level are often biased downwards for the most recent
year (2013) and, to a lesser extent for the 2-3 years prior
to the reporting period. Ideally, surveillance data should
be corrected to more accurately describe the trends in
HIV diagnoses.
SURVEILLANCE REPORT
In this report, we apply a statistical approach, as

described by Heisterkamp, et al [1] to adjust the surveillance data for reporting delays. Yearly reporting delay
probabilities were estimated using historical data from
2004 to 2013. Countries were excluded from reporting
delay adjustment:
1 when they showed an inconsistent and non-stationary
pattern in their reporting delay distribution during the
period 20042013,
2 when they reported aggregated data during the period
20042013, or
3 when the average number of diagnosed HIV cases per
year over the period 20042013 was lower than 50.
Adjusting for reporting delays is a valuable tool to indicate HIV trends more precisely, as well as in monitoring
the timeliness of data collection, an important aspect of
quality control.
Reporting delays were applied for the graphs representing trends for the EU/EEA and by transmission mode.
The list of countries with number of reported diagnoses
adjusted for reporting delay are presented in Annex 6.
FigureA1: Geographical/epidemiological division of the WHO European Region

West
Centre
East
Andorra
Luxembourg
Malta
Monaco
San Marino
The countries covered by the report are grouped as follows:
West, 23 countries: Andorra, Austria*, Belgium*, Denmark*, Finland*, France*, Germany*, Greece*, Iceland, Ireland*, Israel, Italy*, Luxembourg*,
Malta*, Monaco, Netherlands*, Norway, Portugal*, San Marino, Spain*, Sweden*, Switzerland, United Kingdom*.
Centre, 15 countries: Albania, Bosnia and Herzegovina, Bulgaria*, Croatia*, Cyprus*, Czech Republic*, Hungary*, the former Yugoslav Republic of
Macedonia, Montenegro, Poland*, Romania*, Serbia, Slovakia*, Slovenia*, Turkey.
East, 15 countries: Armenia, Azerbaijan, Belarus, Estonia*, Georgia, Kazakhstan, Kyrgyzstan, Latvia*, Lithuania*, Moldova, Russia, Tajikistan,
Turkmenistan, Ukraine, Uzbekistan.
* Countries which constitute the European Union as of 1 July 2014.
86
SURVEILLANCE REPORT
4 Data presentation
Geographical presentation
Data are presented for the WHO European Region and
the EU/EEA. The EU comprises 28 Member States and the
EEA comprises an additional three countries (Norway,
Iceland, Liechtenstein), of which Norway and Iceland are
included in the overview of the EU/EEA.
The tables are presented by EU/EEA countries, non-EU/
EEA countries, by individual countries and by totals. The
53 countries are also subdivided into three geographical areas based on epidemiological considerations and
in accordance with the division used in previous reports
on HIV/AIDS surveillance in Europe: West (23 countries),
Centre (15 countries) and East (15 countries) (see Figure
A1). The division reflects similarities in epidemiological dynamics such as epidemic levels, trends over time
and transmission patterns. In this report these geographical/epidemiological areas are referred to as by
geographical area. Of the EU/EEA countries, 19 Member
States are classified as being in the West, nine in the
Centre and three in the East Regions.
Population data and rates

Data are presented in absolute numbers and rates as
cases per 100 000 population.
The population estimates up to 2013 were derived
from Eurostat for all countries except the five central
Asian republics (Kazakhstan, Kyrgyzstan, Tajikistan,
Turkmenistan and Uzbekistan) and Israel, for which
Eurostat data were not available. United Nations (UN)
Population Division data were used for those countries
[2]. The Eurostat data are from 31 March 2014 (www.epp.
eurostat.ec.europa.eu) and are consistent with the UN
population data.
The population data used for HIV and AIDS for Spain and
for HIV for Italy were adjusted according to the extent of
sub-national coverage.
For data presented by gender, rates were calculated
using relevant male and female population denominators from the source described above.
Data are presented by year but also as cumulative totals
per country. The cumulative total includes all data
reported by that particular country since the beginning
of national reporting and is not limited to the selected
number of years presented.
For maps presenting figures for MSM, rates are calculated using the male population.
Trend data
For presentation of the overall trends, only countries
reporting consistently were included (e.g. data from
Russia, Turkmenistan and Uzbekistan were not included
in the presentation of HIV trends for 20042013).
Russia, Sweden, Turkmenistan and Uzbekistan were not
included in the presentation of AIDS trends.
When presenting HIV trends for 20042013 by transmission mode, countries reporting transmission mode
inconsistently or incompletely were excluded (e.g.
Estonia, Poland and Turkey) from Table 8 and relevant figures reporting trends by transmission mode.
Countries with varying geographic coverage of the
national surveillance system over time (Spain and Italy)
were also excluded from Tables 8 and 9 and from graphs
showing HIV trends.
When presenting AIDS death trends, only countries
reporting consistently were included (e.g. Italy, Sweden,
Ukraine, Uzbekistan were not included in the presentation of AIDS death trends in Table 26 or text description).
5 Data limitations
Surveillance systems are not identical across Europe,
and differences in data collection methods and testing
policies could impact the results and introduce bias in
comparisons between countries. Particularly, factors
such as underreporting and reporting delay may influence the country figures and rankings presented in the
report.
The data in the report are to be considered as provisional because they are subject to regular updates (e.g.
detection and deletion of duplicate cases, inclusion of
new information about cases already reported). The limitations described below need to be taken into account
when interpreting the data presented here.
Official reports of newly diagnosed cases of HIV do not
represent true incidence. Newly reported HIV diagnoses
include recently infected individuals as well as those
who were infected several years ago but only recently
tested for HIV. These reports are also influenced by
several factors such as the uptake of HIV testing, patterns of reporting, the long incubation period and a slow
progression of the disease. In order to better interpret
trends in HIV case reporting data, the total numbers of
HIV tests performed annually for diagnostic purposes
(excluding unlinked anonymous tests and screening of
blood donations) are presented to help provide some
background on HIV testing patterns.
Although the table in Annex 6 adjusts for reporting
delay for those countries where this is possible, no
adjustments are made for underreporting or underascertainment bias. Fewer than 40% of European
countries have evaluated their surveillance systems for
underreporting and only two have published the results
[4]. Previous estimates of underreporting range from
0% to 25% for AIDS cases [3], while national estimates
of underreporting for HIV can range from 10% (Iceland,
Italy) to around 40% (Germany, UK) [4, 5]. Estimates with
regard to the underreporting of AIDS-related deaths are
not available.
When interpreting the data presented in this report,
country-specific comments included in Annex 5 should
be considered and the following noted:
87
Data from Kosovo1 are not included in the tables, but

as footnotes to Tables 17 and 1521.
More detailed information regarding the country-specific HIV and AIDS case reporting systems is available
in Annexes 4 and 5.
References
1
Heisterkmap SH, Jager JC, Ruitenberg EJ, van Druten JAM, Downs
AM. Correcting Reported Aids Incidence: A statistical approach.
Statistics in Medicine, Vol. 8, 963-976 (1989).
United Nations, Department of Economic and Social A airs,

Population Division, World Population Prospects: The 2012
Revision. New York; 2013.
EuroHIV. Completeness of AIDS case reporting in Europe. HIV/AIDS

Surveillance in Europe, Quarterly Report 1996. Paris: Institut de
mdecine et dpidmiologie africaines; 1996. No.49:30-33.
EuroHIV. EuroHIV 2006 survey on HIV and AIDS surveillance in the

WHO European Region. Saint-Maurice: Institut de veille sanitaire;
2007.
Personal communication to ECDC. F. Cazein, 08/11/12.
1 This designation is without prejudice to positions on status, and is in

line with UNSCR 1244 and the IJ Opinion on the Kosovo Declaration
of Independence.
88
SURVEILLANCE REPORT
SURVEILLANCE REPORT
Annex2
List of variables* for the 2013 HIV/AIDS data collection
HIV case-based
AIDS case-based
HIV aggregated
AIDS aggregated
HIV tests (aggregated)
1. RecordID
1. RecordID
1. RecordType
1. RecordType
1. RecordType
2. RecordType
2. RecordType
2. RecordTypeVersion
3. Subject
3. Subject
3. Subject
4. Subject
4. Subject
4. DataSource
4. DataSource
4. DataSource
5. Status
5. Status
5. AgeClass
5. AgeClass
5. DateUsedForStatistics
6. DataSource
6. DataSource
6. Gender
6. Gender
6. ReportingCountry
7. ReportingCountry
7. ReportingCountry
7. ReportingCountry
7. ReportingCountry
7. NumberOfTests
8. DateUsedForStatistics*
9. Age
7. Age
7. Classification
7. Classification
10. Gender
8. Gender
8. Number of cases
8. Number of cases
11. Outcome
9. Outcome
12. DateOfOnset
10. DateOfOnset
13. DateOfDiagnosis
11. DateOfDiagnosis
14. DateOfNotification
12. DateOfNotification
15. Classification
15. Classification
16. ClinicalCriteria
16. ClinicalCriteria
17. LaboratoryResult
17. LaboratoryResult
18. EpiLinked
18. EpiLinked
11. Transmission
11. Transmission
Common set of variables
Disease-specific set of variables

19. HIVType
19. HIVType
20. Stage
20. ARTTreatment
21. Transmission
21. Transmission
22. TransmissionHetero
22. TransmissionHetero
23. TransmissionMTCT
23. TransmissionMTCT
24. HIVStatus
24. DateOfHIVDiagnosis
25. DateOfAIDSDiagnosis
25. DateOfDeath
26. DateOfDeath
26. DateOfReportDeath
27. CountryOfBirth
27. CountryOfBirth
28. CountryOfNationality
28. CountryOfNationality
29. RegionOfOrigin
29. RegionOfOrigin
30. CD4Cells
30. AIDSIndicatorDisease
31. ProbableCountryOfInfection
31. AgeClass
* Additional optional variables PlaceOfNotification and PlaceOfResidence were added from TESSy metadataset 20 for all diseases.
89
SURVEILLANCE REPORT
Annex3
Completeness of variables for data reported in 2012 and 2013
HIV dataset
HIV dataset
Age
Gender
Outcome
Date of onset
Date of diagnosis
Date of notification
Date used for statistics
HIV type
Stage
Transmission
Transmission/hetero
Transmission/MTCT
HIV status
Date of AIDS diagnosis
Date of death
Country of birth
Country of nationality
Region of origin
CD4 cell count
Probable country of infection
AIDS dataset
Age
Gender
Outcome
Date of onset
Date of diagnosis
Date of notification
Date used for statistics
HIV type
ART treatment
Transmission
Transmission/hetero
Transmission/MTCT
Date of HIV
Date of death
Date of reported death
Country of birth
Country of nationality
Region of origin
AIDS indicator disease
90
Number of
countries
2012
Completeness
%
Minimal
Maximal
Number of
countries
2013
Completeness
%
Minimal
Maximal
49
49
40
16
49
41
49
46
44
49
49
49
46
43
40
46
45
46
33
38
99.8
99.6
33.0
4.1
100.0
47.1
100.0
67.8
39.4
88.2
70.8
87.9
67.8
37.7
33.0
67.8
62.1
67.8
38.3
54.6
80.0
91.3
0.2
0.4
100.0
15.6
100.0
67.8
5.9
21.1
20.0
21.1
67.8
5.9
0.9
67.8
4.7
67.8
1.2
10.0
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
98.3
100
48
48
41
19
48
41
48
46
45
48
48
48
46
45
41
46
45
46
35
37
99.8
99.6
33.0
3.7
100.0
43.7
100.0
64.6
35.1
87.0
65.8
86.7
64.6
33.7
33.0
64.2
58.4
64.6
35.1
51.1
83.3
85.8
0.2
0.3
100.0
19.1
100.0
64.6
3.4
9.1
34.9
9.1
64.6
3.4
0.5
64.2
58.4
64.6
7.5
41.7
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
97.7
100
46
46
44
11
46
45
46
46
45
46
46
46
43
43
42
46
45
46
46
100.0
100.0
70.2
7.0
100.0
99.3
100.0
100.0
94.7
90.4
90.5
90.4
95.2
69.2
67.7
100.0
99.5
100.0
100.0
83.3
99.7
6.3
0.2
100.0
3.6
100.0
100.0
94.7
48.4
48.4
48.4
28.1
6.3
6.3
98.7
99.5
100.0
100.0
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
46
46
45
11
46
45
46
46
45
45
46
45
44
45
45
46
45
46
46
99.9
100.0
75.9
8.4
100.0
99.3
100.0
100.0
95.0
89.3
89.3
89.3
97.1
75.0
74.4
100.0
99.4
100.0
100.0
70.0
99.5
3.7
2.9
100.0
5.9
100.0
100.0
95.0
57.0
57.0
57.0
55.3
3.7
3.7
100.0
99.4
100.0
100.0
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
SURVEILLANCE REPORT
Annex4a
HIV surveillance system overview: data source information
Country
EU/EEA
Austria
Belgium
Bulgaria
Cyprus
Croatia
Czech Republic
Denmark
Estonia
Estonia
Finland
France
Germany
Germany
Greece
Hungary
Iceland
Ireland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Sweden
United Kingdom
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Georgia
Israel
Kazakhstan
Kyrgyzstan
Kyrgyzstan
Moldova, Republic of
Montenegro
Monaco
Russia
San Marino
Serbia
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
Data source
Type
Period
Legal
Coverage
AT-HIV
BE-HIV/AIDS
BG-HIV
CY-HIV/AIDS
HR-CNIPH
CZ-HIV/AIDS
DK-HIV
EE-HIV
EE-NAKIS
FI-NIDR
FR-MNOID-HIV
DE-HIV-Pre-IfSG
DE-SURVNET@RKI7.3-HIV
GR-NOTIFIABLE_DISEASES
HU-HIV/AIDS
IS-SUBJECT_TO_REGISTRATION
IE-HIV/AIDS
IE-CIDR
IT-COA-ISS
LV-HIV/AIDS
LT-AIDS_CENTRE
LU-HIV
MT-DISEASE_SURVEILLANCE
NL-HIV/AIDS
NO-MSIS_B
PL-HIV
PT-HIV/AIDS
RO-RSS
SK-EPIS
SI-HIVSUR-HIV
ES-HIV
SE-SweHIVReg
SE-SmiNet
UK-HIV
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
19792013
19802013
19862013
19862013
19852013
19852013
19902013
19882012
2013
19802013
20032013
19932001
20012013
19812013
19852013
19832013
19812011
20122013
20042013
19872013
19882013
19802013
19862013
19802013
19802013
19852013
19832013
19872013
19852013
19852013
20032013
19832009
20102013
19812013
V
V
C
C
C
C
C
C
C
C
C
C
C
C
C
C
V
C
C
C
C
V
C
V
C
C
C
C
C
C
C
C
C
V
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
AL-NIoPH
AD-MoHWFH
AM-NAC
AZ-AIDS-CENTER
BY-NAC
BA-FMoH-MoHSWRS
MK-NHASS
GE-IDACIRC
IL-MOH
KZ-RCfAPC
KG-RCfAPC-GEN
KG-HIV KG 2008
MD-NAC
MD-NAC
MD-NAC-NCfPC-GEN
ME-IOPH
MC-MoSH-GEN
RU-MOH
SM-AIDS/HIV
RS-NAC
RS-Kosova NIPH
CH-FOPH
TJ-RHAC
TR-MOH
TM-NAC
UA-NAC
UZ-RAC
C
C
C
C
C
C
C
C
C
A
C
C
A
C
C
C
C
A
A
C
C
C
C
C
C
A
C
19932013
20042013
19882013
19872013
19812013
19862013
19872013
19892013
19802013
19872013
19872007
20082013
19872006
20122013
20082011
19892013
19852013
20102010
19852013
19842013
20002013
19852013
19912013
19842013
19812012
19872013
19812010
C
V
V
V
C
C
C
C
C
NS/unk
V
V
V
NS/unk
C
C
C
C
C
C
C
C
C
V
V
V
Co
Co
Co
Se
Co
Co
Co
Co
Co
NS/unk
Co
Other
Other
NS/unk
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Other
Co
Type: aggregated (A), case-based (C )

Legal: voluntary reporting (V), compulsory reporting (C ), not specified/unknown (NS/unk)
Coverage: sentinel system (Se), comprehensive (Co), not specified/unknown (NS/unk)
91
SURVEILLANCE REPORT
Annex4b
AIDS surveillance system overview: data source information
Country
EU/EEA
Austria
Belgium
Bulgaria
Cyprus
Croatia
Czech Republic
Denmark
Estonia
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Georgia
Israel
Kazakhstan
Kyrgyzstan
Kyrgyzstan
Monaco
Montenegro
Russia
San Marino
Serbia
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Turkmenistan
Ukraine
Uzbekistan
Data source
Type
Period
Legal
Coverage
AT-AIDS
BE-HIV/AIDS
BG-AIDS
CY-HIV/AIDS
HR-CNIPH
CZ-HIV/AIDS
DK-MIS
EE-AIDS
EE-NAKIS
FI-NIDR
FR-AIDS
DE-AIDS
GR-NOTIFIABLE_DISEASES
HU-HIV/AIDS
IS-SUBJECT_TO_REGISTRATION
IE-HIV/AIDS
IE-CIDR
IT-COA-ISS
LV-AIDS
LT-AIDS_CENTRE
LU-AIDS
MT-DISEASE_SURVEILLANCE
NL-HIV/AIDS
NO-MSIS_A
PL-AIDS
PT-HIV/AIDS
RO-RSS
SK-EPIS
SI-HIVSUR
ES-AIDS
SE-SweHIVReg
UK-AIDS
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
19792013
19782013
19872013
19862013
19852013
19852013
19802013
19882012
2013
19802013
19782013
19702013
19812013
19852013
19832013
19812011
20122013
19822013
19902013
19882013
19802013
19862013
19832013
19802013
19852013
19832013
19852013
19852013
19852013
19812013
19822007
19802013
V
V
C
C
C
C
C
C
C
C
C
V
C
C
C
V
V
C
C
C
V
C
V
C
C
C
C
C
C
C
C
V
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
AL-NIoPH
AD-MoHWFH
AM-NAC
AZ-AIDS-CENTER
BY-NAC
BA-FMoH-MoHSWRS
MK-NHASS
GE-IDACIRC
IL-MOH
KZ-RCfAPC
KG-RCfAPC-GEN
KG-HIV KG 2008
MD-NAC
MD-NAC-NCfPC-GEN
MD-NAC
MC-MoSH-GEN
ME-IOPH
SM-AIDS/HIV
RS-NAC
RS-Kosova NIPH
CH-FOPH
TJ-RHAC
TR-MOH
TM-NAC
TM-NAC
UA-NAC
UZ-RAC
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
19932013
20042013
19882013
19872013
19912013
19862013
19872013
19892013
19802013
19932013
19872007
20082013
19892007
20082011
20122013
19852013
19902013
19852013
19852013
19862013
19802013
19982013
19842013
19812006
20082012
19882013
19922010
C
V
V
V
C
C
C
C
C
NS
V
NS
V
NS
V
C
C
C
C
C
C
C
C
V
V
V
V
Co
Co
Co
Se
Co
Co
Co
Co
Co
NS
Co
NS
Co
NS
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Co
Type: aggregated (A), case-based (C )

Legal: voluntary reporting (V), compulsory reporting (C ), not specified/unknown (NS/unk)
Coverage: sentinel system (Se), comprehensive (Co), not specified/unknown (NS/unk)
92
SURVEILLANCE REPORT
Annex5
Country-specific comments regarding national HIV and AIDS reporting
Country
Comments
EU/EEA
Bulgaria
Case-based reporting of HIV is available from 2007 onwards.
Czech Republic
Foreigners with short-time stays in the Czech Republic are not included in reported data.
Estonia
Surveillance system was substantially modified in 2008. Previously, the probable mode of HIV transmission was not reported by Estonia (from
2003 to 2007 Estonia supplied partial information on PWID only).
France
Case-based data reported through TESSy are not exhaustive, because of reporting delays (cases reported several months or several years after
the diagnosis) but also because of underreporting (cases that are diagnosed but never reported). The most recent estimates of underreporting
are 41% in 20072009 for AIDS and 29% in 2013 for HIV in France. To assess the real the number of HIV and AIDS diagnoses in France it is
essential to use adjusted data, which take into account both reporting delays (for 20122013) and underreporting (for 20032013). Adjusting
for these factors, the estimated number of new HIV diagnoses in 2013 is 6220 95%CI [5759-6682] and estimated number of new AIDS diagnoses
is 1212 95% CI [1092-1333].
Ireland
HIV was made a notifiable disease in September 2011. HIV reporting system was modified substantially in 2012. AIDS cases and deaths among
AIDS cases are now only reported if at the time of HIV diagnosis.
Italy
New HIV diagnoses were reported by 10 of the 22 Italian regions between 2004 and 2006, 11 regions in 2007, 12 regions in 2008, 18 regions in
2009, and all of the 22 regions of Italy for 2012 and 2013. Between 2004 and 2011, population denominators are based on the annual resident
population in the regions reporting cases. From 2012 the coverage of the surveillance system is national and, thus, the total Italian population
is used as a denominator. AIDS deaths for years 2011, 2012, 2013 are not reported due to lack of updated data from the national mortality
register.
Liechtenstein
Liechtenstein with only 35 000 inhabitants has small numbers of communicable diseases. Therefore public health authorities refrain
from collecting data due to limited public health added value. In 1970 Liechtenstein adopted the Swiss Law of Epidemiology. Since then all
communicable disease data are reported to the officials in Switzerland as demanded by the Federal Office of Public Health.
Luxembourg
HIV tests reported up to 2010 include only tests performed at two major public laboratories and, thus, underestimate the total number of HIV
tests performed during those years. From 2011, tests reported include all laboratories in the country.
Malta
New HIV reporting system started in 2004.
Netherlands
New HIV reporting system started in 2002; 2002 data include many cases diagnosed in previous years. Data prior to 2002 are from a national
cohort of HIV-positive adults receiving antiretroviral therapy; 1999 data include many cases diagnosed in previous years.
Portugal
PT-HIV database is now fully case-based containing details of cases diagnosed from 1983. In 2013, the Portuguese HIV/AIDS Programme
implemented a strategy to address underreporting and reporting delay, resulting in significant increases in the number of reported cases
which were diagnosed between 1983 and 2012 which are reflected in the present report.
Romania
New HIV diagnoses who have AIDS are reported only in in the AIDS database and AIDS tables. The total number of new HIV diagnoses for
Romania is a sum of the HIV and AIDS case reports for any given year. Data on AIDS deaths for 2013 are not complete and will be updated in
future reporting years.
Spain
HIV reporting has existed since the 1980s in some of the 19 Autonomous Regions of Spain. For 200311 data are available only for 9 Regions:
Asturias, Balearic Islands, Basque Country, Canary Islands, Catalonia, Ceuta, Extremadura, La Rioja, and Navarre; since 2004, data are
available for 10 Regions (+ Galicia); since 2007, data are available for 11 Regions (+Madrid); since 2008, data are available for 14 Regions (+
Aragn, Castilla-La Mancha and Melilla); since 2009, data are available for 17 Regions (+ Cantabria, Castilla-Len and Murcia); since 2012
data are available for 18 Regions (+Valencia). Since 2013 data are available for all the 19 Regions of Spain (+ Andaluca). Rates based on the
corresponding populations for each year.
AIDS reporting, 2013: for technical reasons, it has not been possible to include data from one region. Rates in 2013 are based on the
corresponding population.
Sweden
Due to changes in the HIV/AIDS surveillance system, AIDS reporting has not been mandatory since 2000. Since 2008, no AIDS data are
reported from Sweden because the national AIDS surveillance system has been discontinued.
Non-EU/EEA
Andorra
New HIV reporting system started in 2004; 2004 data include many cases diagnosed in previous years.
Moldova
Official data on incidence rates in the Republic of Moldova may vary from these ones, given that the incidence rate in Moldova is reported for
both banks of the Dniester River, while the denominator is not inclusive of the left bank of the river (Transnistrian region).
Serbia
Updated information from national statistics for two AIDS diagnoses was reported as date of diagnosis in 2008 instead of 2009.
Ukraine
HIV cases in persons infected through mother-to-child transmission are not available for the years before 2005 while data for 20052007 are
calculated from best available data, 20082011 data are validated and final, and data for 2012 and 2013 are operational and may be adjusted
in the coming few years.
93
SURVEILLANCE REPORT
Annex6
HIV diagnoses and rate per 100 000 population, adjusted for reporting delay and adjustment coefficients*, EU/EEA
countries, 20102013
Country**
EU/EEA
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France***
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Total EU/EEA
2010
N
321
1 199
163
54
41
156
275
376
185
6 240
2 723
634
182
24
330
3 980
274
153
52
18
1 209
258
956
1 824
274
35
35
3 666
473
6 476
32 586
Rate
3.8
11.1
2.2
1.2
5.0
1.5
5.0
28.2
3.5
9.7
3.3
5.7
1.8
7.6
7.3
6.7
12.9
4.9
10.4
4.3
7.3
5.3
2.5
17.5
1.4
1.7
1.7
11.2
5.1
10.4
6.6
2011
N
314
1 183
201
70
54
180
266
366
173
6 085
2 702
960
162
23
327
3 838
299
166
52
21
1 162
269
1 150
1 613
427
55
55
3 390
411
6 392
32 366
Rate
3.7
10.8
2.7
1.6
6.4
1.7
4.8
27.5
3.2
9.3
3.3
8.6
1.7
7.2
7.2
6.5
14.4
5.4
10.2
5.1
7.0
5.5
3.0
15.7
2.1
2.7
2.7
10.3
4.4
10.2
6.5
2012
N
320
1 229
157
77
58
153
201
315
158
6 217
2 975
1 167
219
19
351
4 098
339
160
58
30
1 093
242
1 153
1 542
489
45
45
3 611
410
6 554
33 485
Rate
3.8
11.1
2.1
1.8
6.7
1.5
3.6
23.8
2.9
9.5
3.6
10.5
2.2
5.9
7.7
6.9
16.6
5.3
11.1
7.2
6.5
4.9
3.0
14.7
2.4
2.2
2.2
9.5
4.3
10.3
6.7
2013
N
260
1 115
200
74
54
212
233
325
160
6 220
3 263
910
240
11
332
3 608
340
177
53
36
1 078
233
1 279
1 289
507
44
46
3 278
406
5 994
31 977
Rate
2010
3.1
10.0
2.7
1.7
6.2
2.0
4.2
24.6
2.9
9.4
4.0
8.2
2.4
3.4
7.2
6.0
16.8
6.0
9.9
8.5
6.4
4.6
3.3
12.3
2.5
2.1
2.2
7.0
4.2
9.4
6.2
0
0
0
0
0
0
0
0
<0.01
<0.01
0
<0.01
0
0
0
0
0
0
0
0
<0.01
0
0.01
0.02
0
0
0
0
0.01
0.01
<0.01
Adjustment coefficients*
2011
2012
*
The coefficients present the adjustments for the current year of reporting
** Country-specific comments are in Annex5
*** French data are adjusted for both reporting delay and underreporting. Adjustment coefficients reported are for reporting delay only.
94
0
0
0
0
0
0
0
0
<0.01
<0.01
0
<0.01
0
0
0
0
0
0
0
0
0.02
0
0.01
0.06
0
0
0
0
0.02
0.02
0.01
0
0
0
0
0
0
0
0
<0.01
0.01
0
0.01
0
0
0
0
0
0
0
0
0.02
0
0.02
0.05
0
0
0
0
0.02
0.03
0.02
2013
0
0
0
0
0
0
0.1
0
0.04
0.26
0
0.08
0
0
0
0
0
0
0
0
0.15
0.15
0.17
0.18
0
0
0.1
0
0.06
0.35
0.07
SURVEILLANCE REPORT
Annex7
HIV/AIDS surveillance in Europe: participating countries and national institutions
Country
EU/EEA
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Non-EU/EEA
Albania
Andorra
Armenia
Azerbaijan
Belarus
Macedonia
Georgia
Israel
Kazakhstan
Kyrgyzstan
Moldova
Monaco
Montenegro
Russia
San Marino
Serbia
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
Uzbekistan
National institutions
Federal Ministry of Health, Family and Youth
Scientific Institute of Public Health
Ministry of Health
Croatian National Institute of Public Health
Ministry of Health
National Institute of Public Health
Statens Serum Institut
Health Board
National Public Health Institute (KTL)
Institut de veille sanitaire
Robert Koch Institute
Hellenic Center for Disease Control and Prevention
National Center for Epidemiology (Orszgos Epidemiolgiai Kzpont)
Health Protection Agency Centre for Infections
Health Protection Surveillance Centre (HPSC)
Ministry of Health DG Prevention - Unit V
Centre for Disease Prevention and Control of Latvia
Center for Communicable Diseases and AIDS
National Service of Infectious Diseases, Centre Hospitalier
Department of Health Promotion and Disease Prevention
National Institute for Public Health and the Environment (RIVM)
Norwegian Institute of Public Health Department of Infectious Disease Epidemiology
National Institute of Public Health National Institute of Hygiene (NIZP-PZH)
National Institute of Health Dr Ricardo Jorge (Instituto Nacional de Sade Doutor Ricardo Jorge, I.P.)
Institute of Public Health and National Institute for Infectious Diseases "Prof. Dr. Matei Bals"
Regional Public Health Authority of capital Bratislava
National Institute of Public Health
Instituto de Salud Carlos III Centro Nacional de Epidemiologia
Swedish Institute for Infectious Disease Control
Public Health England
Institute of Public Health
Ministry of Health and Welfare
National Center for AIDS Prevention
National AIDS Center
National Centre for Hygiene, Epidemiology and Public Health
Ministry of Health of Federation of Bosnia and Herzegovina; Public Health Institute of the Republika Srpska
Public Health Institute
Infectious Diseases, AIDS & Clinical Immunology Research Center-IDACIRC
Ministry of Health
State Committee for Sanitary Epidemiological Surveillance
Republican AIDS Centre
National Center for Public Health; Hospital for Dermatology and Communicable Diseases
Ministry of Health and Social Affairs
Institute of Public Health of Montenegro
Federal Scientific and Methodological Center for Prevention and Control of AIDS
Ospedale di Stato
Institute of Public Health of Serbia
Bundesamt fr Gesundheit
Republican HIV/AIDS Center
Ministry of Health
National AIDS Prevention Center
National AIDS Center
Republican Center to fight AIDS
95
HOW TO OBTAIN EU PUBLICATIONS

Free publications:
one copy:
via EU Bookshop (http://bookshop.europa.eu);
more than one copy or posters/maps:
from the European Unions representations (http://ec.europa.eu/represent_en.htm);
from the delegations in non-EU countries (http://eeas.europa.eu/delegations/index_en.htm);
by contacting the Europe Direct service (http://europa.eu/europedirect/index_en.htm) or
calling 00 800 6 7 8 9 10 11 (freephone number from anywhere in the EU) (*).
(*) The information given is free, as are most calls (though some operators, phone boxes or hotels may charge you).
Priced publications:
via EU Bookshop (http://bookshop.europa.eu).
Priced subscriptions:
via one of the sales agents of the Publications Office of the European Union
(http://publications.europa.eu/others/agents/index_en.htm).
TQ-AL-14-001-EN-N
European Centre for Disease

Prevention and Control (ECDC)
Postal address:
ECDC, SE-171 83 Stockholm, SWEDEN
Visiting address:
Tomtebodavgen 11a, Solna, SWEDEN
Tel. +46 858601000
Fax +46 858601001
http://www.ecdc.europa.eu
An agency of the European Union
http://www.europa.eu

1hiv Aids Surveillance Report Europe 2013

Enviado por

Dados do documento

Direitos autorais

Formatos disponíveis

Compartilhar este documento

Compartilhar ou incorporar documento

Opções de compartilhamento

Você considera este documento útil?

Este conteúdo é inapropriado?

Direitos autorais:

Formatos disponíveis

1hiv Aids Surveillance Report Europe 2013

Enviado por

Direitos autorais:

Formatos disponíveis

SURVEILLANCE REPORT

HIV/AIDS surveillance in Europe

HIV/AIDS surveillance in Europe

HIV/AIDS surveillance in Europe 2013

Suggested citation for full report:

The European Centre for Disease Prevention and

HIV/AIDS surveillance in Europe 2013

2 HIV and AIDS in the WHO European Region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9

HIV/AIDS surveillance in Europe 2013

Table12a: EU/EEA and non-EU/EEA countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46

Table26a: EU/EEA and non-EU/EEA countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .74

FigureC: Male-to-female ratio in HIV diagnoses, by country, EU/EEA, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

HIV/AIDS surveillance in Europe 2013

HIV/AIDS surveillance in Europe 2013

Overview of HIV and AIDS in Europe

1 No data available from Uzbekistan or Turkmenistan.

decline in the West and the EU/EEA, it has tripled in the

European Union and European

WHO European Region*

HIV/AIDS surveillance in Europe 2013

among MSM in countries with consistent reporting have

EEA, the number of AIDS cases has consistently declined

WHO European Region

4 No data available from Sweden.

6 No data available from Uzbekistan or Turkmenistan.

Cases per 100 000 population

Rates may increase in the coming years due to reporting delays

HIV/AIDS surveillance in Europe 2013

reported among 1524 year-olds. The male-to-female

(Russia excluded), the regional rate increased by 16%,

7 Data from Turkmenistan and Uzbekistan not included.

Number of cases (100 000s)

Other countries of the WHO European Region

HIV/AIDS surveillance in Europe 2013

outbreak in Romania that started in 2011 and peaked in

indicates a delay in HIV testing with nearly half of cases

HIV/AIDS surveillance in Europe 2013

For the countries in the East, there is a need to scale

Federal Scientic and Methodological Center for Prevention and

World Health Organization. Consolidated guidelines on the use

Hedrich D, Kalamara E, Sfetcu O, Pharris A, Noor A, Wiessing L, et

UNAIDS. Ambitious treatment targets: Writing the nal

HIV/AIDS surveillance in Europe 2013

HIV/AIDS surveillance in Europe 2013

HIV/AIDS surveillance in Europe 2013

FigureA: - 100 000 ,

HIV/AIDS surveillance in Europe 2013

HIV/AIDS surveillance in Europe 2013

427% ( 166 875)

HIV/AIDS surveillance in Europe 2013

HIV/AIDS surveillance in Europe 2013

Hedrich D, Kalamara E, Sfetcu O, Pharris A, Noor A, Wiessing L, et

HIV/AIDS surveillance in Europe 2013

Acquired immunodeficiency syndrome

European Centre for Disease Prevention and Control

European Economic Area

Human immunodeficiency virus

International Court of Justice

Injecting drug use

Men who have sex with men

People who inject drugs

The European Surveillance System

UNAIDS Joint United Nations Programme on HIV/AIDS

United Nations Security Council Resolution